0001079973-15-000654.txt : 20151116 0001079973-15-000654.hdr.sgml : 20151116 20151116104620 ACCESSION NUMBER: 0001079973-15-000654 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProtoKinetix, Inc. CENTRAL INDEX KEY: 0001128189 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943355026 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-32917 FILM NUMBER: 151232394 BUSINESS ADDRESS: STREET 1: 9176 SOUTH PLEASANTS HIGHWAY CITY: ST. MARYS STATE: WV ZIP: 26170 BUSINESS PHONE: 604-926-6627 MAIL ADDRESS: STREET 1: 9176 SOUTH PLEASANTS HIGHWAY CITY: ST. MARYS STATE: WV ZIP: 26170 FORMER COMPANY: FORMER CONFORMED NAME: RJV NETWORK INC DATE OF NAME CHANGE: 20010130 10-Q 1 pktx_10q-093015.htm FORM 10-Q FOR THE PERIOD ENDED 9/30/2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to ___________________.

Commission file number:

PROTOKINETIX, INCORPORATED

(Exact name of registrant as specified in its charter)

Nevada		94-3355026
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

9176 South Pleasants Highway

St. Marys, West Virginia 26170

(Address of principal executive offices)

304-299-5070

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this Chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐
Non-accelerated filer ☐	(Do not check if a smaller reporting company)	Smaller reporting company ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 13, 2015, there were 207,939,933 shares of ProtoKinetix, Incorporated that were issued and outstanding.

PROTOKINETIX, INCORPORATED

TABLE OF CONTENTS

PART I

FINANCIAL INFORMATION

Item 1. Financial Statements

Unaudited Condensed Consolidated Balance Sheets	3

Unaudited Condensed Consolidated Statements of Operations	4

Unaudited Condensed Consolidated Statement of Stockholders' Equity (Deficiency)	5

Unaudited Condensed Consolidated Statements of Cash Flows	6

Notes to Unaudited Condensed Consolidated Financial Statements	7

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	19

Item 3. Quantitative and Qualitative Disclosures About Market Risk	23

Item 4. Controls and Procedures	24

PART II

OTHER INFORMATION

Item 1. Legal Proceedings	25

Item 1A. Risk Factors	25

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	25

Item 3. Defaults Upon Senior Securities	26

Item 4. Mine Safety Disclosure	26

Item 5. Other Information	26

Item 6. Exhibits	27

Signatures	28

PROTOKINETIX, INC.

(A Development Stage Company)

BALANCE SHEETS

(Unaudited)

	September 30, 2015			December 31, 2014

ASSETS
Current Assets
Cash	$	163,526		$	317
Accounts receivable (Note 4)		7,983			5,497
Prepaid expenses and deposits		637			-
Total current assets		172,146			5,814

Intangible assets (Note 5)		65,000			-

Total assets	$	237,146		$	5,814
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)
Current Liabilities
Accounts payable and accrued liabilities	$	79,178		$	270,893
Short-term loans (Note 6)		-			63,250
Convertible note payable (Note 7)		-			100,000
Total current liabilities		79,178			434,143
Stockholders' Equity (Deficiency)
Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 206,502,433 and 175,662,433 shares issued and outstanding as at September 30, 2015 and December 31, 2014 respectively (Note 11)	$	1,103			939
Common stock issuable; nil and 3,840,000 shares as at September 30, 2015 and December 31, 2014 (Note 11)		-			20
Stock subscription received in advance (Note 11)		-			25,000
Common stock to be returned to treasury (Note 11)		-			(25,000	)
Additional paid-in capital		26,777,414			25,411,550
Accumulated deficit		(26,620,549	)		(25,840,838	)
Total stockholders' equity (deficiency)		157,968			(428,329	)
Total liabilities and stockholders' equity (deficiency)	$	237,146		$	5,814

Basis of Presentation – Going Concern Uncertainties (Note 1)

Commitments and Contingency (Note 13)

Subsequent Events (Note 14)

See Notes to Financial Statements

PROTOKINETIX, INC.

(A Development Stage Company)

STATEMENTS OF OPERATIONS

(Unaudited)

For the Three and Nine Months Ended September 30, 2015 and 2014

	Three months ended September 30, 2015			Three months ended September 30, 2014			Nine months ended September 30, 2015			Nine months ended September 30, 2014

EXPENSES
Consulting fees (Note 12)	$	15,000		$	(2,312	)	$	65,000		$	46,966
General and administrative		23,240			20,977			104,790			84,049
Interest		-			8,635			3,969			27,835
Professional fees (Note 12)		49,325			42,661			219,848			52,930
Share-based compensation		117,485			-			290,728			-
Gain on settlement of short-term loan		(7,272	)		(3,116	)		(7,272	)		(3,116	)
Write off of deposit on sale (Note 3)		-			(55,000	)		-			(55,000	)
Research and development		29,850			2,115			101,970			14,990

		(227,628	)		(13,960	)		(779,033	)		(168,654	)

OTHER EXPENSE
Foreign exchange gain (loss)		121			-			(678	)		-

Net loss for the period	$	(227,507	)	$	(13,960	)	$	(779,711	)	$	(168,654	)

Net loss per common share (basic and diluted)	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average number of common shares outstanding (basic and diluted)		202,076,618			175,662,433			194,626,737			171,302,543

See Notes to Financial Statements

PROTOKINETIX, INC.

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY)

(Unaudited)

For the Period from December 31, 2014 to September 30, 2015

	Common Stock						Common Stock
	Shares			Amount			Issuable shares			Amount			Additional paid-in capital			Stock Subscriptions received in advance			Common stock to be returned to treasury			Accumulated deficit			Total
Balance, December 31, 2014		175,662,433		$	939			3,840,000		$	20		$	25,411,550		$	25,000		$	(25,000	)	$	(25,840,838	)	$	(428,329	)
Issuance of common stock for services		1,000,000			5			-			-			39,995			-			-			-			40,000
Issuance of common stock to settle convertible note payable and accrued interest		3,840,000			20			(3,840,000	)		(20	)		-			-			-			-			-
Issuance of common stock pursuant to private placement offering		15,000,000			80			-			-			374,920			-			-			-			375,000
Issuance of common stock pursuant to private placement offering		2,500,000			13			-			-			124,987			-			-			-			125,000
Common stock returned to treasury		(250,000	)		(1	)		-			-			(24,999	)		-			25,000			-			-
Issuance of common stock pursuant to private placement offering		250,000			1			-			-			24,999			(25,000	)		-			-			-
Issuance of common stock pursuant to private placement offering		1,250,000			7			-			-			99,993			-			-			-			100,000
Issuance of common stock pursuant to private placement offering		312,500			2			-			-			24,998			-			-			-			25,000
Issuance of common stock pursuant to private placement offering		375,000			2			-			-			29,998			-			-			-			30,000
Issuance of common stock pursuant to private placement offering		625,000			3			-			-			49,997			-			-			-			50,000
Issuance of common stock for services		200,000			1			-			-			13,999			-			-			-			14,000
Issuance of common stock pursuant to settle promissory note		1,250,000			7			-			-			99,993			-			-			-			100,000
Issuance of common stock pursuant to private placement offering		625,000			3			-			-			24,997			-			-			-			25,000
Issuance of common stock for services and other value		300,000			2			-			-			14,998			-			-			-			15,000
Issuance of units pursuant to private placement offering		3,562,500			19			-			-			142,481			-			-			-			142,500
Fair value of compensatory options issued		-			-			-			-			290,728			-			-			-			290,728
Contribution of services		-			-			-			-			8,780			-			-			-			8,780
Fair value of compensatory warrants issued		-			-			-			-			25,000			-			-			-			25,000
Net loss for the period		-			-			-			-			-			-			-			(779,711	)		(779,711	)

Balance, September 30, 2015		206,502,433		$	1,103			-		$	-		$	26,777,414		$	-		$	-		$	(26,620,549	)	$	157,968

See Notes to Financial Statements

PROTOKINETIX, INC.

(A Development Stage Company)

STATEMENTS OF CASH FLOWS

(Unaudited)

For the Nine Months Ended September 30, 2015 and 2014

	Nine months ended September 30, 2015			Nine months ended September 30, 2014

CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$	(779,711	)	$	(168,654	)
Adjustments to reconcile net loss to cash used in operating activities:
Accretion of short-term loan		-			2,630
Issuance and amortization of common stock for services		69,000			8,667
Fair value of compensatory options granted		290,728			-
Fair value of compensatory warrants granted		-			40,300
Contribution of services		8,780			-
Gain on settlement of short term loans		(7,272	)		(3,116	)
Write off of deposit on sale		-			(55,000	)

Changes in operating assets and liabilities:
Accounts receivable		(2,486	)		(2,068	)
Prepaid expenses and deposits		(637	)		12,874
Accounts payable and accrued liabilities		35,557			(26,090	)

Net cash used in operating activities		(386,041	)		(190,457	)

CASH FLOWS FROM INVESTING ACTIVITIES
Deposit on sale		-			30,000
Purchase of intangible assets		(40,000	)		-

Net cash provided by (used in) investing activities		(40,000	)		30,000


CASH FLOWS FROM FINANCING ACTIVITIES
Short-term loan proceeds (repayments), net		-			68,250
Short-term loan settlement		(63,250	)		-
Issuance of common stock for cash		652,500			100,000

Net cash provided by financing activities		589,250			168,250

Net change in cash		163,209			7,793

Cash, beginning of period		317			3,065

Cash, end of period	$	163,526		$	10,858

Cash paid for interest	$	-		$	-

Cash paid for income taxes	$	-		$	-

Supplementary information – non-cash transactions:
Common stock issued for consulting services	$	69,000		$	-
Common stock issued to settle short-term loans		-			25,000
Common stock returned to treasury		25,000			-
Common stock issued for past subscriptions		25,000			-
Common stock issued to settle promissory note		100,000			-
Fair value of warrants issued for intangible asset		25,000			-

See Notes to Financial Statements

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 1. Basis of Presentation – Going Concern Uncertainties

ProtoKinetix, Inc. (the "Company"), a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999. The Company is a medical research company whose mission is the advancement of human health care.

The Company is currently researching the benefits and feasibility of synthesized Antifreeze Glycoproteins ("AFGP") or anti-aging glycoproteins, trademarked AAGP. During the nine month period ended September 30, 2015, the Company acquired certain patents and rights for cash consideration of 25,000 Euros, as well as other patent rights for cash consideration of $10,000 and 6,000,000 share purchase warrants with a fair value of $25,000 (Note 5).

A Cease Trade Order ("CTO") was issued in respect of the Company's securities by the British Columbia Securities Commission ("BCSC") on May 9, 2013 based on the Company's failure to file annual financial statements for the year ended December 31, 2012 by the deadline of April 1, 2013. The Company has since completed all of the required filings for annual and interim periods and received a full Revocation Order from the BCSC during the nine month period ended September 30, 2015.

The Company's financial statements are prepared consistent with accounting principles generally accepted in the United States applicable to a going concern.

The Company has not developed a commercially viable product, has not generated any significant revenue to date, and has incurred losses since inception, resulting in a net accumulated deficit at September 30, 2015. These factors raise substantial doubt about the Company's ability to continue as a going concern.

The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities. Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective. Management is presently engaged in seeking additional working capital through equity financing or related party loans.

The accompanying financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company fail in any of the above objectives and is unable to operate for the coming year.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2014, included in the Company's Annual Report on Form 10-K, filed April 14, 2015, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 2. Summary of Significant Accounting Policies (cont'd...)

Use of Estimates

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity related instruments issued and deferred income taxes.

Fair Value of Financial Instruments

Financial instruments, including cash, accounts payable and accrued liabilities, short-term loans and convertible note payable are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 "Fair Value Measurements and Disclosures" which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:

Level 1 – quoted prices in active markets for identical assets or liabilities

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

Level 1 inputs are used to measure cash. At September 30, 2015 there were no other assets or liabilities subject to additional disclosure.

Loss per Share and Potentially Dilutive Securities

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period. Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. The effect of 14,600,000 stock options (September 30, 2014 – nil), 12,262,500 outstanding warrants (September 30, 2014 – 11,000,000) and debt convertible into common shares nil (September 30, 2014 – 12,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company's losses.

Share-Based Compensation

The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services. The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

The Company accounts for share-based compensation under "Share-Based Payment," which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 2. Summary of Significant Accounting Policies (cont'd...)

Share-Based Compensation (cont'd…)

The Company accounts for stock compensation arrangements with non-employees in accordance with FASB Codification 505 – 50 "Equity-Based Payments to Non-Employees", which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

Common stock

Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty's performance is complete.

Transaction costs directly attributable to the issuance of common stock and stock options are recognized as a deduction from equity, net of any tax effects.

Pursuant to ASC 470-20 "Debt with Conversion and Other Options", the proceeds from the issue of units is allocated between common stock and share purchase warrants on a pro-rata basis based on the relative fair values as follows: the fair value of the common stock is based on the market closing price on the date the units are issued and fair value of the share purchase warrants is determined using the Black-Scholes Option Pricing Model.

Related Party Transactions

A related party is generally defined as (i) any person that holds 10% or more of the Company's securities and their immediate families, (ii) the Company's management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Recent Accounting Pronouncements

In August 2014, the FASB issued Accounting Standards Update 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance on determining when and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessment of an entity's ability to continue as a going concern within one year of the date of issuance of the entity's financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is substantial doubt about the entity's ability to continue as a going concern. The requirement is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 3. Sales Agreement with Intrepid Innovations Corporation

During the year ended December 31, 2013, the Company entered into an agreement with Intrepid Innovations Corporation ("Intrepid") to sell the exclusive rights for the application of the AAGP molecule. The total purchase price for the exclusive rights to the application was $2,500,000 and was to be paid as follows:

$25,000 cash deposit (received);

$25,000 paid by cash on or before April 22, 2014 as a balance of the transaction deposit (received);

Six monthly payments of $25,000 on or before May 22, June 22, July 22, August 22, September 22 and October 22, 2014 ($5,000 received); and

$2,300,000 paid by the issuance of 3,500,000 restricted shares of the buyer as payment of the outstanding balance. These shares can be redeemed by a cash payment at any time within the first 6 months of the effective date of this agreement.

Once the Company had received $2,500,000 in total through payment, sale of the shares and through the redemption of the shares, any surplus shares would have been returned to Intrepid. In the event that the total payment had not totaled $2,500,000, Intrepid would pay the difference to the Company no later than 13 months after the effective date of this agreement.

The agreement was terminated during the year ended December 31, 2014 due to non-payment of the agreed to amounts. The amounts advanced are non-refundable in accordance with the agreement and as at December 31, 2014, the Company recognized a gain on deposit on sale in the amount of $55,000 to the statement of operations.

Note 4. Accounts Receivable

Accounts receivable consists of refundable sales tax paid on purchases made in Canada.

Note 5. Intangible Assets

During the nine month period ended September 30, 2015, the Company entered into an Assignment of Patents and Patent Application (effective January 1, 2015) (the "Patent Assignment") with the Institut National des Sciences Appliquees de Rouen ("INSA") for the assignment of certain patents and all rights associated therewith (the "Patents"). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company upon payment to INSA in the sum of 25,000 Euros (paid).

During the nine month period ended September 30, 2015, the Company entered into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the "Patent Rights"). In exchange for the Patent Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company's common stock at an exercise price of $0.10 per share for a period of five years. The Patent Rights had a total fair value of $35,000, which was allocated as $10,000 to the cash consideration paid, with the remaining $25,000 being allocated to the warrant component of the overall consideration.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 5. Intangible Assets (cont'd…)

The remaining 50% ownership of the Patent Rights was acquired from the Governors of the University of Alberta in exchange for a future gross revenue royalty further discussed in Note 13(c).

Note 6. Short-Term Loans

During the year ended December 31, 2013, the Company received a loan of $20,000. The loan was to be repaid by November 8, 2014, along with $10,000 in interest. In addition, the Company issued 500,000 warrants to the lender, exercisable at $0.25 for a period of 5 years. The proceeds of the loan were allocated between the debt and warrants based on a relative fair value approach, which bifurcates between the values of the two securities at the time of issuance. Using this approach, the fair value of the warrants was estimated at $4,400, with the remaining $15,600 being allocated to the debt portion; to be accreted to its settlement value over the term of the loan.

The loan was settled in August 2014 for $23,500 (Note 7), and total accretion for the year ended December 31, 2014 was $2,630, while accrued interest on the loan principal totaled $7,653 as at the settlement date. A gain on settlement of $3,116 was recognized based on a settlement payment made totaling $23,500 (Note 7).

A total of $60,250 in short-term loans were paid directly by the Company's CEO. The amount was owing to the CEO and had been included in accounts payable and accrued liabilities as at December 31, 2014 as no formal loan agreements had been completed. These amounts were settled in part of the financing detailed in Note 11(c).

The remainder of the short-term loans in the amount of $nil (December 31, 2014 - $63,250) were unsecured, non-interest bearing and were repayable on demand.

Note 7. Convertible Note Payable

On July 1, 2011, the Company executed a loan agreement under which the Company issued to a corporation an 8% convertible promissory note in exchange for $300,000. The note holder had the right to demand payment of outstanding principal and interest at any time with a 30-day grace period. The note was due and payable no later than June 30, 2016, and was convertible into shares of the Company's common stock at $0.025 per share. No beneficial conversion feature was applicable to this convertible note.

During the year ended December 31, 2014, the Company and the corporation commenced discussions in regards to the settlement of the convertible note. A settlement agreement was finalized during the nine month period ended September 30, 2015, but the Company has accounted for the transaction as at December 31, 2014. The settlement agreement stipulated that the convertible note plus accrued interest of $84,000 (included in accounts payable and accrued liabilities as at December 31, 2014) was to be settled through the issuance of 3,840,000 shares of the Company's common stock. The fair value of the shares was determined to be $192,000 ($0.05 per share) and the Company recognized a gain on settlement in the amount of $192,000 as at December 31, 2014. The settlement agreement also stipulated the payment of $161,750 to the corporation to settle other amounts included in accounts payable and accrued liabilities and short-term loans, all of which has been paid as at September 30, 2015.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 7. Convertible Note Payable (cont`d)

On June 17, 2014, the Company executed a loan agreement under which the Company issued an 8% convertible promissory note in exchange for an initial amount of $10,000, with the ability to be increased to $100,000, to the Company`s President and CEO. During the year ended December 31, 2014, additional amounts totaling $90,000 were advanced, $23,500 of which was paid directly to settle certain short-term loans outstanding (Note 6). The note holder has the right to demand payment of outstanding principal and interest at any time with a 30-day grace period. The note is due and payable no later than December 31, 2015, and is convertible into shares of the Company's common stock at $0.25 per share. No beneficial conversion feature was applicable to this convertible note. On July 1, 2015, the Company`s board of directors approved an adjustment to the conversion price from $0.25 to $0.08. During the nine month period ended September 30, 2015, the Company issued 1,250,000 shares of the Company's common stock at the adjusted price of $0.08 per share to settle the promissory note. A gain of $7,272 was recognized associated with interest forgiven on the note.

Note 8. Share-Based Compensation

During the nine month period ended September 30, 2015, the Company issued shares of common stock to non-employee consultants for services and other value rendered as follows:

2015	Number of Shares		Value per Share		Total

February 2015		1,000,000	$	0.04	$	40,000
June 2015		100,000		0.07		7,000
September 2015		100,000		0.07		7,000
September 2015		300,000		0.05		15,000
		1,500,000			$	69,000

Note 9. Stock Options

Stock option transactions are summarized as follows:

	Number of Stock Options		Weighted Average Exercise Price		Weighted Average Fair Value		Weighted Average Remaining Life
			$		$		(Years)
Outstanding, December 31, 2014		-		-		-
Options granted		14,600,000		0.03		0.03
Outstanding, September 30, 2015		14,600,000		0.03		0.03		3.34

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 9. Stock Options (cont`d)

The fair values of the stock options granted during the nine month period ended September 30, 2015 were estimated using the Black-Scholes Option Pricing Model. The weighted average assumptions used in the pricing model for these options are as follows:

	For the nine month period ended September 30, 2015
Risk-free interest rate		0.73	%
Dividend yield		0.00	%
Expected stock price volatility		125.00	%
Expected forfeiture rate		0.00	%
Expected life	4.15 years

The following non-qualified stock options were outstanding and exercisable at September 30, 2015:

Expiry date	Exercise Price		Number of Options Outstanding		Number of Options Exercisable
	$
March 12, 2016		0.10		1,000,000		500,000
February 25, 2017		0.04		2,000,000		-
February 24, 2018		0.05		1,000,000		1,000,000
February 25, 2020		0.04		4,000,000		2,800,000
February 28, 2020		0.04		5,000,000		3,750,000
June 30, 2017		0.10		1,000,000		499,998
June 30, 2018		0.10		600,000		300,000
				14,600,000		8,849,998

As at September 30, 2015, the aggregate intrinsic value of the Company's stock options is $nil (December 31, 2014 – $nil).

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 10. Warrants

Warrant transactions are summarized as follows:

	Number of Warrants			Weighted Average Exercise Price
Balance, December 31, 2014		5,200,000		$	0.09
Issued		9,562,500		$	0.08
Expired		(2,500,000	)	$	0.05
Balance, September 30, 2015		12,262,500		$	0.09

The following warrants were outstanding and exercisable as at September 30, 2015:

Number of Warrants		Exercise Price		Expiry Date
	1,600,000		0.10	January 1 , 2016
	300,000		0.05	January 1 , 2016
	300,000		0.15	January 1 , 2016
	500,000		0.25	November 8, 2018
	6,000,000		0.10	April 22, 2020
	3,562,500		0.04	December 28, 2015

	12,262,500

Note 11. Stockholders' Equity (Deficiency)

The Company is authorized to issue 400,000,000 (December 31, 2014 – 400,000,000) shares of $0.0000053 par value common stock. Each holder of common stock has the right to one vote but does not have cumulative voting rights. Shares of common stock are not subject to any redemption or sinking fund provisions, nor do they have any preemptive, subscription or conversion rights. Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid as of September 30, 2015 (December 31, 2014 - $nil).

During the nine month period ended September 30, 2015, the Company:

a)	Issued 1,000,000 shares of common stock with a fair value of $40,000 ($0.04 per share) pursuant to a directorship agreement entered into on February 25, 2015 (Note 12).

b)	Issued 3,840,000 shares of common stock with a fair value of $192,000 ($0.05 per share) pursuant to a settlement agreement completed on March 2, 2015 with a convertible note holder (Note 7).

Issued 15,000,000 shares of common stock at $0.025 per share pursuant to a stock subscription agreement with the Company's President and CEO. The proceeds of $375,000 were offset by certain amounts owing to the President and CEO as previously included in accounts payable and accrued liabilities and short-term loans (Note 6). The remaining proceeds of $205,000 were received in cash during the nine months ended September 30, 2015.

PROTOKINETIX, INC.

(A Developmental Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 11. Stockholders' Equity (Deficiency) (cont'd…)

d)	Issued 2,500,000 shares of common stock to two investors (one of which was the President and CEO of the Company) at $0.05 per share for gross proceeds of $125,000.

e)	Cancelled 250,000 shares of common stock that were returned to treasury. The shares had been issued in error and the Company had accounted for the return as "Common stock to be returned to treasury" as at December 31, 2014.

f)	Issued 250,000 shares of common stock pursuant to a stock subscription received during the year ended December 31, 2010.

g)	Issued 1,250,000 shares of common stock at $0.08 per share for gross proceeds of $100,000 pursuant to private placement offering.

h)	Issued 312,500 shares of common stock at $0.08 per share for gross proceeds of $25,000 pursuant to private placement offering.

i)	Issued 375,000 shares of common stock at $0.08 per share for gross proceeds of $30,000 pursuant to private placement offering.

Issued 625,000 shares of common stock at $0.08 per share pursuant to a stock subscription agreement with the Company's President and CEO. The proceeds of $50,000 were offset in their entirety by certain amounts owing to the President and CEO as previously included in accounts payable and accrued liabilities.

k)	Issued 200,000 shares of common stock with a fair value of $14,000 ($0.07 per share) pursuant to a consulting agreement entered into on March 1, 2015 (Note 13).

l)	Issued 1,250,000 shares of the Company's common stock at an adjusted conversion price of $0.08 per share on conversion of a promissory note (Note 7).

m)	Issued 625,000 shares of common stock at $0.04 per share for gross proceeds of $25,000 pursuant to a stock subscription agreement with the Company's President and CEO.

n)	Issued 300,000 shares of common stock with a fair value of $15,000 ($0.05 per share) pursuant to a settlement agreement entered into on September 29, 2015 for services and other value received.

Issued 3,562,500 units at $0.04 per unit or gross proceeds of $142,500. Each unit is comprised of one share of common stock and one share purchase warrant exercisable at a price of $0.04 until December 28, 2015. At total of $42,038 was allocated to the warrant component of the unit under the relative fair value approach, using the Black-Scholes Option Pricing model with the following assumptions: Risk-free interest rate - 0.52%, Dividend yield - 0%, Expected stock price volatility – 125.00%, Expected forfeiture rate - 0%, and Expected life – 0.25 years.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

September 30, 2015

Note 12. Related Party Transactions and Balances

During the nine month period ended September 30, 2015, the Company:

Entered into a directorship agreement effective February 25, 2015 with a newly appointed director of the Company. Pursuant to the agreement, the director was issued 1,000,000 shares of common stock as an engagement fee (Note 11) and will be entitled to a compensatory service fee. The director is also entitled to 1,000,000 stock options on signing (Note 9) exercisable into common shares of the Company for a period of 3 years at a price of $0.05 per share.

During the nine month period ended September 30, 2015, the director provided $8,780 in contributed services, which were recorded as professional fees against additional paid-in capital.

During the nine month period ended September 30, 2015, this director resigned from the board but has been appointed to the Company's Business and Scientific Advisory Board as a consultant.

Entered into a consulting agreement dated March 30, 2015 (effective January 1, 2015) with the Company's President and CEO whereby he will be compensated at a nominal amount of $1 for services through to December 31, 2015. The agreement also stipulates a termination fee that would pay the Company's President and CEO $100,000 if terminated without cause or in the case of termination upon a change of control event, the termination fee would be equal to $100,000 plus 2.5% of the aggregate transaction value of the change of control.

Entered into a consulting agreement dated March 30, 2015 (effective January 1, 2015) with the Company's CFO whereby she will be compensated at a monthly fee of $4,000 for services through to December 31, 2018 ($4,000 per month for fiscal 2015, then increased by not less than 5% each year thereafter). A total of $36,000 was paid or accrued to the Company's CFO during the nine month period ended September 30, 2015 (nine month ended September 30, 2014 - $nil).

She is also entitled (as of February 26, 2015) to 4,000,000 stock options (Note 9) exercisable into common shares of the Company for a period of 5 years at a price of $0.04 per share. The options will vest monthly in tranches of 400,000 over 10 months. She will also be entitled to an additional 2,000,000 stock options exercisable for a period of 2 years at a price of $0.04 per share that will vest only upon a change in control. If terminated without cause, the agreement also stipulates a termination fee that would pay the Company's CFO three times her monthly consulting fee in effect as of the date of termination or if terminated without cause after January 1, 2016, six times her monthly consulting fee in effect as of the date of termination. In the case of termination upon a change of control event, the termination fee would be equal to two times the amount that she would receive as if terminated without cause.

Entered into a directorship agreement effective July 1, 2015 with a newly appointed director of the Company. Pursuant to the agreement, the director was issued 1,000,000 stock options on signing (Note 9) exercisable into common shares of the Company for a period of 2 years at a price of $0.10 per share. The options will vest in monthly installments of 166,666 options beginning July 31, 2015 with the final 166,670 options vesting on December 31, 2015.

e)	Recognized $137,810 (nine month ended September 30, 2014 - $nil) in share-based compensation associated with stock options granted to key management personnel.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

Note 12. Related Party Transactions and Balances (cont`d)

As at September 30, 2015 and December 31, 2014, the following amounts are due to related parties:

		September 30, 2015		December 31, 2014
Clarence Smith (CEO)	Accounts payable and accrued liabilities	$	495	$	129,592
	Short-term loans	$	nil	$	20,000
	Convertible note payable	$	nil	$	100,000

Susan Woodward (CFO)	Accounts payable and accrued liabilities	$	nil	$	12,000

Amounts included in accounts payable and accrued liabilities are non-interest bearing, unsecured and repayable on demand. Amounts included in short-term loans and convertible note payable have terms disclosed in Notes 6 and 7 respectively.

Note 13. Commitments and Contingency

During the nine month period ended September 30, 2015, the Company:

Entered into a consulting agreement effective March 1, 2015, whereby the Company would pay the consultant $10,000 on signing (paid) and $5,000 per month for an initial term of 1 year for providing research and development services. The consultant is also entitled to 5,000,000 stock options within 30 days of the consulting agreement (Note 9), with each stock option exercisable into a common share at a price of $0.04 for a period of 5 years. The stock options vested 25% on grant and 25% every 3 months thereafter.

Entered into a consulting agreement effective March 1, 2015, whereby the Company would pay the consultant $2,700 per month for an initial term of 1 year for providing public relations services. The consultant is also entitled to 400,000 shares of common stock, which will be issued at a rate of 25% (100,000 shares) every 3 months over the term of the agreement. The consultant is also entitled to 1,000,000 stock options on signing (Note 9), with each stock option exercisable into a common share at a price of $0.10 for a period of 5 years. The stock options will vest at the rate of 25% every 3 months over the term of the agreement.

Entered into a royalty agreement with the Governors of the University of Alberta (the "University") whereby the University had developed certain intellectual property (the "Additional Patent Rights") in conjunction with and by permission of the Company employing patented intellectual property of the Company. The agreement assigns the Additional Patent Rights to the Company in return for 5% of any future gross revenues (the "Royalty") derived from products arising from the Patent Rights. The Company will have the right and option for two years from the earlier of the first date that the University publishes its research related to the Additional Patent Rights or September 1, 2015 to buy out all of the University's Royalty for consideration of the aggregate sum of CDN $5,000,000.

d)	Entered into a consulting agreement effective May 1, 2015, whereby the Company would pay the consultant $4,000 per month for an initial term of 1 year for providing research and development services.

Entered into a consulting agreement for business development services effective July 1, 2015. The consultant was granted 600,000 stock options exercisable into common shares of the Company at a price of $0.10 per share for a period of 3 years. The options will vest in monthly installments of 100,000 options beginning July 31, 2015 with the final vesting on December 31, 2015.

PROTOKINETIX, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

Note 13. Commitments and contingency (cont`d)

The Company was delinquent in filing certain income tax returns with the U.S. Internal Revenue Service and reports disclosing its interest in foreign bank accounts on form TDF 90-22.1, "Report of Foreign Bank and Financial Accounts" ("FBARs"). In September 2015, the Company filed the delinquent income tax returns and has sought waivers of any penalties under the IRS Offshore Voluntary Disclosure Program for late filing of the returns and FBARs. Under the program, the IRS has indicated that it will not impose a penalty for the failure to file delinquent income tax returns if there are no underreported tax liabilities. The Company may be liable for civil penalties of up to $10,000 for each of its foreign bank accounts for not complying with the FBAR reporting and recordkeeping requirements. The Company is unable to determine the amount of any penalties that may be assessed at this time. Management is of the opinion that penalties, if any, that may be assessed would not be material to the consolidated financial statements as a whole.

Note 14. Subsequent Events

Subsequent to the nine month period ended September 30, 2015, the Company:

a)	Completed a private placement offering of 1,437,500 units at a price of $0.04 per unit for gross proceeds of $57,500. Each unit is comprised at one share of common stock and one share purchase warrant, exercisable at a price of $0.04 to December 28, 2015.

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context requires otherwise, references in this document to "ProtoKinetix", "we", "our", "us" or the "Company" are to ProtoKinetix, Incorporated.

The following discussion provides information regarding the results of operations for the nine month period ended September 30, 2015 and 2014, and our financial condition, liquidity and capital resources as of September 30, 2015, and December 31, 2014. The financial statements and the notes thereto contain detailed information that should be referred to in conjunction with this discussion.

Cautionary Note Regarding Forward-Looking Statements

The information discussed in this Quarterly Report on Form 10-Q include "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"). All statements, other than statements of historical facts, included herein and therein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. These forward looking statements are identified by their use of terms and phrases such as "may," "expect," "estimate," "project," "plan," "believe," "intend," "achievable," "anticipate," "will," "continue," "potential," "should," "could," and similar terms and phrases. Although we believe that the expectations reflected in these forward looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not considered to be) guarantees of future performance. Our results could differ materially from those anticipated in these forward looking statements as a result of certain factors, including, among others:

•

Our capital requirements and the uncertainty of being able to obtain additional funding on terms acceptable to us;

•

Our plans to develop and commercialize products from the AAGP™ molecule;

•

Ongoing testing of the AAGP™ molecule;

•

Our intellectual property position;

•

Our commercialization, marketing and manufacturing capabilities and strategy;

•

Our ability to retain key members of our senior management and key scientific consultants;

•

The effects of competition;

•

Our potential tax liabilities resulting from conducting business in the United States and Canada;

•

The effect of further sales or issuances of our common stock and the price and volume volatility of our common stock; and

•

Our common stock's limited trading history.

Finally, our future results will depend upon various other risks and uncertainties, including, but not limited to, those detailed in our filings with the SEC under the Exchange Act and the Securities Act, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2014. All forward looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements in this paragraph and elsewhere in this Quarterly Report. Other than as required under securities laws, we do not assume a duty to update these forward looking statements, whether as a result of new information, subsequent events or circumstances, changes in expectations or otherwise.

Business Overview

ProtoKinetix, Incorporated ("ProtoKinetix" or the "Company") is a research and development stage bio-technology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, trademarked as AAGPs™. The Company has recently been in the process of directing major efforts to the practical side of commercial validation. The commercial applications for AAGPs™ in large markets such as skincare/cosmetic products and targeted health care solutions are numerous, and ProtoKinetix is currently working with researchers, business leaders and advisors and commercial entities to bring AAGP™ to market.

Results of Operations

The following table shows selected financial data and operating results for the periods noted. Following the table, please see management's discussion of significant changes.

	For the Nine Months Ended
	September 30,
	2015			2014
Revenues	$	-		$	-
Cost of sales		-			-
Gross (loss) profit		-			-
Operating Expenses
Consulting Fees	$	65,000		$	46,966
General and Administrative		104,790			84,049
Interest Expense		3,969			27,835
Professional Fees		219,848			52,930
Research and Development		101,970			14,990
Share-Based Compensation		290,728			-
Total operating expenses		786,305			226,770
Loss from Operations		(786,305	)		(226,770	)

Other Expense
Foreign Exchange Loss		678			-
Total other expenses		(678	)		-

Other Income
Gain on Settlement of Short-Term Loan		7,272			3,116
Write Off of Deposit on Sale		-			55,000
Total other income		7,272			58,116
Net Loss	$	(779,711	)		(168,654	)

Revenues

We had no revenues for the nine month period ended September 30, 2015 and 2014.

Gross Profit and Expenses

The Company's net loss was $779,711 for the nine month period ended September 30, 2015 compared to $168,654 for the nine month period ended September 30, 2014. These expenses were primarily incurred for professional fees, consulting services related to the operations of the Company's business, research and development and other general and administrative expenses. Significant changes from the prior nine month period ended September 30, 2014 include:

·	Consulting fees increased by $18,034 from $46,966 to $65,000 primarily as a result of consulting contracts being entered into for the current year.

·	General and administrative expenses increased by $20,741 from $84,049 to $104,790 primarily as a result of an increase in travel expenses associated with the office relocation, the lifting of the Cease Trade Order in British Columbia (the "CTO") and the changing of the management of the Company.

·	Interest expense decreased by $23,866 from $27,835 to $3,969 primarily as a result of a decrease in short-term loans and notes payable.

·	Professional fees increased by $166,918 from $52,930 to $219,848 primarily as a result of an increase in activity with our independent accountants as well as an increase in legal fees associated with the CTO and company operations.

·	Research and development increased by $86,980 from $14,990 to $101,970 primarily as a result of management's intention to move the Company forward in the development of the AAGP™ molecule.

·	Share-based compensation increased by $290,728 from $nil to $290,728 primarily as a result of consulting contracts being entered into for the current year.

Liquidity and Capital Resources

The following table summarizes our statements of cash flows at September 30, 2015 and December 31, 2014:

	September 30, 2015		December 31, 2014

Cash	$	163,526	$	317

Working Capital (Deficiency)	$	92,968	$	(428,329	)

At September 30, 2015, we had $163,526 in cash and $172,146 in total current assets. As of September 30, 2015 we had a working capital position of $92,968. Based upon our working capital equity as of September 30, 2015, we require additional equity and/or debt financing in order to meet cash flow projections and carry forward our business objectives. There can be no assurance that in the future we will be able to raise capital from outside sources in sufficient amounts to fund our new business.

The failure to secure adequate outside funding would have an adverse effect on our plan of operation and results therefrom and a corresponding negative impact on stockholder liquidity.

Sources and Uses of Cash

Net Cash Used in Operating Activities

Net cash used in operating activities increased by $195,584 from $190,457 to $386,041 for the nine months ended September 30, 2014 and 2015, respectively. This increase was predominantly due to an increase in cash-based expenditures as well as the Company's efforts to reduce historical accounts payable and accrued liabilities concurrent with the change in management completed in 2015.

Net Cash Used in Investing Activities

Net cash used in investing activities was $40,000 for the nine month period ended September 30, 2015 while the Company had net cash provided by investing activities of $30,000 for the comparative period. This decrease was due to the Company's following actions:

Entering into an Assignment of Patents and Patent Application (effective January 1, 2015) (the "Patent Assignment") with the Institut National des Sciences Appliquees de Rouen ("INSA") for the assignment of certain patents and all rights associated therewith (the "Patents"). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company upon payment to INSA in the sum of 25,000 Euros (paid).

Entering into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the "Patent Rights"). In exchange for the Patent Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company's common stock at an exercise price of $0.10 per share for a period of five years.

Acquiring the remaining 50% ownership of the Patent Rights from the Governors of the University of Alberta (the "University") in exchange for a future gross revenue royalty. The Company entered into a royalty agreement with the University whereby the University had developed certain intellectual property (the "Additional Patent Rights") in conjunction with and by permission of the Company employing patented intellectual property of the Company. The agreement assigns the Patent Rights to the Company in return for 5% of any future gross revenues (the "Royalty") derived from products arising from the Patent Rights. The Company will have the right and option for two years from the earlier of the first date that the University publishes its research related to the Patent Rights or September 1, 2015 to buy out all of the University's Royalty for consideration of the aggregate sum of CDN $5,000,000.

Sources and Uses of Cash (cont'd…)

Net Cash Provided by Financing Activities

Net cash provided by financing activities increased by $421,000 from $168,250 to $589,250 for the nine months ended September 30, 2014 and 2015, respectively due to an increase in private placements.

Going Concern

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"), which contemplate continuation of the Company as a going concern. The history of losses and the inability for the Company to make a profit from selling a good or service has raised substantial doubt about our ability to continue as a going concern. In spite of the fact that the current cash obligations of the Company are relatively minimal, given the cash position of the Company, we have very little cash to operate. We intend to fund the Company and attempt to meet corporate obligations by selling common stock. However the Company's common stock is at a low price and is not actively traded.

Off-Balance Sheet Arrangements

None.

Contractual Obligations

As a smaller reporting company, we are not required to provide the information required by paragraph (a)(5) of this Item.

Critical Accounting Policies

The preparation of financial statements in conformity with U.S. GAAP requires management to make a variety of estimates and assumptions that affect (i) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and (ii) the reported amounts of revenues and expenses during the reporting periods covered by the financial statements.

Our management routinely makes judgments and estimates about the effect of matters that are inherently uncertain. As the number of variables and assumptions affecting the future resolution of the uncertainties increase, these judgments become even more subjective and complex. Although we believe that our estimates and assumptions are reasonable, actual results may differ significantly from these estimates. Changes in estimates and assumptions based upon actual results may have a material impact on our results of operation and/or financial condition. Our significant accounting policies are disclosed in Note 2 to the Financial Statements included in this Form 10-Q.

While all of the significant accounting policies are important to the Company's financial statements, the following accounting policies and the estimates derived there from have been identified as being critical.

Share-Based Compensation

On July 1, 2015, the Board of Directors of the Company adopted the 2015 Stock Option and Stock Bonus Plan (the "Plan"). The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services outside of the Plan, and beginning July 1, 2015 pursuant to the Plan. The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

Sales and Marketing

The Company is currently not selling or marketing any products.

Inflation

Although management expects that our operations will be influenced by general economic conditions, we do not believe that inflation had a material effect on our results of operations during the nine months ended September 30, 2015.

Contractual Obligations

As a smaller reporting company as defined by Item 10 of Regulation S-K, we are not required to provide the information requested by paragraph (a)(5) of this Item.

Critical Accounting Policies and Estimates

There are no material changes from the critical accounting policies set forth in "Management's Discussion and Analysis of Financial Condition and Results of Operations" set forth in our Annual Report on Form 10-K for the year ended December 31, 2014, and as filed with the SEC on April 14, 2015. Please refer to that document for disclosures regarding the critical accounting policies related to our business.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

Item 4: Controls and Procedures

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 (the "1934 Act") is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the 1934 Act is accumulated and communicated to management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Our management, under the direction of our Chief Executive Officer (who is our principal executive officer), and Chief Financial Officer (who is our principal accounting officer) has evaluated the effectiveness of our disclosure controls and procedures as required by 1934 Act Rule 13a-15(b) as of September 30, 2015 (the end of the period covered by this report). Based on that evaluation, our principal executive officer and our principal accounting officer concluded that these disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosure and are effective to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time periods specified by the SEC's rules and forms.

The Company, including its Chief Executive Officer and Chief Financial Officer, does not expect that its internal controls and procedures will prevent or detect all error and all fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated by the SEC under the 1934 Act) during the third quarter ended September 30, 2015, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Other than reported in the Company's Quarterly Report on Form 10-Q for the nine month period ended September 30, 2015, the Company and its management are not aware of any regulatory or legal proceedings or investigations pending involving the Company, any of its subsidiaries or affiliates, or any of their respective officers, directors or employees.

Item 1A. Risk Factors

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item. However, in addition to the risk factors set forth below, our current risk factors are set forth in our Annual Report on Form 10-K for the year ended December 31, 2014 as filed with the SEC on April 14, 2015, and such risk factors are incorporated herein by this reference.

The Company has been delinquent in filing certain income tax and information reporting returns. The Company was delinquent in filing certain income tax returns with the U.S. Internal Revenue Service and reports disclosing its interest in foreign bank accounts on form TDF 90-22.1, "Report of Foreign Bank and Financial Accounts" ("FBARs"). In September 2015, the Company filed the delinquent income tax returns and has sought waivers of any penalties under the IRS Offshore Voluntary Disclosure Program for late filing of the returns and FBARs. Under the program, the IRS has indicated that it will not impose a penalty for the failure to file delinquent income tax returns if there are no underreported tax liabilities. The Company may be liable for civil penalties of up to $10,000 for each of its foreign bank accounts for not complying with the FBAR reporting and recordkeeping requirements. The Company is unable to determine the amount of any penalties that may be assessed at this time. Management is of the opinion that penalties, if any, that may be assessed would not be material to the consolidated financial statements as a whole.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On July 1, 2015, in connection with the appointment of a new director to the Board of Directors of the Company, the Company issued to the director a two-year option for 1,000,000 shares of common stock subject to vesting exercisable at $0.10 per share pursuant to the 2015 Stock Option and Stock Bonus Plan. The option vests in monthly installments of 166,666 shares beginning July 31, 2015 with the final 166,670 shares vesting on December 31, 2015. The director had current information regarding the Company and no general solicitation was used in this offering. For this sale of securities, the Company relied on the exemption from registration available under Sections 4(a)(2) and 4(a)(5) of the Securities Act with respect to transactions by an issuer not involving any public offering. No commissions were paid in connection with this issuance of securities. No Form D was filed for this transaction.

Also on July 1, 2015, in connection with entering into a consulting agreement for business development services, the Company issued to the consultant a three-year option for 600,000 shares of common stock subject to vesting exercisable at $0.10 per share pursuant to the 2015 Stock Option and Stock Bonus Plan. The option vests in monthly installments of 100,000 shares beginning July 31, 2015 with the final shares vesting on December 31, 2015. The consultant had current information regarding the Company and no general solicitation was used in this offering. For this sale of securities, the Company relied on the exemption from registration available under Section 4(a)(2) of the Securities Act with respect to transactions by an issuer not involving any public offering. No commissions were paid in connection with this issuance of securities. No Form D was filed for this transaction.

On September 1, 2015, the company issued 100,000 shares of common stock to a consultant pursuant to a consulting agreement for public relations services. The consultant had current information regarding the Company and no general solicitation was used in this offering. For this sale of securities, the Company relied on the exemption from registration available under Section 4(a)(2) of the Securities Act with respect to transactions by an issuer not involving any public offering and/or Regulation S of the Securities Act. No commissions were paid in connection with this issuance of securities. No Form D was filed for this transaction.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds (cont'd…)

On September 9, 2015, the Company entered into an agreement with Clarence E. Smith, the Company's President and CEO, pursuant to which Mr. Smith agreed to purchase 625,000 shares of common stock of the Company at a price of $0.04 per share, representing aggregate total proceeds of $25,000, a portion of which had been advanced by Mr. Smith previously to the Company to pay Company expenses. For this sale of securities, the Company relied on the exemption from registration available under Sections 4(a)(2) and/or 4(a)(5) of the Securities Act and/or Rule 506(b) of Regulation D promulgated under the Securities Act with respect to transactions by an issuer not involving any public offering. No commission or other remuneration was paid on the issuance of the common stock. A Form D was filed with the SEC on September 18, 2015.

On September 29, 2015, the Company issued 300,000 shares of common stock pursuant to a settlement agreement with an outside contractor for services and other value provided to the Company. For this sale of securities, the Company made the issuance to an accredited investor and relied on the exemption from registration available under Sections 4(a)(2) and/or 4(a)(5) of the Securities Act with respect to transactions by an issuer not involving any public offering. No commission or other remuneration was paid on the issuance of the common stock. No Form D was filed for this transaction.

On September 30, 2015, the Company issued 3,562,500 units (the "Units") at $0.04 per Unit, each Unit comprised of one share of common stock of the Company and one non-detachable warrant to purchase one share of common stock of the Company exercisable until December 28, 2015 at $0.04 per share for gross proceeds of $142,500 pursuant to a private placement with accredited investors. No solicitation was used in this offering. For this sale of securities, the Company relied on the exemption from registration available under Sections 4(a)(2) and/or 4(a)(5) of the Securities Act and/or Rule 506(b) of Regulation D promulgated under the Securities Act with respect to transactions by an issuer not involving any public offering. No commissions were paid in connection with this issuance of securities. A Form D was filed on October 9, 2015.

Other than previously reported, there have been no unregistered sales of equity securities during the nine month period ended September 30, 2015.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosure

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

EXHIBIT INDEX

The following documents are being filed with the Commission as exhibits to this Quarterly Report on Form 10-Q.

Exhibit		Description
3.1		Certificate of Incorporation¹
3.2		Bylaws¹
4.1		2015 Stock Option and Stock Bonus Plan²
10.1		Director Consulting Agreement between the Company and Edward P. McDonough, dated July 1, 2015²
31.1		Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2		Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1		Certification of the Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
32.2		Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101.INS		XBRL Instance Document
101.SCH		XBRL Schema Document
101.CAL		XBRL Calculation Linkbase Document
101.DEF		XBRL Definition Linkbase Document
101.LAB		XBRL Label Linkbase Document
101.PRE		XBRL Presentation Linkbase Document

1.	Incorporated by reference from the Company's registration statement on Form 10-SB filed on June 22, 2001 with the SEC.

2.	Incorporated by reference from the Company's Quarterly Report on Form 10-Q filed on August 14, 2015 with the SEC.

Filed herewith.

Furnished, not filed herewith.

SIGNATURES

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 16, 2015		PROTOKINETIX, INCORPORATED

		By: /s/ Clarence E. Smith
		Clarence E. Smith
		Chief Executive Officer

		By: /s/ Susan M. Woodward
		Susan M. Woodward
		Chief Financial Officer

EX-31.1 2 ex31x1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clarence E. Smith, certify that:

I have reviewed this Quarterly Report on Form 10-Q of ProtoKinetix, Incorporated for the period ended September 30, 2015;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

November 16, 2015	/s/ Clarence E. Smith
	Name:	Clarence E. Smith
	Title:	Chief Executive Officer (Principal Executive Officer)

EX-31.2 3 ex31x2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Susan M. Woodward, certify that:

I have reviewed this Quarterly Report on Form 10-Q of ProtoKinetix, Incorporated for the period ended September 30, 2015;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

November 16, 2015	/s/ Susan M. Woodward
	Name:	Susan M. Woodward
	Title:	Chief Financial Officer (Principal Financial Officer)

EX-32 4 ex32.htm EXHIBIT 32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ProtoKinetix, Incorporated, (the "Company") on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Clarence E. Smith, Chief Executive Officer and Principal Executive Officer of the Company and Susan M. Woodward, Chief Financial Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned's knowledge and belief:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

November 16, 2015	/s/ Clarence E. Smith
	Name:	Clarence E. Smith
	Title:	Chairman of the Board and Chief Executive Officer (Principal Executive Officer)

November 16, 2015	/s/ Susan M. Woodward
	Name:	Susan M. Woodward
	Title:	Chief Financial Officer (Principal Financial Officer)

This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-101.INS 5 pktx-20150930.xml XBRL INSTANCE DOCUMENT 0001128189 2015-01-01 2015-09-30 0001128189 2014-09-30 0001128189 2015-09-30 0001128189 2014-12-31 0001128189 2014-01-01 2014-09-30 0001128189 us-gaap:CommonStockMember 2014-12-31 0001128189 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001128189 us-gaap:RetainedEarningsMember 2014-12-31 0001128189 us-gaap:CommonStockMember 2015-01-01 2015-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-09-30 0001128189 us-gaap:RetainedEarningsMember 2015-01-01 2015-09-30 0001128189 us-gaap:CommonStockMember 2015-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2015-09-30 0001128189 us-gaap:RetainedEarningsMember 2015-09-30 0001128189 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001128189 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001128189 us-gaap:ConvertibleDebtSecuritiesMember 2015-01-01 2015-09-30 0001128189 us-gaap:ConvertibleDebtSecuritiesMember 2014-01-01 2014-09-30 0001128189 pktx:CommonStockIssuableMember 2015-01-01 2015-09-30 0001128189 pktx:CommonStockIssuableMember 2014-12-31 0001128189 pktx:CommonStockIssuableMember 2015-09-30 0001128189 pktx:StockSubscriptionMember 2015-01-01 2015-09-30 0001128189 pktx:StockSubscriptionMember 2014-12-31 0001128189 pktx:StockSubscriptionMember 2015-09-30 0001128189 pktx:CommonStockToBeReturnedToTreasuryMember 2015-01-01 2015-09-30 0001128189 pktx:CommonStockToBeReturnedToTreasuryMember 2014-12-31 0001128189 pktx:CommonStockToBeReturnedToTreasuryMember 2015-09-30 0001128189 pktx:ClarenceSmithCEOMember 2014-12-31 0001128189 pktx:SusanWoodardCFOMember 2015-09-30 0001128189 pktx:SusanWoodardCFOMember 2014-12-31 0001128189 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001128189 us-gaap:WarrantMember 2014-12-31 0001128189 us-gaap:WarrantMember 2015-09-30 0001128189 2013-12-31 0001128189 pktx:ClarenceSmithCEOMember 2015-09-30 0001128189 us-gaap:StockOptionMember 2015-01-01 2015-09-30 0001128189 us-gaap:StockOptionMember 2014-12-31 0001128189 us-gaap:StockOptionMember 2015-09-30 0001128189 pktx:Date1Member 2015-09-30 0001128189 pktx:Date2Member 2015-09-30 0001128189 pktx:Date3Member 2015-09-30 0001128189 pktx:Date4Member 2015-09-30 0001128189 pktx:Date5Member 2015-09-30 0001128189 2015-07-01 2015-09-30 0001128189 2014-07-01 2014-09-30 0001128189 pktx:FebruaryMember 2015-01-01 2015-09-30 0001128189 pktx:JuneMember 2015-01-01 2015-09-30 0001128189 2015-11-13 0001128189 us-gaap:StockOptionMember 2014-01-01 2014-09-30 0001128189 pktx:SeptemberMember 2015-01-01 2015-09-30 0001128189 pktx:SeptemberOneMember 2015-01-01 2015-09-30 0001128189 pktx:Date7Member 2015-09-30 0001128189 pktx:Date6Member 2015-09-30 0001128189 pktx:WarrantOneMember 2015-09-30 0001128189 pktx:WarrantOneMember 2015-01-01 2015-09-30 0001128189 pktx:WarrantTwoMember 2015-09-30 0001128189 pktx:WarrantTwoMember 2015-01-01 2015-09-30 0001128189 pktx:WarrantThreeMember 2015-09-30 0001128189 pktx:WarrantThreeMember 2015-01-01 2015-09-30 0001128189 pktx:WarrantFourMember 2015-09-30 0001128189 pktx:WarrantFourMember 2015-01-01 2015-09-30 0001128189 pktx:WarrantFiveMember 2015-09-30 0001128189 pktx:WarrantFiveMember 2015-01-01 2015-09-30 0001128189 pktx:WarrantSixMember 2015-09-30 0001128189 pktx:WarrantSixMember 2015-01-01 2015-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure --12-31 pktx 2015-09-30 No Smaller Reporting Company No 10-Q false 2015 ProtoKinetix, Inc. 0001128189 Yes Q3

79178

270893

129592

12000

495

157968

-428329

939

25411550

-25840838

1103

26777414

-26620549

25000

-25000

.0000053

400000000

206502433

175662433

206502433

175662433

0 3840000

0.08

0.03

63250

20000

100000

207939933

-26620549

-25840838

26777414

25411550

-25000

25000

1103

939

79178

434143

100000

63250

237146

5814

65000

172146

5814

637

7983

5497

10858

163526

317

3065

237146

5814

194626737

171302543

202076618

175662433

-0.00

-779711

-168654

-779711

-227507

-13960

-678

121

779033

168654

227628

13960

101970

14990

29850

2115

290728

117485

219848

52930

49325

42661

3969

27835

8635

104790

84049

23240

20977

65000

46966

15000

-2312

7272

3116

7272

3116

-55000 -55000

175662433

206502433

3840000

3840000 -3840000

163209

7793

589250

168250

652500

100000

-63250

8780 8780 40300 69000 8667

2630

69000 25000 25000 25000 25000

68250

-386041

-190457

35557

-26090

637

-12874

2486

2068

-40000

30000

40000

30000

100000

1500000

1000000

100000

300000

25000 25000 290728 290728 142500 19 142481 3562500 15000 2 14998 300000 25000 3 24997 625000 100000 7 99993 1250000

40000

39995

200000 50000 3 49997 625000 30000 2 29998 375000 25000 2 24998 312500 100000 7 99993 1250000 1 24999 -25000 250000

-1

-24999

25000

-250000

125000 13 124987 2500000 375000 80 374920 15000000 20 -20

12262500

11000000

12000000

14600000

0.04 0.07 0.07 0.05

14600000

5200000

12262500

14600000

2000000

1000000

4000000

5000000

1000000

600000

9562500

14600000

0.09

0.03

0.04

0.05

0.04

0.10

0.03

P3Y4M2D

0.0073

0.0000

1.2500

0.0000

P4Y1M24D

8849998

1000000

2800000

3750000

500000

499998

300000

-2500000

0.05

0.10 0.05 0.15 0.25 0.10 0.04

12262500

1600000

300000

500000

6000000

3562500

January 1, 2016 January 1, 2016 January 1, 2016 November 8, 2018 April 22, 2020 December 28, 2015

ProtoKinetix, Inc. (the "Company"), a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999.  The Company is a medical research company whose mission is the advancement of human health care.   The Company is currently researching the benefits and feasibility of synthesized Antifreeze Glycoproteins ("AFGP") or anti-aging glycoproteins, trademarked AAGP.  During the nine month period ended September 30, 2015, the Company acquired certain patents and rights for cash consideration of 25,000 Euros, as well as other patent rights for cash consideration of $10,000 and 6,000,000 share purchase warrants with a fair value of $25,000 (Note 5).   A Cease Trade Order ("CTO") was issued in respect of the Company's securities by the British Columbia Securities Commission ("BCSC") on May 9, 2013 based on the Company's failure to file annual financial statements for the year ended December 31, 2012 by the deadline of April 1, 2013. The Company has since completed all of the required filings for annual and interim periods and received a full Revocation Order from the BCSC during the nine month period ended September 30, 2015.   The Company's financial statements are prepared consistent with accounting principles generally accepted in the United States applicable to a going concern.   The Company has not developed a commercially viable product, has not generated any significant revenue to date, and has incurred losses since inception, resulting in a net accumulated deficit at September 30, 2015.  These factors raise substantial doubt about the Company's ability to continue as a going concern.   The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities.  Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective.  Management is presently engaged in seeking additional working capital through equity financing or related party loans.   The accompanying financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company fail in any of the above objectives and is unable to operate for the coming year.

Basis of Presentation   The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2014, included in the Company's Annual Report on Form 10-K, filed April 14, 2015, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.   Use of Estimates   Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity related instruments issued and deferred income taxes.   Fair Value of Financial Instruments   Financial instruments, including cash, accounts payable and accrued liabilities, short-term loans and convertible note payable are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.   The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 "Fair Value Measurements and Disclosures" which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:   Level 1 quoted prices in active markets for identical assets or liabilities Level 2 quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 inputs that are unobservable (for example cash flow modeling inputs based on assumptions)   Level 1 inputs are used to measure cash. At September 30, 2015 there were no other assets or liabilities subject to additional disclosure.   Loss per Share and Potentially Dilutive Securities   Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.  Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.  The effect of 14,600,000 stock options (September 30, 2014 nil), 12,262,500 outstanding warrants (September 30, 2014 11,000,000) and debt convertible into common shares nil (September 30, 2014 12,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company's losses.   Share-Based Compensation   The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services.  The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.   The Company accounts for share-based compensation under "Share-Based Payment," which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest.  The fair value of stock options is determined using the Black-Scholes Option Pricing Model.   The Company accounts for stock compensation arrangements with non-employees in accordance with FASB Codification 505 50 "Equity-Based Payments to Non-Employees", which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.   Common stock   Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty's performance is complete.   Transaction costs directly attributable to the issuance of common stock and stock options are recognized as a deduction from equity, net of any tax effects.   Pursuant to ASC 470-20 "Debt with Conversion and Other Options", the proceeds from the issue of units is allocated between common stock and share purchase warrants on a pro-rata basis based on the relative fair values as follows: the fair value of the common stock is based on the market closing price on the date the units are issued and fair value of the share purchase warrants is determined using the Black-Scholes Option Pricing Model.   Related Party Transactions   A related party is generally defined as (i) any person that holds 10% or more of the Company's securities and their immediate families, (ii) the Company's management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.  A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.   Recent Accounting Pronouncements   In August 2014, the FASB issued Accounting Standards Update 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance on determining when and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessment of an entity's ability to continue as a going concern within one year of the date of issuance of the entity's financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is substantial doubt about the entity's ability to continue as a going concern. The requirement is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

During the year ended December 31, 2013, the Company entered into an agreement with Intrepid Innovations Corporation ("Intrepid") to sell the exclusive rights for the application of the AAGP molecule. The total purchase price for the exclusive rights to the application was $2,500,000 and was to be paid as follows:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; width: 0.25in; font: 8pt Times New Roman, Times, Serif"></td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif; text-align: justify">$25,000 cash deposit (received);</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; width: 0.25in; font: 8pt Times New Roman, Times, Serif"></td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif; text-align: justify">$25,000 paid by cash on or before April 22, 2014 as a balance of the transaction deposit (received);</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; width: 0.25in; font: 8pt Times New Roman, Times, Serif"></td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif; text-align: justify">Six monthly payments of $25,000 on or before May 22, June 22, July 22, August 22, September 22 and October 22, 2014 ($5,000 received); and</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; width: 0.25in; font: 8pt Times New Roman, Times, Serif"></td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif; text-align: justify">$2,300,000 paid by the issuance of 3,500,000 restricted shares of the buyer as payment of the outstanding balance.  These shares can be redeemed by a cash payment at any time within the first 6 months of the effective date of this agreement.</td></tr> </table>   Once the Company had received $2,500,000 in total through payment, sale of the shares and through the redemption of the shares, any surplus shares would have been returned to Intrepid.  In the event that the total payment had not totaled $2,500,000, Intrepid would pay the difference to the Company no later than 13 months after the effective date of this agreement.   The agreement was terminated during the year ended December 31, 2014 due to non-payment of the agreed to amounts. The amounts advanced are non-refundable in accordance with the agreement and as at December 31, 2014, the Company recognized a gain on deposit on sale in the amount of $55,000 to the statement of operations.

Accounts receivable consists of refundable sales tax paid on purchases made in Canada.

During the nine month period ended September 30, 2015, the Company entered into an Assignment of Patents and Patent Application (effective January 1, 2015) (the "Patent Assignment") with the Institut National des Sciences Appliquees de Rouen ("INSA") for the assignment of certain patents and all rights associated therewith (the "Patents"). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company upon payment to INSA in the sum of 25,000 Euros (paid).   During the nine month period ended September 30, 2015, the Company entered into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the "Patent Rights").  In exchange for the Patent Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company's common stock at an exercise price of $0.10 per share for a period of five years. The Patent Rights had a total fair value of $35,000, which was allocated as $10,000 to the cash consideration paid, with the remaining $25,000 being allocated to the warrant component of the overall consideration.   The remaining 50% ownership of the Patent Rights was acquired from the Governors of the University of Alberta in exchange for a future gross revenue royalty further discussed in Note 13(c).

During the year ended December 31, 2013, the Company received a loan of $20,000. The loan was to be repaid by November 8, 2014, along with $10,000 in interest. In addition, the Company issued 500,000 warrants to the lender, exercisable at $0.25 for a period of 5 years. The proceeds of the loan were allocated between the debt and warrants based on a relative fair value approach, which bifurcates between the values of the two securities at the time of issuance. Using this approach, the fair value of the warrants was estimated at $4,400, with the remaining $15,600 being allocated to the debt portion; to be accreted to its settlement value over the term of the loan.   The loan was settled in August 2014 for $23,500 (Note 7), and total accretion for the year ended December 31, 2014 was $2,630, while accrued interest on the loan principal totaled $7,653 as at the settlement date. A gain on settlement of $3,116 was recognized based on a settlement payment made totaling $23,500 (Note 7).   A total of $60,250 in short-term loans were paid directly by the Company's CEO. The amount was owing to the CEO and had been included in accounts payable and accrued liabilities as at December 31, 2014 as no formal loan agreements had been completed. These amounts were settled in part of the financing detailed in Note 11(c).   The remainder of the short-term loans in the amount of $nil (December 31, 2014 - $63,250) were unsecured, non-interest bearing and were repayable on demand.

On July 1, 2011, the Company executed a loan agreement under which the Company issued to a corporation an 8% convertible promissory note in exchange for $300,000.  The note holder had the right to demand payment of outstanding principal and interest at any time with a 30-day grace period.  The note was due and payable no later than June 30, 2016, and was convertible into shares of the Company's common stock at $0.025 per share.  No beneficial conversion feature was applicable to this convertible note.   During the year ended December 31, 2014, the Company and the corporation commenced discussions in regards to the settlement of the convertible note. A settlement agreement was finalized during the nine month period ended September 30, 2015, but the Company has accounted for the transaction as at December 31, 2014. The settlement agreement stipulated that the convertible note plus accrued interest of $84,000 (included in accounts payable and accrued liabilities as at December 31, 2014) was to be settled through the issuance of 3,840,000 shares of the Company's common stock. The fair value of the shares was determined to be $192,000 ($0.05 per share) and the Company recognized a gain on settlement in the amount of $192,000 as at December 31, 2014. The settlement agreement also stipulated the payment of $161,750 to the corporation to settle other amounts included in accounts payable and accrued liabilities and short-term loans, all of which has been paid as at September 30, 2015.   On June 17, 2014, the Company executed a loan agreement under which the Company issued an 8% convertible promissory note in exchange for an initial amount of $10,000, with the ability to be increased to $100,000, to the Company`s President and CEO.  During the year ended December 31, 2014, additional amounts totaling $90,000 were advanced, $23,500 of which was paid directly to settle certain short-term loans outstanding (Note 6). The note holder has the right to demand payment of outstanding principal and interest at any time with a 30-day grace period.  The note is due and payable no later than December 31, 2015, and is convertible into shares of the Company's common stock at $0.25 per share.  No beneficial conversion feature was applicable to this convertible note. On July 1, 2015, the Company`s board of directors approved an adjustment to the conversion price from $0.25 to $0.08.  During the nine month period ended September 30, 2015, the Company issued 1,250,000 shares of the Company's common stock at the adjusted price of $0.08 per share to settle the promissory note. A gain of $7,272 was recognized associated with interest forgiven on the note.

During the nine month period ended September 30, 2015, the Company issued shares of common stock to non-employee consultants for services and other value rendered as follows:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">       2015</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Value per Share</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Total</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; width: 59%; text-align: justify; font: 8pt Times New Roman, Times, Serif">February 2015</td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 10%; text-align: right; font: 8pt Times New Roman, Times, Serif">40,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">June 2015</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">100,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">7,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">September 2015</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">100,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">7,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">September 2015</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">300,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.05</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">15,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">1,500,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">69,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>

Stock option transactions are summarized as follows:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Number of Stock Options</td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Weighted Average Exercise Price</td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Weighted Average Fair Value</td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Weighted Average  Remaining Life</td> <td nowrap="nowrap" style="text-align: center; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">$</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">$ </td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">(Years)</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">Outstanding, December 31, 2014</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">-</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">-</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">-</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">Options granted</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">14,600,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.03</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.03</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">Outstanding, September 30, 2015</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">14,600,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.03</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.03</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">3.34</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>   The fair values of the stock options granted during the nine month period ended September 30, 2015 were estimated using the Black-Scholes Option Pricing Model.  The weighted average assumptions used in the pricing model for these options are as follows:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">For the nine month period ended September 30, 2015</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="width: 84%; text-indent: 0.05in; font: 8pt Times New Roman, Times, Serif">Risk-free interest rate</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 13%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.73</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-indent: 0.05in; font: 8pt Times New Roman, Times, Serif">Dividend yield</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.00</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="text-indent: 0.05in; font: 8pt Times New Roman, Times, Serif">Expected stock price volatility</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">125.00</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="text-indent: 0.05in; font: 8pt Times New Roman, Times, Serif">Expected forfeiture rate</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.00</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif">%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-indent: 0.05in">Expected life</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">4.15 years</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>   The following non-qualified stock options were outstanding and exercisable at September 30, 2015:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">Expiry date</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Number of Options Outstanding</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Number of Options Exercisable</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">$</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="width: 59%; font: 8pt Times New Roman, Times, Serif">March 12, 2016</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 10%; text-align: right; font: 8pt Times New Roman, Times, Serif">500,000</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 25, 2017</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">2,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">-</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 24, 2018</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.05</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 25, 2020</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">4,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">2,800,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 28, 2020</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">5,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">3,750,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">June 30, 2017</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">499,998</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">June 30, 2018</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.10</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">600,000</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">300,000</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"> </td> <td nowrap="nowrap" style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">14,600,000</td> <td nowrap="nowrap" style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">8,849,998</td> <td nowrap="nowrap" style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>   As at September 30, 2015, the aggregate intrinsic value of the Company's stock options is $nil (December 31, 2014 $nil). Warrant transactions are summarized as follows:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> Number of Warrants</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> Weighted Average Exercise Price</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; width: 62%; text-align: justify; font: 8pt Times New Roman, Times, Serif">Balance, December 31, 2014</td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 16%; text-align: right; font: 8pt Times New Roman, Times, Serif">5,200,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 16%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.09</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">      Issued</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">9,562,500</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.08</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: justify">      Expired</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(2,500,000</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">)</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.05</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: justify">Balance, September 30, 2015</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">12,262,500</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">0.09</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>   The following warrants were outstanding and exercisable as at September 30, 2015:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">Number of Warrants</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">Exercise Price</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> Expiry Date</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 28%; text-align: right; font: 8pt Times New Roman, Times, Serif">1,600,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 28%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; width: 39%; text-align: right; font: 8pt Times New Roman, Times, Serif">January 1 , 2016</td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">300,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.05</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">January 1 , 2016</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">300,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.15</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">January 1 , 2016</td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">500,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.25</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">November 8, 2018</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">6,000,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">April 22, 2020</td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">3,562,500</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.04</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">December 28, 2015</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">12,262,500</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"> </td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>

The Company is authorized to issue 400,000,000 (December 31, 2014 400,000,000) shares of $0.0000053 par value common stock.  Each holder of common stock has the right to one vote but does not have cumulative voting rights. Shares of common stock are not subject to any redemption or sinking fund provisions, nor do they have any preemptive, subscription or conversion rights. Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid as of September 30, 2015 (December 31, 2014 - $nil).   During the nine month period ended September 30, 2015, the Company:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif; width: 0.25in">a)</td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif">Issued 1,000,000 shares of common stock with a fair value of $40,000 ($0.04 per share) pursuant to a directorship agreement entered into on February 25, 2015 (Note 12).</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">b)</td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif">Issued 3,840,000 shares of common stock with a fair value of $192,000 ($0.05 per share) pursuant to a settlement agreement completed on March 2, 2015 with a convertible note holder (Note 7).</td></tr> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">c)</td> <td style="text-align: justify; font: 8pt Times New Roman, Times, Serif">Issued 15,000,000 shares of common stock at $0.025 per share pursuant to a stock subscription agreement with the Company's President and CEO. The proceeds of $375,000 were offset by certain amounts owing to the President and CEO as previously included in accounts payable and accrued liabilities and short-term loans (Note 6). The remaining proceeds of $205,000 were received in cash during the nine months ended September 30, 2015.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">d)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 2,500,000 shares of common stock to two investors (one of which was the President and CEO of the Company) at $0.05 per share for gross proceeds of $125,000.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">e)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Cancelled 250,000 shares of common stock that were returned to treasury. The shares had been issued in error and the Company had accounted for the return as "Common stock to be returned to treasury" as at December 31, 2014.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">f)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 250,000 shares of common stock pursuant to a stock subscription received during the year ended December 31, 2010.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">g)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 1,250,000 shares of common stock at $0.08 per share for gross proceeds of $100,000 pursuant to private placement offering.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">h)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 312,500 shares of common stock at $0.08 per share for gross proceeds of $25,000 pursuant to private placement offering.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">i)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 375,000 shares of common stock at $0.08 per share for gross proceeds of $30,000 pursuant to private placement offering.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">j)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 625,000 shares of common stock at $0.08 per share pursuant to a stock subscription agreement with the Company's President and CEO. The proceeds of $50,000 were offset in their entirety by certain amounts owing to the President and CEO as previously included in accounts payable and accrued liabilities.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">k)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 200,000 shares of common stock with a fair value of $14,000 ($0.07 per share) pursuant to a consulting agreement entered into on March 1, 2015 (Note 13).</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">l)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 1,250,000 shares of the Company's common stock at an adjusted conversion price of $0.08 per share on conversion of a promissory note (Note 7).</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">m)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 625,000 shares of common stock at $0.04 per share for gross proceeds of $25,000 pursuant to a stock subscription agreement with the Company's President and CEO.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">n)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 300,000 shares of common stock with a fair value of $15,000 ($0.05 per share) pursuant to a settlement agreement entered into on September 29, 2015 for services and other value received.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">o)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Issued 3,562,500 units at $0.04 per unit or gross proceeds of $142,500.  Each unit is comprised of one share of common stock and one share purchase warrant exercisable at a price of $0.04 until December 28, 2015.  At total of $42,038 was allocated to the warrant component of the unit under the relative fair value approach, using the Black-Scholes Option Pricing model with the following assumptions: Risk-free interest rate - 0.52%, Dividend yield - 0%, Expected stock price volatility 125.00%, Expected forfeiture rate - 0%, and Expected life 0.25 years.</td></tr> </table>

During the nine month period ended September 30, 2015, the Company:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">a)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Entered into a directorship agreement effective February 25, 2015 with a newly appointed director of the Company. Pursuant to the agreement, the director was issued 1,000,000 shares of common stock as an engagement fee (Note 11) and will be entitled to a compensatory service fee. The director is also entitled to 1,000,000 stock options on signing (Note 9) exercisable into common shares of the Company for a period of 3 years at a price of $0.05 per share.</td></tr> </table>   During the nine month period ended September 30, 2015, the director provided $8,780 in contributed services, which were recorded as professional fees against additional paid-in capital.   During the nine month period ended September 30, 2015, this director resigned from the board but has been appointed to the Company's Business and Scientific Advisory Board as a consultant.   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">b)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Entered into a consulting agreement dated March 30, 2015 (effective January 1, 2015) with the Company's President and CEO whereby he will be compensated at a nominal amount of $1 for services through to December 31, 2015. The agreement also stipulates a termination fee that would pay the Company's President and CEO $100,000 if terminated without cause or in the case of termination upon a change of control event, the termination fee would be equal to $100,000 plus 2.5% of the aggregate transaction value of the change of control.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">c)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Entered into a consulting agreement dated March 30, 2015 (effective January 1, 2015) with the Company's CFO whereby she will be compensated at a monthly fee of $4,000 for services through to December 31, 2018 ($4,000 per month for fiscal 2015, then increased by not less than 5% each year thereafter). A total of $36,000 was paid or accrued to the Company's CFO during the nine month period ended September 30, 2015 (nine month ended September 30, 2014 - $nil).</td></tr> </table>   She is also entitled (as of February 26, 2015) to 4,000,000 stock options (Note 9) exercisable into common shares of the Company for a period of 5 years at a price of $0.04 per share. The options will vest monthly in tranches of 400,000 over 10 months. She will also be entitled to an additional 2,000,000 stock options exercisable for a period of 2 years at a price of $0.04 per share that will vest only upon a change in control. If terminated without cause, the agreement also stipulates a termination fee that would pay the Company's CFO three times her monthly consulting fee in effect as of the date of termination or if terminated without cause after January 1, 2016, six times her monthly consulting fee in effect as of the date of termination. In the case of termination upon a change of control event, the termination fee would be equal to two times the amount that she would receive as if terminated without cause.   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">d)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Entered into a directorship agreement effective July 1, 2015 with a newly appointed director of the Company. Pursuant to the agreement, the director was issued 1,000,000 stock options on signing (Note 9) exercisable into common shares of the Company for a period of 2 years at a price of $0.10 per share. The options will vest in monthly installments of 166,666 options beginning July 31, 2015 with the final 166,670 options vesting on December 31, 2015.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">e)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Recognized $137,810 (nine month ended September 30, 2014 - $nil) in share-based compensation associated with stock options granted to key management personnel.</td></tr> </table>   As at September 30, 2015 and December 31, 2014, the following amounts are due to related parties: <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">September 30, 2015</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">December 31, 2014</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; width: 19%; font: 8pt Times New Roman, Times, Serif">Clarence Smith (CEO)</td> <td style="vertical-align: top; width: 53%; font: 8pt Times New Roman, Times, Serif">Accounts payable and accrued liabilities</td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">495</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">129,592</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Short-term loans</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">Nil</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">20,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Convertible note payable</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">Nil</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">100,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Susan Woodward (CFO)</td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Accounts payable and accrued liabilities</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">Nil</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">12,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>   Amounts included in accounts payable and accrued liabilities are non-interest bearing, unsecured and repayable on demand. Amounts included in short-term loans and convertible note payable have terms disclosed in Notes 6 and 7 respectively.

Subsequent to the nine month period ended September 30, 2015, the Company:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> <td style="width: 0.25in; font: 8pt Times New Roman, Times, Serif">a)</td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: justify">Completed a private placement offering of 1,437,500 units at a price of $0.04 per unit for gross proceeds of $57,500.  Each unit is comprised at one share of common stock and one share purchase warrant, exercisable at a price of $0.04 to December 28, 2015.</td></tr> </table>

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2014, included in the Company's Annual Report on Form 10-K, filed April 14, 2015, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity related instruments issued and deferred income taxes.

Financial instruments, including cash, accounts payable and accrued liabilities, short-term loans and convertible note payable are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.   The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 "Fair Value Measurements and Disclosures" which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:   Level 1 quoted prices in active markets for identical assets or liabilities Level 2 quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 inputs that are unobservable (for example cash flow modeling inputs based on assumptions)   Level 1 inputs are used to measure cash. At September 30, 2015 there were no other assets or liabilities subject to additional disclosure.

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.  Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.  The effect of 14,600,000 stock options (September 30, 2014 nil), 12,262,500 outstanding warrants (September 30, 2014 11,000,000) and debt convertible into common shares nil (September 30, 2014 12,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company's losses.

The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services.  The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.   The Company accounts for share-based compensation under "Share-Based Payment," which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest.  The fair value of stock options is determined using the Black-Scholes Option Pricing Model.   The Company accounts for stock compensation arrangements with non-employees in accordance with FASB Codification 505 50 "Equity-Based Payments to Non-Employees", which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty's performance is complete.   Transaction costs directly attributable to the issuance of common stock and stock options are recognized as a deduction from equity, net of any tax effects.   Pursuant to ASC 470-20 "Debt with Conversion and Other Options", the proceeds from the issue of units is allocated between common stock and share purchase warrants on a pro-rata basis based on the relative fair values as follows: the fair value of the common stock is based on the market closing price on the date the units are issued and fair value of the share purchase warrants is determined using the Black-Scholes Option Pricing Model.

A related party is generally defined as (i) any person that holds 10% or more of the Company's securities and their immediate families, (ii) the Company's management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.  A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

In August 2014, the FASB issued Accounting Standards Update 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance on determining when and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessment of an entity's ability to continue as a going concern within one year of the date of issuance of the entity's financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is substantial doubt about the entity's ability to continue as a going concern. The requirement is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">       2015</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Value per Share</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Total</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; width: 59%; text-align: justify; font: 8pt Times New Roman, Times, Serif">February 2015</td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 10%; text-align: right; font: 8pt Times New Roman, Times, Serif">40,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">June 2015</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">100,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">7,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">September 2015</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">100,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.07</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">7,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; text-align: justify; font: 8pt Times New Roman, Times, Serif">September 2015</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">300,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.05</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">15,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">1,500,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">69,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">Expiry date</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Number of Options Outstanding</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> Number of Options Exercisable</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">$</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"> </td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="width: 59%; font: 8pt Times New Roman, Times, Serif">March 12, 2016</td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="width: 10%; text-align: right; font: 8pt Times New Roman, Times, Serif">500,000</td> <td nowrap="nowrap" style="width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 25, 2017</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">2,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">-</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 24, 2018</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.05</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 25, 2020</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">4,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">2,800,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">February 28, 2020</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.04</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">5,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">3,750,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="font: 8pt Times New Roman, Times, Serif">June 30, 2017</td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">1,000,000</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="font: 8pt Times New Roman, Times, Serif"> </td> <td style="text-align: right; font: 8pt Times New Roman, Times, Serif">499,998</td> <td nowrap="nowrap" style="font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif">June 30, 2018</td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.10</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">600,000</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">300,000</td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"> </td> <td nowrap="nowrap" style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">14,600,000</td> <td nowrap="nowrap" style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">8,849,998</td> <td nowrap="nowrap" style="border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">Number of Warrants</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">Exercise Price</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> Expiry Date</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 28%; text-align: right; font: 8pt Times New Roman, Times, Serif">1,600,000</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 28%; text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; width: 39%; text-align: right; font: 8pt Times New Roman, Times, Serif">January 1 , 2016</td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">300,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.05</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">January 1 , 2016</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">300,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.15</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">January 1 , 2016</td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">500,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.25</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">November 8, 2018</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">6,000,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">0.10</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; text-align: right; font: 8pt Times New Roman, Times, Serif">April 22, 2020</td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">3,562,500</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">0.04</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">December 28, 2015</td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">12,262,500</td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif; text-align: right"> </td> <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; border-bottom: black 2.25pt double; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">September 30, 2015</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" nowrap="nowrap" style="vertical-align: top; border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center">December 31, 2014</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; width: 19%; font: 8pt Times New Roman, Times, Serif">Clarence Smith (CEO)</td> <td style="vertical-align: top; width: 53%; font: 8pt Times New Roman, Times, Serif">Accounts payable and accrued liabilities</td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">495</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; width: 11%; text-align: right; font: 8pt Times New Roman, Times, Serif">129,592</td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Short-term loans</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">Nil</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">20,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Convertible note payable</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">Nil</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">100,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: white; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif"> </td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="background-color: #CCEEFF; font: 8pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Susan Woodward (CFO)</td> <td style="vertical-align: top; font: 8pt Times New Roman, Times, Serif">Accounts payable and accrued liabilities</td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">Nil</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td> <td style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif">$</td> <td style="vertical-align: bottom; text-align: right; font: 8pt Times New Roman, Times, Serif">12,000</td> <td nowrap="nowrap" style="vertical-align: bottom; font: 8pt Times New Roman, Times, Serif"> </td></tr> </table>

14000 1 13999

69000

40000

7000

15000

290728

EX-101.SCH 6 pktx-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENT OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENT OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 1. Basis of Presentation - Going Concern Uncertainties link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 2. Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 3. Sales Agreement with Intrepid Innovations Corporation link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 4. Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 5. Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 6. Short-Term Loans link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 7. Convertible Note Payable link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 9. Stock Options link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 10. Warrants link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 11. Stockholders' Equity (Deficiency) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 12. Related Party Transactions and Balances link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 13. Commitments and Contingency link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 14. Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 9. Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 10. Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 12. Related Party Transactions and Balances (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 6. Short-Term Loans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 9. Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 9. Stock Options (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 9. Stock Options (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 10. Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 10. Warrants (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 12. Related Party Transactions and Balances (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pktx-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 pktx-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 pktx-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Common Stock Statement, Equity Components [Axis] Additional Paid-In Capital Accumulated Deficit Warrant Antidilutive Securities [Axis] Convertible Debt Securities [Member] Common Stock Issuable Stock Subscriptions Received in Advance Common Stock to be Returned to Treasury Clarence Smith (CEO) Related Party [Axis] Susan Woodard (CFO) Award Type [Axis] Stock options February 25, 2017 Exercise Price Range [Axis] February 24, 2018 February 25, 2020 February 28, 2020 March 12, 2016 February 2015 June 2015 September 2015 September 2015 June 30, 2017 June 30, 2018 Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Five [Member] Warrant Six [Member] Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Document Period End Date Trading Symbol Current Fiscal Year End Date Entity Filer Category Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Current Reporting Status Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Accounts receivable (Note 4) Prepaid expenses and deposits Total current assets Intangible assets (Note 5) Total assets LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) Current Liabilities Accounts payable and accrued liabilities Short-term loans (Note 6) Convertible note payable (Note 7) Total current liabilities Stockholders' Equity (Deficiency) Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 206,502,433 and 175,662,433 shares issued and outstanding as at September 30, 2015 and December 31, 2014 respectively (Note 11) Common stock issuable; nil and 3,840,000 shares as at September 30, 2015 and December 31, 2014 (Note 11) Stock subscription received in advance (Note 11) Common stock to be returned to treasury (Note 11) Additional paid-in capital Accumulated deficit Total stockholders' equity (deficiency) Total liabilities and stockholders' equity (deficiency) Common Stock, Par Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Common stock issuable shares Income Statement [Abstract] Expenses Consulting fees (Note 12) General and administrative Interest Professional fees (Note 12) Share-based compensation Gain on settlement of short-term loan Write off of deposit on sale (Note 3) Research and development Total OTHER EXPENSE Foreign exchange gain (loss) Net loss for the period Net loss per common share (basic and diluted) Weighted average number of common shares outstanding (basic and diluted) Statement [Table] Statement [Line Items] Equity Components [Axis] Beginning Balance, Shares Beginning Balance, Amount Issuance of common stock for services, shares Issuance of common stock for services, amount Issuance of common stock to settle convertible note payable and accrued interest, shares Issuance of common stock to settle convertible note payable and accrued interest, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Common stock returned to treasury, shares Common stock returned to treasury, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock for services, shares Issuance of common stock for services, amount Issuance of common stock pursuant to settle promissory note, shares Issuance of common stock pursuant to settle promissory note, amount Issuance of common stock pursuant to private placement offering, shares Issuance of common stock pursuant to private placement offering, amount Issuance of common stock for services and other value, shares Issuance of common stock for services and other value, amount Issuance of units pursuant to private placement offering, shares Issuance of units pursuant to private placement offering, amount Fair value of compensatory options issued Contribution of services Fair value of compensatory warrants issued Net loss for the period Ending Balance, Shares Ending Balance, Amount Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net loss to cash used in operating activities: Accretion of short-term loan Issuance and amortization of common stock for services Fair value of compensatory options granted Fair value of compensatory warrants granted Gain on settlement of short term loans Write off of deposit on sale Changes in operating assets and liabilities: Accounts receivable Prepaid expenses and deposits Accounts payable and accrued liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Deposit on sale Purchase of Intangible asset Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES Short-term loan proceeds (repayments), net Short-term loan settlement Issuance of common stock for cash Net cash provided by financing activities Net change in cash Cash, beginning of period Cash, end of period Cash paid for interest Cash paid for income taxes Supplementary information - non-cash transactions: Common stock issued for consulting services Common stock issued to settle short-term loans Common stock returned to treasury Common stock issued for past subscriptions Common stock issued to settle promissory note Fair value of warrants issued for intangible assets Notes to Financial Statements [Abstract] Basis of Presentation - Going Concern Uncertainties Summary of Significant Accounting Policies Sales Agreement With Intrepid Innovations Corporation Sales Agreement with Intrepid Innovations Corporation Accounts Receivable Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Short-Term Loans Convertible Note Payable Share-Based Compensation Stock Options Warrants Stockholders' Equity (Deficiency) Related Party Transactions And Balances Related Party Transactions and Balances Commitments and Contingencies Disclosure [Abstract] Commitments and Contingency Subsequent Events Basis of Presentation Use of Estimates Fair Value of Financial Instruments Loss per Share and Potentially Dilutive Securities Share-Based Compensation Common stock EX-101.PRE 10 pktx-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`/%5<$>0&ZUDM`$``(L6```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CIZ4/`9O2;8O4_H";3(A%'%NV"?#WM0-4;916 MT!)I-GEPQW-O,LY9,'G;:;"#K2PK.XT*Y_0#(38M0'(;*PV55W)E)'?^UBR) MYNF*+X&PT6A,4E4YJ-S0A1[1;/)2@S$B@\'C7@B]IQ'7NA0I=T)5I*ZR5M>A MRG.10J;2M?1+8N>MXM2[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?' M5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7. MU49V[M,41Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997 M'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_ MV/P"4$L#!!0````(`/%5<$=+^1`9A`$``(,5```:````>&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'/%V$MN@S`0QO&K1!R@9L9Y*\FJFVS;7L`B$T`)#]FN MVMR^E$5%'QYU$>G;@`!I_-_PD^5=&_+MDUQ=K+LV5'4?9N_-M0W;X?T^JV+L MM\:$HI+&A8>NEW;X>NY\X^+PZ$O3N^+B2C&^O\)50B,9CQ1@_#`L/G6R__6;X[G^M"'KOBM9$V_E%AOA;(3#J( MTT$,";+I(`L)FJ>#YI"@13IH`0E:IH.6D*!5.F@%"5JG@]:0H$TZ:`,)HER1 M,<C-&; M%;T9HSC-&;ZOH;3%Z6T5OB]';*GI;T%F)=EB"T=LJ>EN,WG:B=ZBA:!M56?8SM`CFU2D\#*_OJ=M%B+%OQX M6)[2R;WS<6>2T!.Z=3Q1,D-E.&IX3!.AC\EXTI@;DQT[CH[FF#+=)(B@W:E4 M*3/TJ6:.G$YYA`,9+5(4QNFT6D<./AH4,<;[6>FTX?9L%"_+$AXQPZ5P+WFD MI)93`_YCA$G/>0G(&>0YP&BAN%FYK0)3->68(&()]BF6.V6)Q@+U;,PQ?9EF M3*R; M3UKW-,=+C(Q4ZS8MS6>[%,O(-EW? MA)2?;L`=TVB7)XTE4YP)TP#-_])GIU&$+:SY.LFT4>ZM5/=ZCFATSRF-^;** MK:YYUSWHY@A:;2*=LC)W+=M&W=82TY,0!]U&I?HG%\!$ M#+XP-(YP(8I0U+RJ).7JU!MZH[X/P;GOAP'L70NVB+G!^.L'X;!'(M1R@M`+ M_4M_%,+X#,83_\H++\:CDOPV)PC'_5_GX^'`OPJ^@/_[^N)M3M\+SN%L.+[= M':?=A%.FN08YA8E"3>KE6L$^_)2\7K).$X)%FC*ULJR`SP2G!M+(@!=%E=;C2!J$"5MM3>"[]4L7T#ZI MB3'8NPV%WCYV/PAO9'0/X\QBZI-HMYIPRY0B:;<`VFLW1Y0SSFP>JT/ZHW[(7L79I;(/53UY_TJOAO('*)A5%]SJ=-=C4Z#^EE^K=,Z2'WY6^'0?B?AF=%Y3R]V9E,+W9;) MSLZMG\7J&UI]#%\\?<[F7S;W'U!+`P04````"`#Q57!'!%9PA3X!``!I`P`` M$0```&1O8U!R;W!S+V-O&ULS9--3\,P#(;_"NJ]2[/!D**N!T"+?S=8))0:`#H2-*LNK5;(UM3$D&?55&QS4/.+=2K13( MNW8H^YV*G1&\#DY#ZJO:IIFU$Q271R8DO?YTTLZFUR9 M@-P(B*J@&+8.9MFI\]OD_F'QF%7C@M[DE.9TNJ`%N[YE$_IQF.S,WV!8=T/\ M6\;-#(M-WTFD(0@O'*HK+D(ES#?Q`D6=LM/$'@YJ!.FR[:% MMK%>ABK=KR$ZO)RXLK7U[3'U(SI[5=474$L#!!0````(`/%5<$>97)PC$`8` M`)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O& M-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5' MY^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X M?+&A`T%116F]? M(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D M3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS* MVG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3 M]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H M0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9I MTAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_] M]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N M(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3 M?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0 MKH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`J MQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3- M"S-#MW)+ZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@: M0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\ MEAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`># MKU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@3 M9ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$! M=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_ M6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND M]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC? MAT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2. MX>V+OP%02P,$%`````@`\55P1]9=,FI\`@``=@P```T```!X;"]S='EL97,N M>&ULS5==;YLP%/TKEC--K30%2-2T70%IJA1ITU9-2A[V5IE@B"5_,&.RI+]^ M_B`0HK!L65J%%U_NO3[GV+YP(2S5AN+9$F,%UHSR,H)+I8J/GE1 MX@@^7[W_60GU\`ZX]"W1Z"_5!SW*-\)'51]=P1ZA@N%68)E#_Y^_"#) MO2'QZF..PTSP]K1'T#GBL'P!*T1U?F#2%X(*"90N)ZW&>CABV&4\(DH228PS M0XS0C7./C,-68)W'"!?2TZ'8PRR.4=I>G'7%8 M(*6PY%-]`VI[OBGTXKC@V(FT>4>RAF9X(=-&\B9(IEPQS`K2L.*]"SL^"1>LLX9`ST9%03>?*,DYPTZL%L-`.+"%88:G(8M?S2Z)BCM>JKF!OG?4I/'7)KZGI_+O6 MJM$E^-;;BP:+`49ZBBZCM9"66#$6SMKT9^,&FRY@U$!%O[&TY) MQ=Q'8_NG$?\&4$L#!!0````(`/%5<$>CX9Z9Z@,``-D+```/````>&PO=V]R M:V)O;VLN>&ULE9;?<]HX$(#_%8U?+O<0P#*0A"F=(>`TF4N!PV[S+&P!FM@2 ME61H^M??RI!D'73T[@G_TB>M]M.RG\Q@K_3S4JEG\K,LI!GH8;"Q=CMHMTVV MX24S+;7E$MZME"Z9A5N];JO52F1\HK*JY-*V::?3;VM>,"N4-!NQ-<&19OX+ MS6PU9[G9<&[+X@`KF9#!YT]FL!(%_\ZU`3!AV^V4E7P8_"P"4C!CXUQ8G@^# M+MRJ/6\\T-7VMA*%N^EU>D';P5Y#G6N2J9P?8.E&F*?CBX#D?,6JPJ:PV-=Y MAT%(NY3V#PSWV7?!]P8#W0/",BMV/&7+8=`)"*NLNA.%Y7K"+/^B5;45<@VL M@*R$-C9QX=9?ED**4OQRZX8[LU'[>Z7%+R4M*Y),JZ*H1[D7]2"8P;P]@35: MD34^M&RY<)D8!OT.`'?"B*4HA'T9!O5UP5TD[0^AU-O_?D5DO3FO*29,YB26 M%BCD01Z2!UOCU@`?/^3UQ'H@X$(_Y.%AJS#H=O0XFHYCDMS'<9J0BV^2576R M_D0,BACT_S#(Q9QI!(H0*#H%)>DHC;_&TY3,[LAL'B]&Z<-L^D9$H"X"=7\# M2M+9^*_[V>,D7B1_D/CO;P$U$.@WF]`XU%R3^X>9T^^%?41J'\*"EODEAEA MB%J1N>8&@;NLPM;2&+'C&Q8XYEY&" M'>Q@YY30:[E9F5R[0T!&QH#Q>'S#88_$?0AEH[2]3+DNR:-BLC$/46!Y0X^]UVX53/-+2#3/`5E"234GYQ&K&WKF-:@0V,)]VH(H?J"L?D1^5JRL6$ M@UT8A?4,/7Z&(.C"_>7`%L#A!T8*RS&N"$,P!*.PH*''T#!RB2E+89V=IJYU MD"@+]9K+[`6CL**AQ]&PZX[-TO`?E1,]WO'F#E&L*/4H>O;8T1"CL*W48^L9 M3\A%RC"J47@]YGYTQ8T':TVC>&-OJ<=;+(T7@(VE'F//IISV,`H+3#T"G]_F M/D9AIZG':4]1<#I;)@I#IHUMQDY3C]-O&5MZ,C;!18)BIZG'Z=.,'9?4V'&L M,_7H_*\4$F).A*V./%:?<-Y!M`'"3D<>IYL.>4**L,J11V4OX4,XC?;!9_(Y M$:,N1F&GH^ZQ\7KOM:#=%)+GKA,U]330RF6N/86?PW]*M^>*CKO_"BWK,'!] M);2055&,X=E,@G!U]W4@OS:DG_\!4$L#!!0````(`/%5<$==O;S:=0(``"<) M```8````>&PO=V]R:W-H965T&ULC5;;CILP%/P5Q`%NPF2=W@-^Z)&Z6(_]ECPKJ=#_S'P'M]K:0>",HBL+QS37$C:M9X'%]V M_BO8'D"F(0;QL\:=F+0]/?DC8Q^Z\_V\\T,]!TSP2>H02+WN^(`)T9&4\N\A MZ*BIB=/V(_I7LUPU_2,2^,#(K_HL*S7;T/?.^()N1+ZS[AL>UI#H@"=&A'EZ MIYN0C#XHOD?19_^N&_/N^B]Q--"6"7`@0$N`Z7$T4"(+`'$9J7]S,RZOB") MRH*SSA,MTJ<-M@K.=1`563?T1JDU";5=_>B]#(O@KL,,B/T4`0T"6$2@8B\* MP(?`'CIT^*_`P45$SP4BNX)H0H\,/7Y.CRT]GM!C0T]F&^`BTN<"B15(''HV M$^@1C4$D_0X#N`&;_+E,:F521V8SDW$1*P0R*Y`Y=#!/E07(BES96(F-RY\E MRWX!LB);N6L!D*U0FS@5NA/F1+V%6'#J` MHPIT(D#G#[&`67'N8/0PB-P(\Y-?PJQ1&:T.7"?#:*ZR@%GQ/P&CWX%K>#C[ MI1R`:WD89GF4Y]&*;`:CZX%K:NBDVA23]I@UJ39:'[C&ADZJ90M+=R1K']<2>S(DJ(`S<)KNW\^&%)B/NZ#=A(^\QSRV M\0,L+JIY:8]2ZN"M*NMV&1ZU/CU$4;L]RBIO[]5)UN:?O6JJ7)O#YA"UIT;F MNZZH*B-*2!)5>5&'JT5W[K%9+=19ET4M'YN@/5=5WOQ>RU)=EB&$[R>>BL-1 MVQ/1:A$-=;NBDG5;J#IHY'X9?H*'#:4VTB5^%/+23O8#"_^LU(L]^+9;AL0R MR%)NM6TB-YM7N9%E:5LR5_YU;72\IBV<[K^W_J7KKL%_SENY4>7/8J>/AI:$ MP4[N\W.IG]3EJ[SV@=L&MZILN]]@>VZUJMY+PJ#*W_IM47?;2_]/2JYE_@)Z M+:!#`;!_%L37@M@IB'JRKE^?V$9,RW;'#I3I4VN& MJS_[NJ+9(GJU[5PCZVF$]I&_$QNH)C,8C;*&Q`81@E=E#8Y!J\BX@L=4(;AD`XRV:0 M$&$8Q+FD'!$DL3"`?$TPV]C)`-&@NN=05\G"`,$!>;.38*')`5VFT4,+`*S M.-U="SPDG!#BH'@:FC$HZ0"2XOK4`4D1"(T%'I3T/P`A<=NG)T!U#$R$$`^8R99X! M8@!\CBCHJ%&*-')W3&:QG3&*J.3]T7L2^XZE5(\@;X'J"?G>8)&D_?I4WZ0W_/F4-1M M\*RT>37OWLKW2FEI6B3W1B-'\\DT')1RK^VN,/M-_Q'1'VAU>O\F&C[,5G\` M4$L#!!0````(`/%5<$?VRJ_@\P$``/`%```8````>&PO=V]R:W-H965T&ULE93?I.+M8PH#AUZGM>MN.TQ>(9MMU0S(; M$F>(LW<-Z6Q(5P8PD=FZ'K#"92'X&,@!F\V.-UHN3!*=V01FH71-4B_7-'HN M85J`L\DS2W9+26(ER5M%Y2O2R$F`GO\J1.(@DH4_G2"RC_VI\Z<+?S;YX:J( M*Q*TJN)=R4V*S%%DOC]?44R2WDJ@E631_*Q@/J.\R00=$_29[E=,T)LIB1", MDBQ=_0B5KXQSB-`;Y4TFY)B0S_1EQ80^S>0K_X,I=TRYQX16.[++O9G6>^8K MTOOLRHZ!Q>$<$'\Q.+8]3+8>*Z)S1G5[T5E^_KD-)HTR8ZUA, M-]+447RXW*_NDB__`E!+`P04````"`#Q57!'/[$KI:H#``#W#P``&````'AL M+W=O=6%^.915GC3FM3KZ];G2R;XEY9G/")%^GJ3%8K5L MQ[Y7JV5Y:;*TT-\KK[[D>5+]%^NLO+XMZ.(V\",]GAH[X*^6_L#;I[DNZK0L MO$H?WA9?Z>N6*@MI$?^F^EI/GCT;_'M9_K(O?^_?%L3&H#.]:ZQ$8KX^]%IG MF54R,__N1<IS8O<3?37PRHH89?M@4V%6K38) MZ48_5I(N_0^KTT/B*81U$/89LL&04<0W\SN#8+<@8H;H8((U1D@.8I@5V3X4 MN1LF']:*3_B\XXMYOACX8L(7'3\`:]U!BA:BNH4,""%@-3#JA7$*DX)1$FMM M,4K(2,IY7\'@*\"^)/`5H%D89P+ZFJ*"#D4BI8`OC*)$J`@:P[!0$!'-&Y.# M,8F-@6!B#.$@IVN)`Y$0M,$@'LD(6,(@IL*)U%U+:K"DL*406%)X1T2<05<. M%)/P[M@H'#&-0@&FW&*Q@$6>T[OJB9*PZ!#M#90=C MT-'J,=-$O`3XDML\H;6=U[KO;%)/*7;&H#.*;\,H#.!M^`EV.SP4;D6'&"4T M@AMEZU"C(HJ><<=&=PR[X]`=P^O(F)+P=*P_`?N=1,VMAY+G$%3FON<<6G0) MRE`&3U1I.I9YBNN\>D9A+/045WH%*ST5.!^,PB7"0N@N<@B]2`6OHL=*]TV- M59[B,J]@F:>XSMOKKP437=4A]&A9_W*;%<$QF/ZNJ:.\8WM M<=LN:I1?+<_)4?^35,>TJ+WWLC&]6-N&'?_4_4$L#!!0````(`/%5<$=O,%?8.@8``,$H```8```` M>&PO=V]R:W-H965T&ULG9I;5'7OPL#UE6 MS7Z?3Y?R:7ZHJNOC8E&^'+)S6G[+K]FE_LMK7IS3JOY8O"W*:Y&E^W;0^;20 MCN,OSNGQ,E\MV^^^%ZME_EZ=CI?L>S$KW\_GM/AOG9WRCZ>YF']^\>/X=JB: M+Q:KY6(8MS^>LTMYS"^S(GM]FO\A'A,5-I)6\?XT-62G[*5J+-+ZY5>VR4ZGQJG>\K^]J=EF,W#\_M,]:J=;E_^'NEIG/MMGK^G[J?J1?R19/P>O,7S)3V7[_^SEO:SR\^>0^>R<_NY>CY?V M]:/[2^#TP^@!LA\@AP%"W1V@^@%J&"#EW0%N/\`U`_3=`5X_P!L&N/?GX/<# M?.X`W0_0IJ3[`X)^0&"ZU,7;Q=&&N4VK=+4L\H]9>4V;75P\UO*B,:F=FS?- MWE$'6=;[2/?MKY4.EXM?C4\O68\ELI4$SE2R(21B*MD2$CF5[`B)FDHB0N). M)3$A\::2!$NTV="B[A?9-#DT38[&N]TF?-"T3G)I)5XK$=KS?>DJ,*4-5JK` M=>I_]HK44)'"%6E0D1IM1[>24(&H-U@C0=1;0N*Y0G@>$.XHX7A67:!8]4#( M8E)6MRE0`W!WA# MR1XN&2YD#[4&5++!)K#8+39181@"UCK80@Q+5O M7:-=_[#N@;V8]5"0Q@6!H^E:6Q?J!DL>T&+&6X(-WMDED5T2VR7)7W%AKL'?;BU!(.M82X%G#87X9:\99RD]*DK"C).E&"&2L*?9:\83%_!$3_B@/"<^ M_2XJW1">S'<,KXBAB1F:A)J;9(9JF$E@:`I=V$7,0AT-H%"Q&2M4`TP"$Q,\ MB:T%P1("5H)]<*B*F)9;GS5AJ':OB*B)XB6&57)?<[N)!I,$AAN\4#'=T)'> M!:7;U1@"$A@7\#K%O(`294#0Q*:?%!4HWAI%MQ%CDS%#D]S7W.ZA82%!P!!* M%%..H"/%9JQR#`D)`H50I!AT-"S$CA_;B4TWJSI0N+4=PRIB:&*&)B%F)IB_ M"X3A(L$`(X')2+69PD9^#8R$(2/!0".!*4+"0AAL-+$QBS2`B3+@B*&)&9J$ M*HEW)I4&CR0#CR3&(P!B_<6'K]&1-'0D&70D,4'`0`D;%*C$<"1#'"C#*F)H M8H8F(4I2O!4J1Y>3"#1"@6(T\HE3R8;P8@5JR$@29(0"Q12"+FLQP&ABTTVJ M.8M"V&5810Q-S-`D1$D>,U##19)Q_4@27$3]?B&\6($:+I*,2T/2SD6$#0X4 M5B$6'&2M1@D22P"%[NE78L(FQP MHCPL8EA%#$W,T"1$25PLD@:+)`.+),8B^J#[-2R2!HLD`XLD<7$%%L+`(DEC M$3KH,K"(H8D9FH0JB8=%RF"1(K`('G05@47409?PX@2J#!8I`HO@05?9L8BP M08$JXIH1P;D,JXBAB1F:A"J)&:C!(H511L"DUHJX?>;YQ$\7PHT5Z>@>&\8' MX<`+\PJ3D4!WV1AH-/'Y#%6Z\+;JCN$5,30Q0Y/0-7FL6`T<*0PTPH%'7D($ MR]DP-%M%4%;H:(D6A]TK8FABAB:QUW2[C8;J%&8?XXZN=KK5WA MPH@9:,K0Q,06'Z3O2\=S0Q@R,4U/ASX\9B]&SUU=T[?LK[1X.U[*V7->5?FY M?7KK-<^KK/9TOM6'L$.6[HUJ^+4]-<7L*PWIUTD=5? MS$67[7\.IBJRIKVMCF%]J72V[QL5>0B,J;#(SN5BO>J?_:C6*W-M\G.I?U1! M?2V*K/IOHW-S>UWPQ?W!S_/QU'0/PO4JG-KMSX4NZ[,I@TH?7A=?^=W_#7;7 MNC'%O/J^YBQ>A>]=H%&SF6M@T$R* ML(U.=@'W+C:`FL-C!UNL4.)Y#V)*0LS:BS&)Y'F`:`H0S0)$?8!8.448)&4O MB7O),H[3F',G%T+'5:)D]-R/G/Q((J'T>0`U!5`H(DLE+0GAQ7L5-@GJ!E,60.&9P MJ%GM/K223E92PHIPK&`-&I\4N8V88!X#Q)DE`,->F.ME%#U4/T[<(2)"^92% MSW#$B<)$KAE.?(L0NU2A9()SY6$(K"$@#$G7$!:AH1HU\V]I*27S&BQ+.DZ@ MSBLCRSJ.8<E2!2+W/GI03AZXBF+ MI`=*N64I3X@7T6.*XI:!G(`@H$I[4)!C#+80]/FRP&(0"`R".U,!QN`R8GBN M(H+Y@!`L"($`(;B3%1"$(^U@G6^!+`D!\(B#QS(-++U`$$FYGSHA0B,^:AZ6 M#`E(GX0L"($`(;AH!P*$2LR[&AWA8%XC;C$(&(,J``PYF:1$A;".^PZ:A2$0,'179QO`C./MH,V6T*,EK&O7]#[O MM`4A$*M*2%U#"9XOW#EW2XF8\GF)+%.!8*IPF0J8EVUYI/NR;2D=2Z3'["XL M5P7!5>%RE1"A;_YSS<=6+%,%P53A,I4082N?:CZV8F$J")@*GSWO;--+P!2M MFP0!2F)O1<3R2LC"5!`P=>NV(42XMABXX+=,%I:E@F"I<%DJ,",?>QH-$*X[$M#VET*OFU/[MSGF_XRW8X6[1A MUJM+=M1_9=7Q7-;!FVD:4_1'=@=C&MU:9%_:M^FDL_UTD^M#TUW&[74UG#`. M-XVYW`],IU/;]?]02P,$%`````@`\55P1V'/[(:B`0``L0,``!@```!X;"]W M;W)K6B?O3"`%=M#;+.D?U_;@(/2E=H7/#.<<^:,+^6$YL7V`(Z\*:GM*>N=&XZ4 MVKH'Q>T=#J#]GQ:-XLZGIJ-V,,";2%*2LCS_1!47.JO*6'LR58FCDT+#DR%V M5(J;WV>0.)VR7;86GD77NU"@54D3KQ$*M!6HB8'VE-WOCN;``$FH7%+A?KO``4@8AW_AUT7QO&8C;>%5_C--Z]Q=NX0'E M+]&XWIO-,])`RT?IGG'Z!LL(AR!8H[3Q2^K1.E0K)2.*O\VKT'&=YC^'E7:; MP!8"2X0O>30^-XHVOW+'J]+@1.S`P]GMCAYN@HA7#D&8VUNT?OJY>JUV15[2 M:Q!:,._68+MK8XL[_H[-_T?7*XW]#WB\/_Z%\D@6(C4"P"[,.( MMS#[#TWH9D\5F"Y>'4MJ'+6;-R]5T^V\9_%,WN%5.?`.?G#3"6W)!9T_V7BH M+:(#;R6_.V2D]^\G)1):%\+//C;SE9H3A\/Z0-(KK?X`4$L#!!0````(`/%5 M<$=4^*)]HP$``+$#```8````>&PO=V]R:W-H965T&ULC5/; M;J,P$/T5BP^H"2'95420FE95^U"IZL/NLP,#6+4]U#:A^_=K&W!1&VGW!<\, MYYPYXTLQHGXS'8`E'U(H-'$#%(R_><$`L=CLDF6PBMO.^L+M"QHY-5< M@C(<%='0')/;S>&4>T0`_.(PFE5,O/:,:I76V1+BU/VC9[] MF[Z-#KF6ZY,N2,UIUL.-0&T8*SDM[L$M*Y]Q,3`8WUX0\7Z^E* M38G%?GD@\966?P%02P,$%`````@`\55P1Y9)WN^D`0``L0,``!@```!X;"]W M;W)K:>M<=V#, MEBTH;F^P`^W_U&@4=SXU#;.=`5Y%DI(L39(?3'&A:9''VI,I#+&] M4MS\/X'$X4@W="X\BZ9UH<"*G"V\2BC05J`F!NHCO=L<3EE`1,"+@,&N8A*\ MGQ%?0_)8'6D2+("$T@4%[I<+W(.40<@W_C=I?K0,Q'4\J_^.TWKW9V[A'N5? M4;G6FTTHJ:#FO73/.#S`-,(N")8H;?R2LK<.U4RA1/&W<14ZKL/X9[>?:-<) MZ41(%\)M$HV/C:+-7]SQ(C;(.*50Q#F]A:MGWZL7HI-ML_9 M)0A-F-,:DXZ8!<&\^M46Z=SBE'ZAI]_3MXO#[8J^G1S>?B^0+0+92B";!'Y^ M&O$*9I=\:L)6>ZK`-/'J6%)BK]VX>4MUN9UW:3R3#WB1=[R!/]PT0EMR1N=/ M-AYJC>C`6TEN=I2T_OTLB83:A7#O8S->J3%QV,T/9'FEQ3M02P,$%`````@` M\55P1V%A/?NC`0``L0,``!D```!X;"]W;W)K&UL MC5/;;IPP$/T5RQ\0`\NVT8I%RJ:*FH=(41[:9R\,8,478ILE_?OX`@Y*5VI? M\,QPSIDSOE2STJ]F`+#H77!ICGBP=CP08IH!!#4W:@3I_G1*"VI=JGMB1@VT M#23!29%EWXB@3.*Z"K5G75=JLIQ)>-;(3$)0_><$7,U'G..U\,+ZP?H"J2N2 M>"T3(`U3$FGHCO@N/YQ*CPB`7PQFLXF1]WY6ZM4GC^T19]X"<&BL5Z!NN<`] M<.Z%7..W1?.SI2=NXU7](4SKW)^I@7O%?[/6#LYLAE$+'9VX?5'S3UA&V'O! M1G$3OJB9C%5BI6`DZ'MA[V+W\C_ZETF@W`B4RXC%EQ&O879?FI#-G@K0?;@Z!C5JDC9N M7JJFVWE7A#/YA-?52'MXHKIGTJ"SLNYDPZ%V2EEP5K*;/4:#>S\IX=!9'WYW ML8Y7*B96C>L#2:^T_@!02P,$%`````@`\55P1WS(GD"C`0``L0,``!D```!X M;"]W;W)K&ULA5/+;J0P$/P5BP^(&0:2:,0@9;): M[1Y6BG)(SAYHP(KM9FTS9/\^M@$'94?*!7)#,W.(!R?UK4DEF7ZHZ:00-K`DD*FJ7I+96,JZ0J0^U)5R6.5G`% M3YJ844JF_YU`X'1,=LE:>.9=;WV!5B6-O(9+4(:C(AK:8_*P.YQRCPB`%PZ3 MV<3$>S\COOGD=W-,4F\!!-36*S"W7.`1A/!"KO'?1?.SI2=NXU7]9YC6N3\S M`X\H7GEC>VY]7KL(ZS7^* M_4*[3L@60A8)]VDP/C<*-G\PRZI2XT3,P/S9[0X.KKV(4_:!G]M9-&[ZN7JI M=D5>THL76C"G+2:;,1%!G?K5%MG:XI3]1\^^I^^CP_V&OE\<%M\+Y%$@WPCD MB\#MEQ&O8>Z^-*&;/96@NW!U#*EQ5';>O%B-M_,A"V?R":_*@77PA^F.*T/. M:-W)AD-M$2TX*^E-D9#>O9^8"&BM#^]&ULC5/;;IPP$/T5RQ\0`\NFZ8I%RB:JVH=*41[:9R\,8,478ILE_?OZ`@Y* M5FI?\,QPSIDSOE2STB]F`+#H37!ICGBP=CP08IH!!#4W:@3I_G1*"VI=JGMB M1@VT#23!29%EMT10)G%=A=J3KBLU6&;]8'V! MU!5)O)8)D(8IB31T1WR?'TZE1P3`+P:SV<3(>S\K]>*3'^T19]X"<&BL5Z!N MN<`#<.Z%7./71?.]I2=NXU7]6YC6N3]3`P^*_V:M'9S9#*,6.CIQ^ZSF[[", ML/>"C>(F?%$S&:O$2L%(T+>X,AG6.?XI\X5VG5`LA"(1[K)@/#8*-A^II76E MU8S,2/W9Y0<'UU[$*?O`S^TL&C=]K%[J?']7D8L76C"G+::(F(0@3OUJBV)M M<2H^T8M_TW?)X6Y#W\7NY7_T+Y-`N1$HEQ&_?ACQ"N8V^]"$;/94@.[#U3&H M49.TR8-.BOK3C8<:J>4!6*5B8M6X/I#T2NN_4$L#!!0````(`/%5<$=+;(;'HP$``+$#```9 M````>&PO=V]R:W-H965TCI@'.\%)YYU[M0(%5)5E[#)2C+M4(&V@.^S??'(B`B MX`^'R6YB%+R?M'X)R4-SP%FP``)J%Q287\YP!T($(=_X==9\;QF(VWA1_Q6G M]>Y/S,*=%G]YXWIO-L.H@9:-PCWKZ3?,(UP'P5H+&[^H'JW3_V((N+8[T$YU^3=^M#G<;^BYU+[[1OU@% MBHU`,8](/XQX";/[T(1L]E2"Z>+5L:C6HW)I\];J>CMO:3R3=WA5#JR#1V8Z MKBPZ:>=/-AYJJ[4#;R6[NL:H]^]G302T+H0_?&S2E4J)T\/R0-976OT'4$L# M!!0````(`/%5<$>E;,4CHP$``+$#```9````>&PO=V]R:W-H965T&,"*+\0V2_KW M]04`G!H MK%>@;KG"`W#NA5SCUT7SO:4G;N-5_5N8UKF_4`,/BO]FK1V]B]_(_^I=)H-P(E,N(^P\CWL([] MI(1#9WWXQ<4Z7JF86#6N#R2]TOHO4$L#!!0````(`/%5<$>U1]>NHP$``+$# M```9````>&PO=V]R:W-H965T-S"0$U7^.P-5\P#E>"R^L'ZPOD+HBB=&4PFTV,O/>34F\^>6H/./,6@$-CO0)URQD>@',OY!K_7C0_6WKB-E[5 M?X1IG?L3-?"@^"_6VL&9S3!JH:,3MR]J?H1EA&LOV"ANPA.?,E]HEPG%0B@2X2X+QF.C8/,[M;2NM)J1&:D_NWSOX-J+.&4?^+F= M1>.FC]5SG=_<5N3LA1;,<8LI(B8AB%._V*)86QR+O^C%O^F[Y'"WH>]B]_(_ M^I=)H-P(E,N(=U]&O(3Y]J4)V>RI`-V'JV-0HR9IX^:E:KJ=]T4XDT]X78VT MAY]4]TP:=%+6G6PXU$XI"\Y*=G6-T>#>3THX=-:'MR[6\4K%Q*IQ?2#IE=8? M4$L#!!0````(`/%5<$=RRK]-H@$``+$#```9````>&PO=V]R:W-H965TD7,P!8]":X-`<\6#ON"3'-`(*:*S6"='\Z MI06U+M4],:,&V@:2X*3(LA]$4"9Q787:DZXK-5G.)#QI9"8AJ/YW!*[F`\[Q M6GAF_6!]@=052;R6"9"&*8DT=`=\F^^/I4<$P!\&L]G$R'L_*?7BDU_M`6?> M`G!HK%>@;CG#'7#NA5SCUT7SO:4G;N-5_2%,Z]R?J($[Q?^RU@[.;(91"QV= MN'U6\R,L(UQ[P49Q$[ZHF8Q58J5@).A;7)D,ZQS_E/E"NTPH%D*1"#^S8#PV M"C;OJ:5UI=6,S$C]V>5[!]=>Q"G[P,_M+!HW?:R>Z_PFJ\C9"RV8XQ931$Q" M$*=^L46QMC@6G^C%U_1=Q>_F-_F42*#<"Y3)B_F'$2YB/+LEF3P7H M/EP=@QHU21LW+U73[;PMPIF\P^MJI#W\IKIGTJ"3LNYDPZ%V2EEP5K*K:XP& M]WY2PJ&S/KQQL8Y7*B96C>L#2:^T_@]02P,$%`````@`\55P1^Y8[NRE`0`` ML`,``!D```!X;"]W;W)K&ULC5/+;J0P$/P5RQ\0 M`^-D5B,&*9,H2@XK13GLGCW0@!4_B&V&[-^O'T!0$FGW@KN;JNIJ/\I)FU?; M`SCT+H6R1]P[-QP(L74/DMDK/8#R?UIM)',^-1VQ@P'61)(4I,BR&R(95[@J M8^W95*4>G>`*G@VRHY3,_#F!T-,1YW@IO/"N=Z%`JI*LO(9+4)9KA0RT1WR; M'TXT("+@%X?);F(4O)^U?@W)4W/$6;```FH7%)A?+G`'0@0AW_AMUOQH&8C; M>%%_B--Z]V=FX4Z+W[QQO3>;8=1`RT;A7O3T"/,(UT&PUL+&+ZI'Z[1<*!A) M]IY6KN(ZI3\TGVG?$XJ94*R$'UDTGAI%F_?,L:HT>D)V8.'L\H.'FR#BE4,0 MYO86K9\^52]5OM^5Y!*$9LQIBRD29D40K_YMBV)I<2J^T(M_TW>KP]V&ODO= MZ7_TIZL`W0C0*$#IIPF_0O(]_=2#;+94@NGBS;&HUJ-R:>_6ZGHY;XMX)!_P MJAQ8!S^9Z;BRZ*R=/]AXIJW6#KR5[.H:H]X_GS41T+H0[GULTHU*B=/#\C[6 M1UK]!5!+`P04````"`#Q57!'XI3:):,!``"Q`P``&0```'AL+W=O2F1OL M0;D_#6K)K$MU2TVO@=6!)`7-TO262L954A:A]JS+`@S24HPU$1#"'7^.^L^=G2$]?QHOX8IG7NS\S``XHW7MO.F4T3 M4D/#!F%?<'R">82=%ZQ0F/`EU6`LRH62$,D^II6KL([3GSR?:=<)V4S((N$N M#<:G1L'F+V9966@F9/[O-P<&U%W'*/O!S.XO&33]5+^5FOROHQ0O-F-,: MDTV8B*!._6J+;&EQRK[1LY_IV^APNZ)O9X>W/POD42!?">2SP/[+B-2M!MN#J&5#@H.VU>K,;;>9^%,_F$ET7/6OC#=,N5(6>T[F3#H3:(%IR5 M]&:7D,Z]GY@(:*P/]R[6TY6:$HO]\D#B*RW_`U!+`P04````"`#Q57!'`59$ MY:(!``"Q`P``&0```'AL+W=OG55I0ZU+=$3-HH$T@"4Z*++LF M@C*)JS+47G15JM%R)N%%(S,*0?6_(W`U'7".E\(KZWKK"Z0J2>(U3(`T3$FD MH3W@NWQ_W'I$`/QA,)E5C+SWDU)O/GEN#CCS%H!#;;T"=C16 MB86"D:`?<64RK%/\LRMFVF5",1.*1+C-@O'8*-A\H)96I583,@/U9Y?O'5Q[ M$:?L`S^WLVC<]+%ZKO*;7R4Y>Z$9J2K/94@.["U3&H5J.TE0/MX#?5'9,&G91U)QL.M57*@K.27>TPZMW[20F'UOKPQL4Z7JF86#4L M#R2]TNH_4$L#!!0````(`/%5<$>%MX@ZHP$``+$#```9````>&PO=V]R:W-H M965TVF8UKD_4P,/BO]AK1V< MV0RC%CHZZR8#PV"C:_4TOK2JL9F9'ZL\L/#JZ]B%/V@9_;631N^EB]U/G=KB(7+[1@ M3EM,$3$)09SZU1;%VN)4?*`7G]-WR>%N0]_%[N47^I=)H-P(E,N(Y;L1KV'V M[YJ0S9X*T'VX.@8U:I(V;EZJIMMY7X0S>8/7U4A[^$5USZ1!9V7=R89#[92R MX*QD-WN,!O=^4L*ALS[\YF(=KU1,K!K7!Y)>:?T?4$L#!!0````(`/%5<$>V MC[JV!@(``'L&```9````>&PO=V]R:W-H965TU%I=5>M-<.3`):&U/;A.W;US;$0<02N<$_G#G? M#.`A'QC_%#6`]+XH:<7!KZ7L]@B)L@:*Q0OKH%5WSHQ3+-627Y#H..#*!%&" MHB#8(8J;UB]RL_?.BYSUDC0MO'-/])1B_N\(A`T'/_1O&Q_-I99Z`Q4YLG%5 M0Z$5#6L]#N>#_QKNCZ&1&,7O!@8QFWLZ^1-CGWKQLSKX@!\?G/_;LI5Z9^P@#=&_C25K%6V@>]5<,8]D1]L^`%3#;$V M+!D1YNJ5O9",WD)\C^*O<6Q:,P[CG3B9PMP!T100V8`T,(F/()/F-RQQD7,V M>*+#^N6%>R7GVD0YZXFN6Z4H5/7C[K4(TUV.KMIHTASGFFC46`52[DY$=$,< MHX?P:#U\8S/AV06DCD,EM^V M2Y.L0\+@?H("AT6Z/$(N4?8$9W92PP<+U5N7')=H>5K0K#E0X!?3`X57LKZ5 M8Q>PN[;/OD:FN=SE1=[A"_S"_-*TPCLQJ5J4Z4YGQB2H7((7];W7ZD]@%P3. M4D\3->=C;QP7DG6W5F__-\5_4$L#!!0````(`/%5<$&PO=V]R:W-H965T&,"*[:&V6=*_KVW`0>E*[0N>&U;_' M:;W[,[?P@/*G:%SOS>89::#EHW2O.#W",L)M$*Q1VO@E]6@=JI62$<7?YU7H MN$[SGZ)8:-<);"&P1/B:1^-SHVCS&W>\*@U.Q`X\G-WNX.$FB'CE$(2YO47K MIY^KEXKEK*27(+1@3EL,BYA=0E"O?K4%6UN2W]QFI/?O)R426A?"+SXV\Y6:$X?#^D#2*ZW^`%!+ M`P04````"`#Q57!'&]9@++\!``![!```&0```'AL+W=O\'CX?N9@;'S0:IWW0(8],F9T(>H-:;;8ZS+%CC1-[(#8=_44G%B M[%8U6'<*2.5)G.$TCC/,"151D?O`#&G)`U_I@TORT=<1G/ZH^^6UO]B6AXD.POK4QKBXTC5$%->F9> MY?`$4PL[)UA*IOT3E;TVDL^4"''R.:Y4^'48WV3I1%LGI!,A#82[V!<^&ODR M?Q-#BES)`>F.N'^7["U<.1&K[`+7MRU1V^['[+E(XUV.STYHPAR7F-1CDH#` M5GW5(ITMCND/>GJ=O@D5;A;TS>B^_0__;1#8+@2V4XO918MKF-OK)KM@LEL1 MN+LP6)%WI($_1#54:'22QLZH'\]:2@.VE/C&-MS:FR!L&-3&A;&ULC53=;ILP%'X5BP>HP8&NB@A2TVG:+B95O=BN'3B` M5?\PVX3N[6<;<%&*U-W$QX?O[\AVRDGI5],#6/0FN#2GI+=V.&)LZAX$-7=J M`.F^M$H+:MU6=]@,&F@32()CDJ;W6%`FDZH,O6==E6JTG$EXULB,0E#]]PQ< M3:]:D-7B3#[0R>?T0TQXV-`/LWO^'_YY%,@W`ODRXN%FQ#U,_KE) M$4V*'8'BQF0/`GU1V3 M!EV4==D`0``L0,``!D```!X;"]W;W)K&ULA5/;3N,P$/T5RQ^`$[<%MDHC41""AY40#[O/;C))+'P)MM.P?[^V MDY@(*O$2STS..7/&EV+4YLUV``Y]2*'L`7?.]7M";-6!9/9*]Z#\GT8;R9Q/ M34ML;X#5D20%H5EV323C"I=%K+V8LM"#$US!BT%VD)*9?T<0>CS@'"^%5]YV M+A1(69#$J[D$9;E6R$!SP'?Y_K@-B`CXPV&TJQ@%[R>MWT+R7!]P%BR`@,H% M!>:7,]R#$$'(-WZ?-3];!N(Z7M0?X[3>_8E9N-?B+Z]=Y\UF&-70L$&X5ST^ MP3S"+@A66MCX1=5@G98+!2/)/J:5J[B.TY_=9J9=)M"90!/A-HO&IT;1Y@-S MK"R,'I'M63B[?._A)HAXY1"$N;U%ZZ>?JN>2YC<%.0>A&7-<8VC$Y`E!O/K% M%G1I<:3?Z/1G^B8YW*SHF]GA[<\"VR2P70EL9X%?7T:\@*'9ER9DM:<23!NO MCD65'I2;-B]5T^V\H_%,/N%ET;,6?C/3"O9U0ZCSK^? ME`AH7`AO?&RF*S4E3O?+`TFOM/P/4$L#!!0````(`/%5<$=UZ1Q9_P$``.4% M```9````>&PO=V]R:W-H965T0J.?'+E@1.FE.(6R%4`.EL1HB*,H#QFIFZ`L M[-ZS*`O>*5HW\"R0[!@CXM\&*._701R,&R_UJ5)F(RR+T/,.-8-&UKQ!`H[K MX#%>;9<&80%_:NCEU1P9[SO.7\WBUV$=1,8"4-@KHT#T<(8M4&J$=.&W0?-2 MTA"OYZ/Z#YM6N]\1"5M._]8'56FS48`.<"0=52^\_PE#A,P([CF5]A_M.ZDX M&RD!8N3=C75CQ]X]68RT:0(>"-@3XJ\)R4!(+H34)G7.;*XGHDA9"-XCV1+S MLN.5A@LCHI7-Q!R4SB3U<;G=T2>S%=(?(CDBI\.(?"\0.H%T@F!Y.84'*:QF,R=0II'YG>3YAX8S7O) MO)=LPDLZ+Y![@?P;8?(O/+H4]X@81Q_C?NIEX;TL)KQD\P)++[#\1ICEA%6< MX^SNS4P`X\E,X=7U82!.MJU(M.==H]PGZG=]YWK$YOK=[&]T1W,-Z")3%BTY MP6\B3G4CT8XK?;GMO3YRKD#[C![T-U#IGNL7%([*3'430<*U(;=0O!V;JN_L MY7]02P,$%`````@`\55P1S,#T6J<`0``KP,``!D```!X;"]W;W)K&ULA5/;;N,@%/P5Q`<4&^M#)N2UOONPUC[M""%NX..S!A MI4&KA0^M/3+761!U(FG%>):MF!;2T*I,<\^V*O'DE33P;(D[:2WL^P,H[+)%WEL?9Q@5(K['Y66]I M%BV`@H./"B(,9]B!4E$H;/QWU/RW923.ZXOZ4TH;W.^%@QVJ/[+V;3";45)# M(T[*OV#_`\8(RRAX0.72EQQ.SJ.^4"C1XFT8I4EC/ZPLLY'V.8&/!#X1\L67 MA&(D%%<$-CA+N1Z%%U5IL2>N$_&R\TV`VR@2E&,1#RIDYA@^8/Y'[&X1139!6##PJ0L^N>`S?I'X^2+_7J"8!(J9P&*,L;Z*,6!, MPJP3)KN*<8M8%7QYG83-SK831_@E[%$:1_;HPS6E&VH0/03%[&Y)21M>S]0H M:'PLUZ&VPP\U-!Z[R_.8WFCU`5!+`P04````"`#Q57!'1<%CT80"``#T"0`` M&0```'AL+W=O_$K9.R\) M$=Y'4[=\XY="=$]!P/,X(,V:NH``9`$#:Y: MO\CUV2LK M)//OP>G(J0RGZYOWKSI=&?X.<_)"ZU_5090R6N![!W+$YUJ\T>LW,N00*X=[ M6G/]Z^W/7-#F9N)[#?[HWU6KW]?^2P('LWD#-!@@8Q"F.O">2(?Y!0M M/=YA)1Y\DG"FG$C/:J'REB%RF7U_>BD06N?!13D:,-LI!FD,-(A`>I^E0#>* M+;+,$8ZO#]&$]QDZ&=BO/Z+&V]`A=]1C;&68N>F1S>CCDA,:>1W;/ M6P(@8`F@KY\[HF!R*S>$G?3PP;T]/;>BOW[-J1EPGI&^U4=XD7?X1'Y@=JI: M[NVHD+.!'@N.E`HBHP$K^2\LY0AF-C4Y"K5,Y9KU0TF_$;2[S5AFT"O^`E!+ M`P04````"`#Q57!'(O16,C8"``#%!P``&0```'AL+W=O?_QH899XV0[ZJ@5`%UX*T^%M@L@SX"/.Y2<5JH452#I<1,^HZ6>3?LF@5W8 M?`#N`K`/B%P`:$$NS6]$DSR3H@E43>R/AYZ,7%H3XVP'=M\F165VWZY>%$])&-\V2+Q!,I-J,DIUJAE(/F6DGI'.,-(1(_W"<2P]:7G'P2^_ M0%IYTFJ&M!R1III[SFWM&>L9QFK$6`]VLW8:N(!W_%D1["L*SG#6XY*"CX(& MI8NFH!B.05/1/:>&<(_!,Q@TQN!']].7.9JI\WC2BZ)'07V5HYDRCZ,Q:$X4 MCSA@T&8YE2=WFZA@+\Z5;ONI7_4WUC-V;;J7YUE-3O07D:>R4L%.:-/L79\_ M"J&IR04N3,LHS)WJ)XP>M1TNS5BVMTP[T:*^7IK^YL[_`U!+`P04````"`#Q M57!'1>^08\P!```$!0``&0```'AL+W=OUD)QJLY0-5H,$6CD2 M9YC$\0%SVO51D;O:LRQR<=6LZ^%9(G7EG,I_9V!B/$6[:"F\=$VK;0$7.?:\ MJN/0JT[T2$)]BAYWQW-F$0[PNX-1K>;(9K\(\6H7/ZM3%-L(P*#45H&:X09/ MP)@5,L9_9\UW2TMK=&O"QA&JH*97IE_$^`/F%E(K M6`JFW!.55Z4%7R@1XO1M&KO>C>/T)EEH80*9"<032.*"3T8NYC>J:9%+,2(U M4/OO=D<#EU;$*-N)[=M$5*;[J7HK2)+F^&:%9LQYC2$.L_,(;-2#%F2Q.),/ M='*?OO<)]RMZ,B<\;!*&,-E]D\2;)`&!+QN3$.;K?9/4FZ0?!=)X8Q+"?.)K M'[S)(2!`-B8!S&H4N0IO#XLY)+80&$R5^,%^U-5>27S"HM9UF9BZG4SHM MM!B6.\=??,5_4$L#!!0````(`/%5<$?ME`TLW`(``.<-```9````>&PO=V]R M:W-H965T\[M*(C5;5>U%I=5> MM-?>Q$G0`DZQDVS?OC80C&)+F>[F(A@RGC.,^7+PXB*Z-WG@7`7O3=W*97A0 MZO@817)SX`V3#^+(6_W+3G0-4_JTVT?RV'&V[2BO/7>K MA3BINFKY`^I2;@1M>R_ M@\U)*M%M-L6L`%F[`>"^XYDOS%*EE^08/WQFF-19;P!@P M?-"!P2(+&`^&3Y@P6+8!8\/@^K!Y^\&\_H"E&WQ.C/B3!@LM8+P8?&:,6`%J M@:48+Z:N%Z/?/BW8%&/%E+@,^*2BV3O\D>WY3];MJU8&KT+I[4"_$]@)H;C. M&3_H!_6@=UW32Z&?$-K_>;"!2-*#\45R$90)]_):*#,!LA2X MO'/):"U+7GN"7@[^"]H?$38A-N)/25LYZGO&_(GS#S/X=3[XT'B@%]$'TR2.^X/Z#[M<;?]$)'WEU=_RK`KM%OK>F5[(K5+OO/U) M^S6$1C#GE;1/+[])Q=F0XGN,?'5M6=NV[=Y$09^VG(#[!.P2`FB-=R!K\SM1 M)$L%;SW9$+-Y:*_#A1'1RJ9CUJTM2KWZ;O:>X2A*P=T(]3''<0RV,T< M:;=BFW?S;<9XY9H21TKFI!A.2,F(E-@8N(')KC@"(3P0-JM M((U.,5H@X2D)+9)6?-$/TAX89>FWT,?].3/`Z,:Q:BXVE(LO9S?:M45(S?K MROV+K?;@$9ZE#;G2WT1E&F&^N^ MZ$IT-U"\&6X<=^UE_P%02P,$%`````@`\55P1[>6)G+-`@``8PP``!D```!X M;"]W;W)K&ULE5?;CMHP$/V5*!^PL2?DPBI$6K:J MVH=*JWUHGPT8B#:)J6U@^_>UG1"GV!(N#\0V9^:,3W+BH;HR_B&.E,KHLVM[ ML8J/4IZ>DT1LC[0CXHF=:*]^V3/>$:FF_)"($Z=D9X*Z-@&$\J0C31_7E5E[ MXW7%SK)M>OK&(W'N.L+_K&G+KJL8Q[>%]^9PE'HAJ:MDBMLU'>U%P_J(T_TJ M?L'/:R@TQ"!^-O0J9N-(%[]A[$-/ON]6,=(UT)9NI4Y!U.5"7VG;ZDR*^?>8 MU'+JP/GXEOVKV:XJ?T,$?67MKV8GCZI:%$<[NB?G5KZSZSL%>8[ MVIZ%9-TM)(XZ\CEHX!@\$3(E'9O11PHUB#$PYI M^CA!.M68SA(LQAH7=S4.F-Y@LJ%&@!PRA!XS+2:FA8YP@FQ)D`:5F;JDY MTI_'1/E$E'N(\CNB?$:T-!CT%'#GBHFD$`4=R0^3/F8I)Q(2D^"Y>,$RRG! M,D#SI:-Y&B@Y1M8K*$#T$?2OZBC@(<(S4^(`X;V@`.4Q6!YP4Y0AFEAOXA!S M8M>=P?);?!> M_A$TEW]XWP?H#]:LX#&KH_\(^N]W/EA'@\_1]_+[0.4B@,?:&3QV+@.>%+!& MA9#C%MSS-LT".P.P9H60$Q=\1RX*T<5:&D).71^HS.]XDED3V%%^,+VNB+;L MW,NAVYM6IW[Z!4P3:>%U=2('^H/P0].+:,.D:D5-%[IG3%)5"WI2`A]5QS]- M6KJ7>EBH,1]ZX&$BV>G6TD__*^J_4$L#!!0````(`/%5<$?1=UKE"@(``*,& M```9````>&PO=V]R:W-H965T<_Q]GQ&*D?%WT1`B MO<^.]F+O-U(..P#$L2$=%D]L(+VZNP_SW,Z%LW/NA?UMX:\^-U`N@+(#UU6U'>M&RWN/D MM/>_A+L*:841_&S)*!9C3[,?&'O7D^_UW@\T`J'D*'4"5ILKEK@L.!L] M,6#]LL.=DG,=HI+U0#=*U214NZ;5:PGSK`!7'31KGI<:.&G^552N(@JL!"B` MNQ304L"%/S;^.%A!3)+>2#(CR5"8Y2L05P6S($?1-DQD82('!L)U2Z+%;X=D-B`9+NMB8,9HV15BJL)(4H0W$9)+4KZ0%/3 MS::Z"K4=!0\T-;,@V9VFHA5(M@GB*L+@,9+&UL[7WI;AM'NNCO4T]1$!2,!%",2(I:DDP`698< MG22RQE*2.SBXP&V21:G'S6ZF%\D*SFN<\T#S9/=;:NV%I&0GP6`\@R0VN]:O MOGVI^J8H2EFE\:^5.LNJM/SKUO!DL"4_+)*T^.O6?5DNO_KRRV)ZKQ91T<^6 M*H4O\RQ?1"7\-;_[LECF*IH5]TJ5B^3+X?[^X9>+*$ZWOOVFB+_]IOSV=3:M M%BHM993.Y'E:QN63O$QYA#A+Y9XL[J-<%=]\67[[S9?8A_N=R!^SM+POH,], MS>I?;]2R+T?[/3G<'XSK'Z^RA[XJC#_T8.1IOV.<,UA$'B709*8^R._54^=*;Y^6C6D& M^WM_J_]V"JUGU.,BB>[J7^=14C2&L7->?D>WN#X=YHT`''BSA1 MN3R#?G=9W@#BS2)*\/L[M=OX:`6]E-&9558\:_-VG#C)`M%H"Q-V4V M?=^3-T1&\FU5%B7@-@S8>=@:Z/K,+^#GQA1_&ZWK34?6VO?5Z0^G5V?G\N:[ M\_/;&[GS4QI5L[A4LUV@]I]N7LN=[=W&Z&H*"#8@FCWH0I;3HE!E8[JSJ+AO MD,)TBLRLD+F:JO@AFB1*[EQEI9('C:FO<[6,XIE4'X"[%0!"Y`PS.)4B;DR& M?/&K8AE-U5^W@/$5*G]06]_*!CUD)4!HJI<=M2[[$M`LO8MQ9=Q`+W#<6""/ MUCZ*`#E7JGRA4RR*#7K M.VRL[RQ+'Q2@,(Z=8A,S$7UFL?3 M6*73IY:E$$D43!+;^_U]_-]X!$O*Y4.45.IK>;"_W]OG?^14MV?:B:H2]AS_ MIF9?`QX>]L;[P][!:$0`&QR->X>'_'?=/$;RGM'7S%$=')2,2F`"RU(M)L!Z MC)BBAH#G^E>-ZX"AQ5)-R_A!)4\:8H/!RHW1Q`C@KV4:)S3LJ'=\P#LR6WG> M(CKGI1.0134IIGF\)`G))`4;CU,9S1ZB=*HV7'>9R8F"_F65(WN$OY:@/!15 MOF+CIS-@'3`M(`Q2Z1Y,.HV6,2!0"YY7BRH!08#DBRA2MB->$6"5TE@UZ\8J M[N;A*4'QV<.LX(L[UQ'2PCUH#_WA^=2O?7LBWU^?O3F\OWUYM**1&&^ND#1%VKH5+"^\LJH3$_UPIPV,' MP\;<;U2J4%TDYCU;Q"DIH<@V6@2+@ITWD!\TT[DJ"J:EU9,1T/-%EJOX+@7Q/[T'@:SD'6YJ M)\F*HK&**P7B"CY(L!&`U]\C# M(A"J$:PGK8A7`[!":>7+G`W#_YO;MV???O?WA]?F[&Q"L?_OI\O;O(%C/ M+R[/+L^OSOZ^6R.($[E@S%>(^3(PO[KIQ:?D5=^($2#1KF#^U\C\+U-0]%N9 M/X]SX\FI`C1K)ZA.65"M7`6+IW>>>+K5XFF5J'G=+FI>@9F8IG@VKZ($I[9< M$N3R2FVWI>?I`C6XM3T)C"B./5RAG2&ZHJX:3Y&5MG/M'M)2-.P,0F3G` MSQU:HJ^.QIIW/7N1+Y[GF?M95CE^*7'"90Z6!4Z0@#V@F=\<&$)Z]^SE;SIL M^VH#`=BF7G6M9X..'P$??2#+/%N`5`;CG,[CHV#3->0S5^FC-.OOP,RU@?!1 M]-$<;/W*JC1&X^R3(=;SQFM?WT44ZQWH[;(*@`#/-'>-.Y2WM,SC246:*.H" M&C#/F.`QRM&[UC7#.4N\%JZZTBE8[^98ZLIN@=0\.[WY3E[\\/:7#?5%K_W% MN[<_&GWSZHT\/;N]_/GR]O+\IBGR_E$5)1Y2@4<'QE8&^CWR,J-4P*_3J+B7 M5<&B+0,M(R(-,D(SD@R4KUHD%M"W.935"II%)N*8"_1._1:9OIVH_P(4NL-S M;I[P)KC1T76%0BJ=)^,Y&FGC3$E)+&J`9P<.PLNS$ML.H>Z5:E,=UY[N.CR[ MO/KY_&8-GKU>O>:@2T_Q*@?3L`0UAO8A7\>0-(^;P<7 MEU=@*J_>0TLVZG@Y;GL7TIRV.QU98S-E(7PD! MZL@&"+DXFD.CG[,'&JK1#F%)[>8'-U0HB58U(7\*;23NL!CKK0`"2I;1AQ:S MNEHN&8+H.H^#^$Z:I7L$$@R:%`@!H/T&;32,>,6S3IV!W,5IVKHZ7:'&[)ZO M`VVZTF54E(&G[)D+K2DUJ[EB34B:8PP]RO4A!GV0?T5P!@C2;TE#_W`&P%X7&^S'*RWBJP9]F43Z)'6AW^F?:#?[E2#]$L0B9I?:;# M44\.3DY.^O(66NJ)X1A@XH6:H?L.7;KLK-#SRL?[#%@IGBYN&:"`DVC?J1%2 M]]4"6-&]BI(2.H).4Y_`.,R3)SL!`$[@4!.5@A6J)=`N7D*4!UGBOUFY)ODJ=I!BA7JAA=^UNG%V^NMW8EH!&@5;P7W>&AW/F->DC` M,[6(\O=J)DY/WUSWY>L*M4C:#O`DQ5X"S7.[.Q:/IK%>?H:.)S M!SHJ"9-P+SGZ0@K+;8D;`%?-"7<$[&XX)J_W>95G:)P6\A'CL(`()]Q/:`P-*N=J6B6(&+`SD[!#$D$-QB%R`W@E46,E%OV M]29('%.PWS.# M14XU(W-%F9/%?Y%8["&Z:Y&.(234T$34#-ZT![!H6T!4(?,SR]\AW=13* M'TPB"VX(`207\BP6%9QF40`ZTKYA\'E5(M5-*@`1?/'40P*F'1=M>"!B'-ZS M+_H"%IHK(`8`OFYK.5K`8AM[1'$"A@XB-IQDM<0^$^2^A@B:&S9A-X`([@+T M/(%(-R6*18Z$J\LF_^!89A^X3@JBEZ0;3+9DF0\HK=([^)TPNE"*1EXQ67F? M9]7=O0FO64U:`%1SQ?@"I`6?2+GCL^-%P>S4EF`X(^*`
.^1CY.#0=!A,+3R! M33EH)N[DI'>?0)^CPRH!I=4H1O7)YUE6DH=[%A=3X+45^L%2;(+[U[A-^V^E M`0MKQ$N:CRQ=VE(+&-OA[8X.SF>&(ZB9G!.M4E07X1>D3X&Y"`@"A%F:82LOH=A1H`GN%[- M.^@%6!;.?WH<9Y`2"1@_V][WND8X()@0JAQ%'8*K`;V(1";L-STFXR M)#JS\(96F!.D+2+$H/7$*0IKY+\M9U\;DW@W617AR(CN])T5S3FGQQ&7EC^Q M!^V\*.,%\1U*-G-V1RMAMC"[G_HW?>)11A M5A)5T7R.1D9.)Z)FVO5/6VUW8`J.)QOFPDXP8@$NK:W>![4VTORU!8U_;M>+ MB57Y!GZV=BASBMSZ8URX8DP^ZLA7U9GT6D8;9@KV&NXU8S" MVA%[!5A/P7R.<2_,S M:]7'42A_AZ$NOR"''O,X;U@1$&('6OMR[!0,QN/AOMSR(/\CC^UP^[43REMZ MJVC8I'I'0L<'`2T`0J`_X[8!7:.%0AV8.`JOEY18NU@VLX`PX#]%(/G9XO&@ MM?"6U+>+]B84D=_\/@9V!P;+DSD9RVJB%`1`J2VG100'$_^F6"8S?\LFZ)NE MDX[39:4A@$E*]995ZMH*W?;Q'M2'MKWRZ2U1]WP"X*%C=4*GERLE$[1DB6/H M85@=!S-IHCAZ@HME$'AC?B5_P(YR(/_YO_+7BB0OR*$IT;H@`PP@ASXN[>J( MT40BBZ[="N#AALWAH+,H```)R,\.I"+-*YB1W+AN.Z1/..#R7".`@_`O"@!EL4,C.R9=?>8N&KT`$::4?W]8(_.\30VR>-+$K2, M^&"1)5YSDE9]G25(<<0*]BEX+LH5F5]F8]J5S8E@H'RDY"FS8^\2])8.>F)F MH.>&'KY*S7N M4]'1>3`PCM==+>TF92!1-%Q\2&#^<]=P0S<<8J/P#'ZKKC+PK!C6N7,MX&,- M#]2[AA$`[&8:(7>+2PHOD/OTRYZ(V"%+73.JY4@^@_F950:Z36!5=D3;&!\<\"Z%'MJYP?R%:4W$F MH5%Y`#<+0VZODFCZ?N]F"D2%U2J<4GX-'!,;_(@,*I395B.A7`.7ERK\O%2- M^UL^0*\Y!-S;LM)LFH&R]QO*,UC^C#15WX6?!GHK@=QXDK&CB3@$\V8/.GJD M(69,`L(6G@5UV&G)_!,#X7684HPF("[RS:%F$Z<&=.+C08=3A$"C,[S3*@N9 M&1BJ52`TLB=EI%/H%[@XO7D%X\](9Z9!QOMCI+8Q:$-M=1XI.$"QC*-0:%XE9.K#/%62VTB!96SKQC.&%F\[>H$ M2HS).='T'@&9BZ[)W%!_*8+)M**!$:P^QOU,O@-9/*BN`P#1"1Z5G"5':K"V M:.*N7!-;;&(1R1P%\;,9^_?A5"J>BVQ>!C&EOY"!#_P`S$4MVX&Q7]?LF8.C M_3TT:5Z#U!5$ZUS651AOXUO2Y!@[D8C9&M8I-S:81JCDLA`!'B`T,?!&@K)\ M9$]A?7-!G%58X8(SXQQ[@($1:3:>SLJ^@(2=-YZ(0FC,,YCTL?BJ9N@9_)F& MR!^.R9JX0!U4^SJGH7!@-A!KWN29Y\V)N@+(+1R^R0E$.X=_IZ,>UX3)'HX5 M\K06$HE]?[A'4SOQ+B$$8&Y!.P/T1B6WD(/]+U!+)]_(JF"TYD>PWWB!`2\* M4T1@ZY!O8">&"<*^GC-7P&?X7F0+!8R&9[>$0?:/_1MZF_(L04=%8?Z2<'0` M&Q9:[NOSU`T:CE!R2._$#[1IF%(\WF,*9>I[?\AA/H>C0P(,?5:LXI@LO)F: MQH7OW->38+C?2W#2"R;VR;(?K-)(A.?CMRS`AA3!CBDR(+* MP'B_TVY)0U'^L*3&8^E#+8*39RG\>:K%_64J3ZL[$&[:CXL[(>&N\=GU%#>H MP),J\].2"`![[*'#]G7@&@PR=[0W`H#,QU`Y\\5 MXJZ*60$!(!FB(7,"`48A9[!LG5.0'!6X@`5N3AN3BJ.?>R;Z605+95L`95F+ M_XZ"K,!%'V6AX=#E@M5RP'J'R76FDQ10WR^,%F+=*>TAZ99P+3%DRFS5_GA? M$*('Q!,=)##-\*T>R1W`HOJ`T;S4:@./F7KRKCU@@$J';S%/#"_LZ:.QH;3= MOKRHO#B^Z(>WW\F+$WH@,[0A*=9+)(D<:DE MQM13NJX7021L#`0)`"CAL->:@D(KIQX]4E\POLS2FZ+AB,4E19`H5FH^T?$A MUS8X'W,2AK$A4%4@\RJ2J$3FY,\%]C,M6U)ZVI"Y4=$(1FB$6N?I7:X8&L0] M+X&3JF4\@S^DV8/F-F5I0`.V,/ M`Z!H]+PUR)TMTV1KES,ZDX1Q\\,T`?$.)\8I:,($IS1U^'$$S*@#R9N`E$VT MZ[.DPF.K/[`N8H:HCVT\X_[0Z)#8)E>,26^CS#,F5\KL];0E\<__L5ELY#0T MJ?`[)IEJ]VN_#?4'44QM<1\YC(K9*)SJ)8=#[8TA(IQPY879K2_[.N:YB3]P M'A90CTGH]C/M@BDQR0TG_,\*6!K_(>%?C)R#/SI/T7#(2NVTS/BOIA!^F\=V M*R&@T:Y[(PU&L_&ZUCZR@,9L:C@LE,FA2V92/9$_U&S(_.X[RC2D3"A8#X`* M"T5^9XB:-'^D4\WU4.@)1C4_7BC#WYE]Y[#]0U/!:42$Y7@N4H>*A\'\OGQK M5"'GB?+2ZAQ68;R2$=4DZ^@%];BDU]>%C>;([5B%GZG%TJ>#0E=\4[Y9E2\! MR4WG1PKM.0>32==&OF@HT*828!RQ9/6R=+2D885[0&,.,O4Q*IPO/$V MHA%?PR\:FO10'6K5,^JXJ\Y%GND@>;J7JSGHUCJBX[F!A%6NW6(YV*RK4^L) M`CX"^28KEUE[Q&\JP#76\LJ(W,=,DMJ-6OC7'[@0?4.T'?2EK;=YUUEO\YPF MWETR.H]3!ZP-J$1!$@SM;&(1L"7#NU%9G-'FSD!IG$6-Y8[[?IU-^TTW;[)L M]A@G;)(T6OOJ>'<6_MI)GI/2+=I3NNOB%"8"2\N'E7":@!,"_H2LY4+O`F7ZMT+T) MQ_$N`X,/I??5S2D,8H5SL%ZMFPH_+QTC`5KJ0N-L&A.9DM)'*_$76FSMUORR M>'HP(S&A9:X>T!6?U,$F`2(J)>>O(S6S0@/#V#/C]@]X&@-3MPEC2Q9^4K5_ M#*NV4F:!JD2YHH:Y(-O%C6B:+:J%K.7DRQVDA-WG50ILA%;R5DWOTRS)[K07 M!(WEFO+XAISX?P?RO>LX7.3"8W1Z/*8`G_MXB5[;MDJ$YYRX?$<-\=POO8LE MPL/3C7I^;,ACTRAU3%4"PY!%9Z9=;*Y*P7J5=MC^VGUV1$B0Y@`+Q6QPJV!EC8,GIY&6C'$X4V6QV5#V4!A9Y:<'X)20@_$:W.9YQ,(VQ%3$F+=8N^P>%3S%=W*:'D7.4:G=-D@BB'=!1@2V0RQ.]R#!2; MU*@\>XH2S(9FJYJLYJHH*'%(\ITNHYWI;D/&'&+($=-F;C%MYH>V:KAUWU]D M7GFU&%1O23H\G3`#F'YT=HF^CPT4W"L`&XU[;-2)*,G0]X/G;I"$,F.Y@)'H MS>02A&O0?JUQG6@T7B2X$;35F08X::E$`AB.&V@_]G'>^L#UR?)F,.#<]'R3 M&HEA;4&N6/J[W?QKQZS(3OK]4Z,)H& MGK\($Q3Y../"FZ?=:^[*GR(_CH50.N@=$#4WR%%L`Q,_["9'`@:Y[K+T:^,E MI5)U;H->=J^66Z_'1+@H^\L#>PV;N.,L$)*@)&->SO:0;#5[0UU/,U>Z:,^6 MRF^2`FM,[,,1L[-$-2X9,;X97:5,N=-1(JSI<=0['(^T!DUBU&V8(YFG5ED. MZ]JW1[W!X)!6X*G6'CIYS8W()C64IJ;CJ<&!O-@$!1S^<+\W'!.!U;/]!.7W M$)E:9WV8L@\BYNS\K6]ET#JS1\(W;3^=O]5%0S.VY_STC%6IB")(.&TW/205 M,,DY)V(3[*T>5;@I;<&9,;>-240[]%`(?>L:V80KZ)XIT!1T"WV%'7)>3V[, M5.XLVQH4F[8.);0T][('AS'"P^!<%EFE1-SH;$5KS6+:!#"5"`WYB\J9ES+X MR-1:P(>&6#CJ2_\*1]K&-?=:==7CJG9O4_:_\/H'-3WN`ZP=O9E1[5AT.,=Y MGFO,F]2^J>=W@\['7P0Y0K4BZH9$W=8^'.W6QR:-I6/G_L4#J/M@8,&C_;T9*'-W8(ZY!#`[.Q+%C-.=+::'_@3R:&F-6'N; ML5,C,VJCW!^6:?O#L;!:71].4E<0D[MXZN*^<\6IM:34!*4Q)#'JZ;Z!EK^R M;B`0S2ZYP9TLU2:21T(K-YQ`@2Z?.XI%F33@@"'R*/5%G?JM++*1UHF$G!#7 M?%$!:$].PB)#RM;2G$MG5-2=G2&[$@8DS#+:%@HG%R]U::3U9C4SK=%-UI0\ MP%*.#]B(:&.N8DV>=Q=SW?74-<,C?:]>Z!6MW4U:QU#A8VA;>I3G/B1R<:%S M7L'VX&3(>T3<'M>3'M>YH(0']29'-F-W0&+%N45)D86'IWQNLCTX'/2.QOLF M_\-'?WD="'!"94@XYT>C#?06/M[0V_N_Z,BG8+2O@ET MI,9LS-B\3&9S:$;;DMLGVOA`R6Q'+N:''"SZEF`O5FW'@PP'\ MF628)D#YQ'A^:/:3X=&P;KEXCC7" M*HMO0/%W8!6GQI*BX>HZYW%W0G7[_;9KV[7?]OX)/)GZ&!SPZ_G9?B*N2=^ID\_'EMH2# M/H#_L"`7'&2E-KH%?#^21_31"[)NUF+D6HPQK0*;#&PH=5L>GM`?ZH=XTM?W MMKYMOVUI@X\Z[<*_F(HB8`45Q"-."A^4'A3]L86]LO=45X2<&T\JYNZIYG=7 M-];\]LYZ&W^(YTIL`P!V\*V%8E=X=V#W6@S>/?R_SAIT-0->#0<`>$3_"D=J M*>)IZR1'_=%!O2#`JF=^?JHP<[](J6;Q^,+:`3*L&A4Z?BFLN5B/.13WI<(H MHZUCH9J79^LCP(76YSLV(][%Q?L]O&#)L2ZZP6&_?S227XC76'>$][(]Q2J9 M(5#WX==S4R"@KSLEYOJ0H2.0=)?!<%QK"`N=JYA$EAX^_)X`XLB#_D#[*?G, M:`]4B0Z\Y=<*-!+*Q@X/CD`?/&9`Q8:!3[1Y8E_AU#&P#0INUY#?$8W!3`_Y M6KZ>N]G$MOB1KE`9<'K&H:1XA.-+)@/!\2U.RCIB?F4K@(`L7!.N-S_6[,8V ML7^JCS;-5W%FVYOW!OZPN]$\&,% M\J0WUK5M]/LQHSY\V'%I5KO\;>S&;V.QKDJ.9ZB1J7.WKZ7)0G2091,D=0AH MPL5GET#F.IX/B&>C[Y*)3P1R>L770N+\PA8GK;7ZKIAPW[##-X'-+'0$S7+%">,4HJ4OE$+PTG0`C&'`]A]HP0V M"DWXA@SA%^:2S\2E:.5XFQ?=T(1)+YR_2[XY=$3GL`!B((E?R*JR$QYQCA8$A7!?SB01X'EUA M8].4R7>*RX::%EO/AX+6%?#.*8[R8N:`K@K&A&Z,&R>4Y.U5\WD4 M"^#0UC3@$=[S8!()R`(W>R`+U?Y-N#0WNUJZ990=-*B$-IE*>^B`^+1G/HH7 MWM7XE8AV]:,MPLFN#BM&^P5J@7_M"21'W8'OJ//O5XC<,6"K>'"U21O M8W%BZJ`]7@=NZ]CWTC5JRVP^Y53+L%$]8+5H]W;X^.QLZCE=7SYF^GYL=!+M9'Q3IO,"ML,KU-IVS=E[1T]YYIPT$FQV MP-DQ?0%(?(:J"993B:8S*%PG!ATT>)K7(VL'.'=UD5Q[MZG*<_+7AGYXR@TR M<1*;%<_C(SYLG=4@U?%PV%:G7U[,W4FLWM]:,K%8,=O("PS@O?/XY)K9]>$= MU]*LV@[/I)]O]+1#7]P[!CA@[>BCEV`R_S=<0>Q6H!G%1Z]@]#P8_,.NX'#X MW!7\_NQSO-_@GK88#=4=P/BGC^6GXB4QH[YX[ZCG)7)^<.!$YU&WZ/3NG&A( M>?+V.^DY""7\".1CLI+*5CNTK1]>S9KN=]^UK9&!ZTM-,U3Z//^V(/GM!/?B MF5AW\"+*6XV38A5.VL"62!V)ONBKG[+F%3_1AKW%W,UONB\Q3]8RM MJ$NT?0#C3[*#MQY0K[XDXXL:ZEK^/*9TJCE96AH70M#P;2QI5[EWW7\6A4AV M(+'.-FF:M73!DDO&@@7NCXY1*Q`;9;72!]J(N^-^=7KA9HY6POW("5V]GX<79?M[=^&NMS$C?3G=G"K'GRGN-5M_1"^;Y M)/`?B"A\5LCTDS?*("WS7;Q[VCXWU]N2S?4H+T:!\`U,:) M"FZ#(6YJ7Q<5]+IHA,%>3!;H?,'W(U8>%V[I*-3N4C_=GMTYZ!&SB2T./\-T MC[\4XI6]?AVPA2J%2KP5`M^,C"EZ_8J&HRI6%XLE!T.-B%K5&;YUEY48YZA9 M4>6TB>!&-U:N)D\"N;]&<(O2G)6-EQ!C`6&8(1.*5)NSE34S,.HUB6$Z$UX> M:2H4.8="7^41%DVNVH(U:+#2WQ4[XO:QMI]O5:,+04P5"`R#;82K%OOJR8\M/4B_' M:D)JL4R0LBC'!\"*5RNQZ5S:"Q)J2>>C0UV@H7.@D"5J`Z5.N;3[5@^-6!=C MWO'834YY/!RRXO&*PKUU=M'GJ+&C[H2!E,\KR]V''KOW- MUF7<<).M$&L1;@M9FNA2Q,A_-4T3H+SL9B@F(MK!U>0JKB::7`TQD.^CQ62X M0MX;\N#;B[RWO\@;`O"+^\,F68$OH M?S^6BXY/7JZ7;LL7`=Z;]B;($Q4A0$1PH.1R?:XRZV?O?:P>ZR;@M/8U>NRS M5<:UG,&2DUA%3GXA9Q=G`/QPS*$`CIS82S<&AX>]P\-#V\F]0XBP-&GL8\\N M)-6#NAWMVV[F*63O-+O;#J@V!Z,CGK'L.[G,&NN5NJXYK&>8!@>ALY: MPGSL]^K)O]V)+TI+\?JUTXY@.]_YW7[_@67`RAG\/AB>]\&4_(KC7W;33"I2XJ8HH%;_@/06H,N\`>WS6LO1H''?C)WJ+%SDP[446 M]=*HGJN=,D\0-`JDS,PV%"7:$JY77GA/P5ML;.]H=S5BA3RDSD?FW3?@2,E3 MTR$QXCL[8_.V"*K-YOF%:>NSE.U-$1P;W0WQC-E^'R=$NSO8J_/ M#D/KPUEKMEK8Y[A45D_>.WWK3ZC<>C4&IM)TP,KKW!K,E%5A7OKB6ZN]QR># M:Y2]Q6A=4OB:U+A#1.B;?$;[(*F?+/MOA901(;H2EY1M?S!?M#B0.^'2JH.M M+'X.EXK,'38S1/LI]6Y0QA\P-^-)FJMQA%/_-[:C/Q$>#'M'+2E:T!6=*8_!(F[H/`2+A[E=&]]55B;)Y?M@$$!*!@TAJ->NH,KMI](ZU/0B$% M3I[XSD%RT(F:"LF%!H3?-)PN(&Q.7U>$:_XANEB%%?JN)8K0A.>"3HKYX]FS MW\5[&#&X]J+0VW_'AP.[G0&F/!B_GWZY$B5_3($,_)44\F`%X54\A$8LJVU2 MG;O2GC/"P5)AE=JZ%_D^:FL8\`5K^FY@C8[>`1/3H/==8KI$2@L+H_=IB'1! M#,U!)TF-EHT)$=63I"M6W94^;E*P3#68A+G:/WCO-O1MZ7M[SEY?:4'(.2)- MNVHM7WYZ*5=N+TUTI7W/*SOA[O MF^K7K31S*-Q\]!#:)1YE2H_+\84X-SI^X]X4LVHWAA?H)G)C!\1$U@I8E9Q$ MZ7MG43"]+^3MZPMYLK\W'/9A!UOF_;HYOE]'O5Y1+YC)O:EE+)PMN;-U\>KT M'5[])"Z#B':C!HS>P&,/C`^,QM8C_:IN@;Y9Q"RB<<,HP;8%*D<-WT5Y+]_= MB+?S.1HL2OZ<);`R=!5Y)L!UG@%V+@AQ$KJ[FT\@,V_@N:EI.WU@+6;T)??M MF:GTD[_TCAX:S\@!\2D41#=Z_' M04O_3I#:LU_\)E026__C-'Z($P]VL.]JJ2,!UB]..@U\B;GLK@5CT"N+6Z1< M3Q*@%D\1;-ZMU.8=D7SV7JDE,RU[`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`#HOA&,/]_5?-`X M'A_J+C#D1_"0%V2M-V:W0_E?]$+D58"QJ8]/M0<1-P+(YXN0_]R+D%?=1KP1 M-S*W#K^0V?R+7CV\5N+5K\_%\H^>@RRP`4Y7?R&X_NVN)=[\LJ%.K-WPUB') MW5>=<*<%M]EQKBE8_;>H5?W(/,G7](Q@(:^0'E"OW`7]@)U[JUZN:'I+8.!9 M,P2)J4\<52*7UUD84SHWL:1KHWNN>O:/7&W>T/_U(YUTHYA4D_8&;]!V;/^G MF]=R9[O)K&M)'YT*?E.CM!,U!U7+ON6/>N)M^:4^@O:#:"CP[I7"SN=;_KOC M4.NZ_W]+-_MZ)7NC7:W;3J!F:@.P:[E!6UNO4CM9IHP M<^LFDSF+P@/.L7JN6V=6'%[FV2VBRU)N;"\<.3.WD MD*J.-T9!.4#*7C.T$+YH5)T']D*SR_Y^H\L:8Z(IF,?:JD]JS<.S8R/HI.53*QAJ'0WT&;* MFA&&^]T-CML;!(;(JH^-N4.KHHO]MG/)AE^:I$;72RGH"$,=_Z-9Y: M%P(B$?=)QM([6SE8*Z"!R73C^)JG9^1;.-8U*DM-:JQH-#`HO**I:[+; MQVSM@FXIVW!=JXNLRCL;U8V;SD%0<^P:)+2`NH:XB3]TCM"PDC[*,C*4UZTM M&MM#>K;'*NW6MQB:A65@,$@T&*R]X)I\613EM_\?4$L!`A0#%`````@`\55P M1Y`;K62T`0``BQ8``!,``````````````(`!`````%M#;VYT96YT7U1Y<&5S M72YX;6Q02P$"%`,4````"`#Q57!'2'4%[L4````K`@``"P`````````````` M@`'E`0``7W)E;',O+G)E;'-02P$"%`,4````"`#Q57!'2_D0&80!``"#%0`` M&@``````````````@`'3`@``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"%`,4````"`#Q57!'=V^10Q(#``##"0``$```````````````@`&/!``` M9&]C4')O<',O87!P+GAM;%!+`0(4`Q0````(`/%5<$<$5G"%/@$``&D#```1 M``````````````"``<\'``!D;V-097)PC$`8``)PG```3``````````````"``3P)``!X;"]T:&5M92]T M:&5M93$N>&UL4$L!`A0#%`````@`\55P1]9=,FI\`@``=@P```T````````` M`````(`!?0\``'AL+W-T>6QEF>H# M``#9"P``#P``````````````@`$D$@``>&PO=V]R:V)O;VLN>&UL4$L!`A0# M%`````@`\55P1UV]O-IU`@``)PD``!@``````````````(`!.Q8``'AL+W=O M88``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`\55P1S^Q*Z6J M`P``]P\``!@``````````````(`!=AX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`\55P1V'/[(:B`0``L0,``!@````````` M`````(`!92T``'AL+W=O[Z0!``"Q`P``&``` M````````````@`$6,0``>&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`\55P1V%A/?NC`0``L0,``!D``````````````(`!\#(``'AL+W=O M0*,!``"Q M`P``&0``````````````@`'*-```>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`\55P1TML MAL>C`0``L0,``!D``````````````(`!?S@``'AL+W=O&PO=V]R:W-H965TU1]>NHP$``+$#```9``````````````"``3,\``!X;"]W;W)K&UL4$L!`A0#%`````@`\55P1W+*OTVB`0``L0,``!D` M`````````````(`!#3X``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`\55P1P%61.6B`0``L0,``!D``````````````(`! MG$,``'AL+W=O(.J,!``"Q`P``&0``````````````@`%U10``>&PO=V]R:W-H965TVC[JV!@(``'L&```9```````` M``````"``4]'``!X;"]W;W)K&UL4$L!`A0#%``` M``@`\55P1RYS&PO=V]R:W-H965TKP$``!8$```9``````````````"``5U-``!X M;"]W;W)K&UL4$L!`A0#%`````@`\55P1W'4%V>D M`0``L0,``!D``````````````(`!0T\``'AL+W=OD<6?\!``#E!0``&0`````````````` M@`$>40``>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`\55P1T7!8]&$`@``]`D``!D````` M`````````(`!)U4``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`\55P1^V4#2S<`@``YPT``!D``````````````(`!4EP` M`'AL+W=O&PO=V]R:W-H965TWEB9RS0(``&,,```9```````````` M``"``&UL4$L!`A0#%`````@` M\55P1]%W6N4*`@``HP8``!D``````````````(`!SF0``'AL+W=O&PO XML 12 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

10. Warrants (Details 1)
9 Months Ended

Sep. 30, 2015

$ / shares

shares

Number of Warrants 12,262,500

Warrant One [Member]

Number of Warrants 1,600,000

Warrant Exercise Price | $ / shares $ 0.10

Expiry Date January 1, 2016

Warrant Two [Member]

Number of Warrants 300,000

Warrant Exercise Price | $ / shares $ 0.05

Expiry Date January 1, 2016

Warrant Three [Member]

Number of Warrants 300,000

Warrant Exercise Price | $ / shares $ 0.15

Expiry Date January 1, 2016

Warrant Four [Member]

Number of Warrants 500,000

Warrant Exercise Price | $ / shares $ 0.25

Expiry Date November 8, 2018

Warrant Five [Member]

Number of Warrants 6,000,000

Warrant Exercise Price | $ / shares $ 0.10

Expiry Date April 22, 2020

Warrant Six [Member]

Number of Warrants 3,562,500

Warrant Exercise Price | $ / shares $ 0.04

Expiry Date December 28, 2015

X

- Definition
Warrant Exercise Price
+ References
No definition available.
+ Details

Name: pktx_ClassOfWarrantOrRightsExercisePrice

Namespace Prefix: pktx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_ExpiryDateOfWarrant

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_AwardTypeAxis=pktx_WarrantOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pktx_WarrantTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pktx_WarrantThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pktx_WarrantFourMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pktx_WarrantFiveMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pktx_WarrantSixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

12. Related Party Transactions and Balances (Tables)
9 Months Ended

Sep. 30, 2015

Related Party Transactions And Balances Tables

Schedule of related party transactions

September 30,

2015 December 31,
2014

Clarence Smith (CEO) Accounts payable and accrued liabilities $ 495 $ 129,592

Short-term loans $ Nil $ 20,000

Convertible note payable $ Nil $ 100,000

Susan Woodward (CFO) Accounts payable and accrued liabilities $ Nil $ 12,000

X

- References
No definition available.
+ Details

Name: pktx_RelatedPartyTransactionsAndBalancesTablesAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 15 0001079973-15-000654-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001079973-15-000654-xbrl.zip M4$L#!!0````(`-%5<$=H0O'H3F<``$*&!0`1`!P`<&MT>"TR,#$U,#DS,"YX M;6Q55`D``UGZ2599^DE6=7@+``$$)0X```0Y`0``[%U;<_^*3J MO&TG7'W)[LXN=RY3V=,3>^+,[2E%0$E4C<%;@&//K]\2-C'&7`1(@&WZ8:;; M@-:W/BVMIB:>"V<=8.FV`:VWKV>_3;NCZ?7]_5GG M7U?_^S\=_.?+_W6[G3L(3..R77=^>7'Q\?%Q_B&?V^CM0A($\>+/7[Y/]7
%R&BR[Z^"V`H/[Y7?9'NQ]@#.3G>'3^DQAT MNNU9+EK%5\GF(?E,WOT,6@O@N/%?K9_%?.2X?'\R1 M[=H_H`5P*NQA1 ME`;B8/CE(OKQ5MQ%K+R-M#FV$]O81X$;/'*);[P*+$,0@Y*VS_8^`Y81^FC8 ME86M>&/GD^#W'0#!CQMZ4SF7A>=_>Q8X1'+7_M2]6CNU,$O!$W8L';89AIA2 MJV5*.ERFE*XH85_)C:E=;R?%>+M#(V_'VRE%O)W"V]M%"'XFG4Y,E^7>_L?# MFE[;L[EMX7\ZHR5TNOB?,]N:NK;^XQ?_H]HJ9,LQ>"-P0P\VCPP,9CDWH0[= M-=:.`?&;ZV'%ILMUF:KNV57PVI[>7RYB183A7<3C:WPSS&D2(\.`+N94,R<: M-.ZM:VT.7ZT<:LA"X_FG9.RD7CEC]@X*`8O;;1I M9K1I_BBMO'&U<:MA<:OA1G>'[-D6F&MOY3UOZ'QNXUOM\:WA1A0S<]+&P&;& MP/JFB-K(=6"1J[FFTD:DVB-2A<9!TRD>8?`&-#VR_CT%NH=P,P+.[5(W/0,8 MI)-#Z/0PPYCR\6O`W02@Z;N&P+=5?`&^M?VA(805.@XCXTC4UD1W&&O[2@56 M!%J#;@WZ<)9;ZO;0U[:U`,B%+R:X`2_N]FEKXM0FGL%AZ\6;YL5;HS]NHV^> MIT^9*]0]Q[5GSZ'IC7O'\33,ZW%88\;8C*3%728JW_K.'3,:.>/7[4)=:SI- M,IVJ%E(W-M"ZCV;;`->IG>QPXI,Q]5X<'<$YB?.G8PT)JK>AA"*4M&93M]G4 M&T;:^F]0_=<<0D)1]@8GMP9A@I[UZ0IKED`WI MMN5\6X6?A&TCEH;3JEA#+PFGYA-80FF@(7#T"1?;U M<25K?.!:?5K-05/3*QH__FC-XLA<0*13T-;O<<9Z>6U#![;3/T227,,@NATD M-7*05->4;N`;_;F$\1'-["?XQST]VZX13=>H-8_3Z"*U]7QDKC^^%T`IQ6\=V0J(?F9`XL,F\Z&B^WZS1_(9G)<2S2MJ=&9VI:KULSB^W"BV#WL<]M]!;AV99106U3: M2=4&M*=#W.L]!7/7I^A([(2[[XX0UCKPH@8W;OL+N6UNW/8;^XGV3IZK75D6T?O%*UCD]5X/$%JMP/M5VY4QV.MX>Q.25O;;1\>P@!$HT=73/_`AJZ75MQ9V.@C^"5]OZ>LZMN ML,4WK>2P]">D&=!ZFZYF+[992"1Q)6MY.V6%A=S8ND?\Q<1OAV7T"[?YQ)+# MHF]]C_2[;7H6]BBK.V@"Y!02_6"O1<:6N"_2__T:HWFST:J0P.E,,W$9G4
V0Y5_-6H5Q[(C91_$',,V?+?O#FF);M"U@D%/K<9GE"4@H.:[:2=@I M)%$4NK_NUC,I*BQBA'\TR(,[4WLK).-5,QVP%K)36)PBVY9TAW\I9D;$@G=U MBI2Z7XF/X`TZ+@G5#]JL&),39+OVS]`"+ES^HW-OZ>?ANMP5L`_@&J-$FGEO M&6#Y,RAFS>'.3F+),:+7/NRS#9##3`LR_Q<)&5DE)U?[VL44K_A?Y;AJ#Y4: MB/[LLNFZC7V,,]%6Y)Z)D67@7Y`'C.]0>X&FGT6V42(*:$]ZAT0=_RGI='0, MH$/L79RO9\+957\H]@=?+@J(Y8=82D4L]87!4*X5)?.IB(=RO6C3[WU/]=6J(HJJ*M0* M/^$N\E0;D=2!(@QDOG::=8EZ/BL114&N%6X),^GU^WU%5&J%7\A,>CU)4!66 MS3/OW7NIO+)L>'DOA(L`6SKPTH+FUS,7AYVSS@436I+N$4KW23LAGA,OE,BX ML$)[M46&!ZR"IH)0LV@+%3O1T!CY+=_X73,]$&S-R=>)":920R3=/]R=79T+ MY(\:I!&]V%D(/3!(2*L/D3"S$JCQTTJ7)H_HP9`\8DH:<*DB+' M5VI8%AM(%$R)?17'12:0QIY+EO[(S'(U5(4$,@3'B+08<$D7DZX_*,\9MO9T M$4R`4/`C#Y1UXZ.#D[Y]:D36/M_\OJ#S;;5]!P^/R6_^>NEZ(Y7S$YD9=>ZM M]5S='P"^O6,/.5H`I+V!G?U5.SKFOC>"RH$+YT)X2%*=;@=$Z_[Y"+34R@VA MUD;N$T"S;S9"]@<9BI2:<`EWXO:++B\]?;:E)TLJ6P3,)E^EW6#.#EKYN;M\ ML*YM"]N5"[$3?+!=$$SR<9JRWNL#Q0HO@9$I?1GP0BM"M-$]67_*T>^(3DR,=-V;>?Y%!#?@E:3JE/(/,9,8V1*98\R8L]V?C\N/,6%^ MJA1Y^S-7"5+8@,E8&=N;;5&8'/SQ_DSL( MYYBCR"\MRQ#2AZD[DK(Z\+RJG[+\#$U3!@0IA/L3'.66L79FVZ-%EQ2=KO/. MH#*-<9[.U&CG1)3''MT9)E>>N" M6>1`B7TIIG*3\CIRB,U?U0E")PC,<0?N=DFF(HKZM4BSZF]EQQ;/`D/^2MWD MJ3SB0N""-&9L.6SRW`8Q.6-Q8AA"RJA_9=@O!NE:<][W1`O^,;T4UBX,U%`D M)V51E9^K1?5D5>J5%I+.GRSV$3H^/6&')((C,R5%9ITV^S%EJ'2PT/WL`_,"8NK5E*,5E1+ M2*(L2&JXTURC5BFW,E#,F4E"O]<3!TW2).[>@R++>B4UV3MC5'.@CEO>YOMR M[25E@:0KG(>[AADPF*+.:@^-0$UE[TU"FF[/W)#B;LV]I=LS\-UV"FVF2)T` M[/>'?5'<@MN15@(*A0E&H8B]04]5V$.)9:5L*FE6QYPSOERYH\6Q4BP?%TD# M961TV1O3F65;E@'!*+61$0\LTP9I(*4[][WU"*FO"GU6EI'IL?=D]@243YXWLTO)=$5-!0L(/I20/6*/(ZFHB?R03Q M"!R@(?V=]!+!`ICVW.\9\'$UHB`.^R%TJ<(9(BU@4LIPR!]H44L;#M3*P.4U M0$D4U8+8XE/]6!NA-!3Z4F;N)@ML3"("BD4WL*P.5`Q'L@MD$V:_`8@2*$TTDY@BW:EY$EI1HVB_9GA&&_ M7Q;@M4W.U]%=&UW;SGY>2EF;C.2*Q`ME`2V_`2J]8:_'`5K1/@\GIHI."TFR M*.6&HT'+(?-&P!E;MTLRNO.@\TXZUN/7&_"REPM1>L0O]<,@L\0SQIO?YF11 M[%6&MZ`A5LII0>LLR./Z4%,$76"_OI)'<]N![MB::OL)B`5,,S6KN9#8`BM* M:BB[/4%F;ESENV1Y1>5V5SG4WADO4FYH+K%T1K_HG[;K.<^&HQP`+\_S,?P_=D/*S;32JEQ<)/C_S= MD'X_?/QF&2U(AC/^;H)LB2\="BT`,E(!_R)#H#A$&<.4%5HJR^,F2S.N:609A66(K2!9D!Z5DRB`73E@D#OK`[C2(_+W7 MOO]?+T[;:+4YWFE]$A"#O/P*4!28:!?DS^$5'8+8L2-9V)B1D_C_UM;5&ZJG M.QOQB@2]X?[@D!(*/S4*++?U>OUR6@3!GQP*#L@'[)8Q*79\YA!98/&Z%\YM MB$I+.YP"&)BIS:Y7['PG:%LP5;I'E(@[["$N_^Z2S,0Z,RZ-$8R18!>]0%.KE" M^"ZG(J@3/->]M0`.YT@022^@1\)+AP))9ZQ4V!QA[3S9(_T_'D2`=U M"E,;`VQSJ3@:7S;0._""2#T>8R608_KRZ740:DW!W/6U.F;=QO15)S-1CV9E M+3YSF--<73*`2B!SS6>H"729^U6KK:-JLA^8XF*:#,$#&8O<",Z,\4Z5V-R9 MQ,F/;4Y>H`90!>(ZW!AGS"6\6+4U5*L3*P2K"A]6!AA'%\:(+V8>;)OK^QO^ MR)EXB/S;?;(G""YP\YB8F@[6NQ-?`>GEC69D`I3Y)(:R3J`N@ZDFO=A>>CX\ M1@Z*NU)L%\I`;!@GU3A`Z<0&QI;%X!3@SI,(ZMT3*J7":C#X:`A5%0=1YFC MY!1#>>%D&S\K8)-#[*1`W:2X&5[;+:`$4Q+J#I<4,1XL`/N33K/B)B6N.A5D M&DGEXR:CQ+P?CJW1C4O-(:?&:,L8+O^PRPA=/&`*N.`6C\)W,,G5XBL;T3D";)DL*R81V8Q,E_&\]@JLM6' MQWG(H="86P6&!#1G))HXAH9+Y@=STO=+4E#5IURC9HX;3$3QX*D,R\\:\R&F M$>-1!F`;,5^<&VZ=L\5EN&W(7''5WH[_3#&C1AY+3_-C\QU&H-T.7:;$:6K]WI)B59]5F&: M55-/(.@``K7MH0;F8!%8-:K7J$#=:"K*Y5^5#=2\J&EVH,Z!MA&!.C_>.@-U M*78;$J@K]WI)@5J,W4A44"6.!#4_4#^](\#W-+(RP.K4L(X$K$,EHY(TK!K( M:73`S@6W"1&[".`:0W9)?IL1LVOP?BS2LRB4XLG1`<3M#YOW%2.5(F-[@$;) M@/)A-Y:(<@/C_8-%FD!,LZ,L/=A&Q-C<<"DC;.3X__)S<=4;4V-C=-4>,RE) MC%V`9E.W\?14FTT=&(5?VGI#^_IH=N/:=MQ?@/MN5W&E."<83,-N-W0!#0W> M9NA8/*)V-R&U4ITK2W!FB8QU7C,';"4'FM6PEB=>Q:V=,;/4M6?&4,@WC0A> MW2!Z9>,MJ%GS!X7%LLW3AU(,>GK1#/)*M6,[L"PY5=ED)DH<)X7CX*#D##TK0ZEIG#0Z%!]2'#Z<('SH$;@1X7=S&1V3^,N)FKHC;W`0Q_3= M1NX30+/OMI9UYSRG]5%F4-CF"J=:3SSFYNB:*Q!RJ;(:8U:;120+)BI'E@L-:'HN7(`IT#WDWWI\N]1-SP`&@45:CH<;$R9D_!J8 MX@0@WVD7/X2MI.!OJ_@"_-:]N<^+/HU(VEPCP)25&JB.O2VW453O74!ZJ%17 M;]77MK4`R"4W=]^`%W?[E);\(V"]>@,OS;HH':C)4_10_'`TC@^6270HO8.F M0PG1H92G@QZV)$SNX`:]SZ>DW0^ M%Y3]3[J(]0Q[A[J=/55!FH^7DPG1]M-(?D1&RN M;L1->41Z4&_^6/7;:OO*1%N1GT8?&C(VMSN./=?!!1NXV3]X1(MHL$R9?*!V MQ\Q!5LO"R!F_^JY9E+J8CL`UY^RGJM)1LA*-WZ4'2L=!2]18:.)XYB&4==0G MD_[8<=1I)`+<:"X0\QUM>0J42-1F+FT;TX?@2%++./P!\ M>W>!,5H`I+V!VR5`.G3`!$$=E!G7I0_JAUQ:6IHN#:*0MC&V%%);85J;#=-8 MX:"QK%70JK1O&?(I6P;5L#-S;KSE+W6,FCECV_*7.J!M[2\/?_NCWY:_//SM M#Y53^1/Y#(,.E[_]<77+7Q[^]@?A!\'?2[;8EP2Q#R1GQ<'"(D+]41VAY$Z# MR%_%K+QS6YM6_/JWE:C$=XXB'Z,E)S$J&SWDU)&UO28W_D-XLS6>1^C\N$,`W&.FL`VY MC[@.69KGQ$,@SC"%/@O3I-6(*X6WRSG0<3W>P`4T@&541B&3*4I:C2JA\'?; MQ,68T%U50J)XSF@BG%ZGG5RMX)4[&[T"Z&*(E=I."@9FWCN-&>+=1!9.6OE+ M_$526'CI3+BL>PZ;GBO9\,,J"6TP4-9W(7'#6"T)15)0>$\-%T5<7X9(8RN1 M.D-$&IP*)=09(NOS)4Z!$NH,$?54C(0Z081$@Y,(!]3Y(?*AVBM;:BNE[A:5$&N[#V-M9DR2R%,;?'2X(=33NL#W6?IDBPDFB9-BSJ85H5H148EGU_DW&6[ MYT"N-BT$;E02'R1;IU`[DE!+KQM+J/E>/=@+_V^=@8]E4#F6 M;:.\<1-#N21)!(0M5(MNWL*@C>'6G-BIJ-)6AQ8_2F6?!O?^1"-H+;)C36 M`R'+F.`VBP<]F^,;[J"E63K4S,^#RIP;Z.CF?]M[U^:VC6Q1]/NINO^AR]N9 MD:HH1:1$64HFNTI6Y)S,GM@NRY[4_I0#`DT1,0@P>$C6_/J['MV-!@A*I/@" M2)PZ.R-+`'IU]WH_HP1,H,\`_ML@_JC`PSK7@;1!'<+$$5!_NC1SOBP4F$'[I1/(G`$,> M<#L/K@"_&S@/B8B&]#.=%O[CO;QW/$=$H7E\>\,&@G/XK/\(X" M1_B)`F,L/=^%H\`+<6)WI*$0#Z,HD6+L)PG<$3Q/2SK>/;;T(J!AX5$&IR9& MT@E2>!$8\3&>]_<3/!GZ/O]G)7=`QYWO9GT+S;[LX@$*-XMC.(C@T1P>R!$" M!(]J($,Y]--$@'P10^DD_H#BB'ANR6,(CR3^?^!NL=7)$#CB?Z3X)7ATHPE@ ME/3#1!P8G+EZ]\O''(%$%,,W4__(N4/I>6>_U!%I['@2]O)5>@3*U=4O'VTD M^#FCUJ$(80AH*\9P3",Q83^4!#SSA.D0(4Y/F.@[]+S>NJ.&60A7QMB53TP` M#T.UTYAL"#$$(%TG070*$Q^PETB=((+]]_H=4"G$319'`#)@^X,,`OS?"-:) MU?>>_A0>X^ON"7T'USW'G^A?I!&(20;WX0`&/S!W@C5\V*A#(`P=/Q;WE,R# MGU'@'+R'0Q3]P]U&XBMQ+?%`A9D2-/8`G(:9C M/%6S((42?T]$8KKTB,$C_>TM_A.N[3H*LO'`=T3>R`??TYPE7_OM]>VUC>:A M^,UY%)>$@J<$"T5\\0_%M>$Z`Y`4(HW$T`^`2X4@%@+X68D5Y*]*KA`VX=N/ M0+`*WPW3/&4MI*=WX$G'"Y!(8+@_A-=#*&)U->(H$T+U/YP3BS,OXK,FHH)/);"0/X0S12$! MGPLS.EK0+F6'2&?$"A3*9T^`&IE(39WX'W*R=Y"590%=*ER;(T"%8Y7(=;-Q M%M!B'DAPUT^%DU;234&U`I8Z=-PTBA,1.S[\*\D&:%RFB&U>E`W@,X,H2TN\ MRU%:0]9,B'ZF._"^Q,00?CYP.>;@F>L MBR>(`/18`D,'Y%-O&@VEH#9-W2@JD9Z<(&,&3,XF^,X@Y3Q2I6Z7CT#H[8<2 M]P3&#RN<$3$ID#PH<1'>:/"GQ%U)&TU_JJX'3CV63#W`3.'/`3;XW7W.'>\:3JA(S!(D7 M$3L#+H2-#`D7'0\_Q9((KI&U!;#]4%@[P+GP+F,;_>`1X$=C5(X1NPTB@.(; M98%7P#G4C#321T-CFP`CNI@MU'!KM]"'2`F7[N>_/& M_A`((%KFD9)D2(4`L;2RD7./1K0,A='+E%IN3/`0[QLP=(QL:`6:FJ*0*]!) M`-,LR^3+K?CEZLJVP8M*G5;?<[KW"2Z6`TA/'6.3EP$81E$:HGWK&6)#U0HO.'C4 M#(G.92;S,O>`#(761%\0;ZWBB*OO(K]6N#N0>V#0=9#!`7])4_QYHD9DX+F" MY![E)T9`6*=V+'[E6XPF(#)9X(Z-A&.?18YHTW=D(9MAR.B&L!ARSEP5(\S= M!Q.+H',S#U5*&0L](D@-_)1A'M.)&\3PE>'BAZA]HC"MP(72=TD8 MDZ.K^'4D`_H[V_M#(%38?TGD-E8ZS!"07Q(ZL1L0%F/B>OLF&S\25S5L9";W MK9!V7XYOCTDP:?]28O$_Y)]CYZL44A\MT8&3ET:P(ND,A^C0BXG,D&U3[VS" M6Z5^XFN6_LGF*?PNER3X,)L^=[AR]7MH19-7344M\.=J?PP)QVEPM*FO18'\ MAKEU\&'+[<7OD6!+^_9>QI'WQ0-6'$;C]TS2$H6#*PL*1I+ MI+W37<#V^=QG8QJ"Q)J8=60Z^);SFQE\VM;`KVZOQ47O)(]G6Y3U&Z^3,^W< MCD_,\^IZT9,:JAMD3R]^HH/\#3##3T9XU<"%G;%$=Q/I0;P/\J>83;!_%S@_ M_$]2L&78N6IAR-@"[]ALQ%I01<"M5T8^*&JQ.WK46&GDJA.""ILJ1^W8`83T M_R/9PF`%)AHD,KXG+/?#2:9.9`R&2?G)+,R?53R;GG\8@5%4M6?64R?H['B$ M@\297`.ZW5A*$:`[G<2C^@Q[AYQ'U/0S#).`4_!PC`R6',\KMD!G-H'4`*;@+.) M4!S@%##@^1!\PT6=+AS[<53HJ4(SF:/$42S%*`W#8 MJB`9>P/$@R2[69F]U6[M)"-_-`5)\^!#SN)W08#/4%?_%24)&BR"RH*(&#]& M&'^FR"C(59Z$9/DT]DY[14>Z2[%<.BA.\L$D+)H#I:R?`#)V.2L/*C"*GB!*JM$R"6,9-_R6Y1O+"(K?UD; M>66#DT"BNU-1:`OR%"QSY+(YW>>:_3 MA[=M^'4B%H'SS(>Z79W.=:CLUT%:,"O4R=EG!8L_!Q]`9CZ++(E`L0)RQ@OI MYM/%\#P\=8G3A\T.NR"8]O&"_N4ZJ/+Y*25T4LJ>N87C6Q?X+4#!=:X"*\SP@=]0T=H%E)_OLHUW!2^#+O*(5$O6I2R24(S>V-(V MZ:BRX4[9T,;<@;L03$ZX)"PI)K>KG>\:%IRPA'0ZW1!?M--T"[!$]RH%7>&, M#EH0`^25I.JU0X@'6#`;JR@)NB!9*!4&?3@XY9L1QZ0KM,@S"WGP"*?1QLDK MS57:ZY1L.9),!0V`,R9QF++Q4,839X2@L+^"^):3F5% MK/8+=@>C-&A5>6B6_.X42`92#!Y9W\LA)32?1FX5'2TA^,L8(U&G5DH,X"`& MXCO)1^6,,>:!Q02&2!$N34):,6T^B2V+D3<@R<,?9*IS M!(MVQDM)C!W\6$P)K()2U!0!,Q5,/4Y\'7V_GDYKQ:^"(AV`.F+J"/C+J6(2 M"MG'/E,@[@9PF/)9D&$I6XWXH(PYRQ"(%Y5S\VIN%@``L73<$5)';$1*U8+Y MY_Z>%!949B9F]>\"%3TA:$!N)(ZK#-$D10\[(`FFB#II&ON#+#5>:Q5\08RC M0[),9$)%Q),B!]0H1^J)Q_FP@'T9KT<16$:E#AGN&(`&@9CSY%+&=6F6(38!,:>1N8S2K1S"WJN"R[?:546"'QZ<5F%8Y5 MJ*;3HIO`V%75=(;<_:02O3\2"[:8Q_ZY)Z]*6>^^G75:$H`'_B%Q-A`Q":$J MR"'T0R:B>_(=>L4IT>2I"CNE$0("^V.L>Z!,;6?L!Q23/_!A@>*[5EHDN]]\ M?":)QA(T!(;`<'H*])A_85I/'`68*)#H?P2'/V.Q22Y0@&\DC^VY#]P:!;1,`J),4QH@&@A$KQTPS4 M_JR_&RZ]V?A?Q1Q<5-[R;'U@BU$(/[MR/_-O?@W%578'OU"9KXBU9'8KH715 MS":[1;\YN56^3$B2\3B*?L=*LT`\_!*JE&_F#)0%`41U0]D*F$:;%YA=Z[HF M4KU^H5*D:RY%TO8YR'#L&L[B["[SV44`I*`E('GRD2RHSBYZL#+N*$$"@1CC M)E7@3G+)TY$N>8 M*N.=OQE:QLGLM<_^W@UD`K.1UU3:90X?!8O,MBY&8=*YV%[DK=NBD>L/-J M_&'.`:V21@XJEF'=!;';(]L>R*S1(JA$/,3BDOGRI5])_H*E&2:SKPN1I5^SFU'42N M;T>@:R>F_#H016Y:4:=>B>05U53S53L5FK_<.J"$7MW%DC[[.^#6KR"*Y<3W M?@W#Z)YET[5J*0(_K[?!R@K8I=6HXHD*@M..,>FUAU32Z`B/0X2`Z(X^%-9* M]+$(ZUR$=3!6V8]^U*K[P:(4[%5!V/[-#<`:@+OG3A4$B2X<4'1GI_QB*P[0 M[0+0XP*5U)5&6%!I3`XV7_0GRM_7^8[VIS&R^)IBK;H3AC+,$L4,)H[OV8;6 M_))OU;*57`?`8H(@`?*`N_WIU?"\=_0`*\7P,W!:;``B[=UOWC-6>@1/8RJ%M8[:(W2)V'1#[UO_& M_8)`.9[HF*[5':N`X]B8"3'\GQE8+_Q#P+_1)FZO8V6#]GKLI';3B/^I:./@ M-7\[1WW28%KT;]%_\WR]>$E.C.U572\#+EMQ'!8BWGY07N8\Q0\J^5:;E(1%'C`D=WZ1MU$1R1@ M=A?B1]HYS\]QZ,N3XXEM"/*#'>YEE<43L/+TRP]4E)KGTL4RS>(P=S5HD]3& M'M4%`:MC4_;EI[EIJ5`&=X>N"_IM88.=W"+FQ;'C$7FAJ#*6/?&1?50J:U:@ M>QLM5<#7[JG&NMR+-1_B;<4470M&D>LH]S6@!4X>4^XD9KP9!,13/1%T;C`F M<)38"'V>@A>J+%HYK%2-M.K.ZJDN!>%1+(=9Z*FB-"OG*P\CIP6@N4`<^4M% MIP:;6.PPOKASR(UI-%D,V#J\9&J@(U6BS^+>2GPVCK!BGX2"5VQ5_JVI!L7H M%;RB6I2FM!N^TME_S*E8R>%NA:I$7E\XGRX>&F50D$R#B]&N)O2>>W1%UT[H M>$YU4Z$08"F-VA^M%KG\,]B) MN1OO(&>6Q8[H_<-2/VE^F>#(5[`/6_ M,DP'!3SX%&6RX/E\?WME?=0X-0M[4M$"SC&T]H?E$,IC"2]$KD\2M]' MOCD=YTWL'J[V%3ZU/94':^,&M?;3O!RE.&Y(L<]UBF7#5EZ`2IONBTV8Q'KHY'*^;KP=`TEQ1O-5]:D',U9A M#"3-Z&*H'9.O$1L*2^TV$7\N'%Z99BS4)6C4Y=)]Z1[R)B?Q%SR^$-OGYLWP M*,.16^9?!0,D/N2:!>IP=#/7NQ@K+'6/H#AZ=`)L3LH1;XIH9TEBNN0(ZO7> M/3UP#RM5GSF4F>D9AU&$J8$XX082I)$B"FEZI;2&R8:=,V*T4UR2X'@-DOA\-J>D0Z',H"C\4:?;N6XLU3.8D0N$E08L MF15,NGR%FOE85[#[7-10#A^*5]!4NV>F;\?K'KDAU;"*-X<=)=]14O+Y4C+] M'+T7=>[`^2E+TT":%D^:"G4*"P&GFGBJU!_C2'K3.>^?*J\!Z;/YI7))UI5Q M$%A_(DG>Z7;/"0K+G6"1CO6XUIW):*6E#1J6SF.W,>5*W30>W_E)I]9L$?LUN;S%_KF@S5W??+`]2'07T0/Q#N7QN_F@&NI[[(^T"^6?ZA)& M(!2:_U6[E00U^!=#/B#",V.\)?FR9JB&;G&J75ZT2XMD,-E6,0Y.Q]'-R3&! MT?'54RS\NT7AOX/HDJMGGHQS[W,%MDS[ZJB=PO1]'0'BG2+B<0<%D84DD##? M$#V.AG,,@/.08$"Y*&/6!1A-R%4(&_*J<]\JU:BRLO4O4!Z:H6M]"#DXR@?8 M+5FOW^#P=":A4\)_E5J?9X&6M!\R>%TKOOBNT"8#9#\VNXWB1V[$5]:> M7ZN85\5(`WZ!^Z,0(9(*0%WG<=8&7:`=YK)#7$94Y,F8B!/EN!6`?WIRY(') M>A<[[JP.*@86Y$X>]_\T+*<8AJ!PM/(3J$Q0?&FJ<8E64/)C0C)U"FT"B>EK-P@<8UMTILJ"`\%=*-P'JBO64H47C:$"!$I"F\J)A M2QTQ*(Z`H=8?2I*JRMURAE!1=+(O3!T/2^\J@.'J_(D:8V-B@M.-.3'T.*WU M`?N_.&,?4I7`5Q[?)UN#SA+XAY9YJ.6V'2TM!MPOSJR9;M,$RTXYBV@K2O'M MT"QQD+R4CZ%XW;WL\5Z1W/OE1DK/A;V4469N8%J2ZN_/.)$G[M`)DJAXD=)F MN:^[Y]W.F_Z)#@Z7R8*2E?&SNN^:4IKF5>**]TDEH$75H:/]X[DS#M&9IS:H MQ.,9LY-V6>WZH"11]TU5['0IF;^XB'=0:?=I"I6-DQS[+P6"\ZJ-`8W*BJ6C MVOW!"RI;H)@+\/\2FFQ"_3$)1="DJ!XW^3R;M]K^:535MIYX?:EG@AV`<8,(Z\"H+QO>,?J,R^05()EOD&IBF:[:"X])<:F]$XB1MJ% M;MRJ0BHG%P@%WPKW$33(G8ZF>$'N>QFBGZ;WIE?VME@1*\)#@Z'`.>[\>QEJ M#U!)2\W-M4I#K&RMY=[S#T.[YYLJ(+_&5A/4W(I:"NF.0O4O3%HF<*F0(T>) M3[MGFF,Y/JG$;ET63=&>%)R;7MVQBS<_<4!3R=0>.^_4.],?0.W*C M((I_0$&0REGYN>7,TT&4IM'X!6F_TTFM`VRF$Q_Q%^'+V!Y"=.&+-#[GA4OH M999'99_&#&)NK^Z5///^UKZPJ1;/(:CXB:BFLCK\V03CE=[%/$G5@'N`XN%/ MKWJO5@Q#D1.YE/"P=+KS>^IK.Y7Z.XC%]P7">>GW@9\10T]F9A>7SB^,'F)G M\M,K_M]5G^'"R?$M_CR])YH`L3[T,;VP6_392?3YC&9=[>^VH@!BI84^RU3! M+%WN\R+%YX6HN+&U9Z#*QM9OSWJOSWH]!+SQ@WZ2[TW;6_]U?7US\^[=2FRH MIXH2^Y??S9@&L]#"2XBM=W(04W*^,4SF$%_/7)GAR?G+4H68.E:X22)]M%R;/&\,FM MF&U;U4NX#(0JH`&]:+&G$>EO$DC>U9B9U M=MY3>L&9X*0EWZ MOD];<=Z@];8KSN=F!RV6M.SHA=9%O];\C7SE768)<5Q4.KSE7.K^L-4NJD.MY3_>\JF_) M@KWB9#(L:%.3B6M:TG=KS:FV6R_P?+TD&\,WL%Z2JY3;PKI-%=;-((_I@H3- MB9*-K&VG&J^W^F%V=<>JZ@"/0'\GXE/_U!"?S%R::].PLVH1^;<##?,&/5D] MAZB>F--B[;;PY'>)^@/.\<4VP'>R%LA[H_LRXTAZV6)OB[U-PMYWV,Z5"V"Z27VK<]25 MP[0Z1XL+^RAM6BQHL:#%@MG;.#T^7;8=X%JTICQU?(.ISVO)`"^.C3,C>A(K M,9RGS2F_S$&C*82+TS2G-O\]HW;0\TG-,U*T-M M"?;[3@WEG$7H^.W"Z(N7VUSUG'6P'9>\HMJ+,]WX-!\D=-+WP\T%E3[YR=>C M82QE/A\M!OZ]H!V]@>ZW&USB=-L-DM\LJQ=OH27P=S-!WI9+:JMT];-_CX-# M/?'HRZ`NH;`=#(K#O6[4H50?"EFO@-HJ\=Q\FT@7=7^V47A*Z'T4."D-\6VI M:5T'W^WU]Y:>=H9HP`0>2I\F$[]`E6NII94]6Y8]J[67B_2X.C(+=,W3_+2U MLZ,35^,*/CON]L4CIM(WT:6P8PYCB7Q5G=?^5P6-#WVADMM>8_+Y1'I:G ML=V2B[/)X^FD%>[BU@^[G?XB:R'_0`Z7IWY@K'[\*+P%5)9M^5OWP"] M_>VN5=VLB'P#-*UEVRZT][K]O/V]N8/=6'>F\ZK6*+"MJ(8]HGY3_NK?G-@= MB6Z/G$7G"[I9=RL;9>OCNKO+!CEVZSYV_\J[6*6S@DJ=W;J4#2RQY3'HJYDY ML;EYY[O=3>&=',29$S^*7I^DX-QS&-M`_@L"^=NO06EO<+5KJL4;HL6R/3M-/>P5M MW)?1XGMKWNSC+9[5AFNU5[FTI7I1DZO<'S/GHI4RK91IR'>W&0-HIYQV;./[-0ZJ*7-H)3YRR%IIWV#MYB?1PS[54N:ZU>7G8N+^>.*M1+ M]*Q`OJPT'7!%\F?1&$_#LSQKEUVZ7?G6\%/=MW77@46K:<#=\(/=MW77TK2W M(8A40\.S-]77L= MN'71N3A;A7&^F2.N$.&[TVGI*JGNCM2AGMS.W5TL[[`?#@+AAVGLAXGOAWX@#J;F)`NUV3X`AH\<'N=[_L?WDZ_IMQ]N M\5.J&^-V)<5I`_E?APKG`/S[)X4^OW&]_G'3_ M^*<38NSU#UCT](_/'_XX[?ZA@:'?O?KO55R=@D2D\-_$6I=S9RL99N)%'6&;1<1]G)TY9<*;1Q$CB\]YWE0K?YF(^;YW` M"5W9$5.JWX(!H%GZP09*HFN\]/F6J[0[O95X!FI\P@U:>HF+G+OQ4S/P\N3X MY+()*/FDV%B7;-BJ/+#.8>&??DV23"XZOV8E=N4*B'K3ZVV1^BX[_?->I[\V MJ;#K5]-813CH@ ML;-&@Z0NJ92'+:XW0C36F%96T`ID>UBU%<-I;;'T5 MVE%NSZ74+*,'50PX:*".FT]S*J1A-%'CK;E=MQOXLM))<[6YFPWX!%^ME./. MNEHUEO%G/99Q*D6D1A[7^L21>Q?;;N&_FO*!^I[P?BZ];;Q:01URC0[73MLZ MO=SNR:ID>=$5S\R\V;0;;@^#Z:LI;ZW+0>[Z>LUN[;WM4YQ*3VHDW]N.GKE' MF-ZRQ":MMUT-L66)=6")+=];2;9]R_<:M-Y6^5ZOY7M+1@ZB>XXL73S3KJY5 M!;=Y3>CUGAE?L"U5L"Z!M08$.D_77**S MHU?1PK-Y5%W!+(^ZW\+ZJG-6KE8JX.SG@;:U`_>ZDA6E)W%T#MZS34:ZZM.REE0.JW>94,TW=:C-+ MCNX<9\+].$=1`/`F-W]E?OKX/DKESW[B!E&2Q7*K73C74U?W><1M3U5_4^QG MZF3I*.*&GFD$OT@R*<[8%8G_]TRK4^O)0Y&,G!@`B(;B-=@Z^/_ZIV+BQ*JW MJAN-QU$HJ*/JL76O"-"-XXX$WP6^;S\J1DY"35F)DA#(*)3B'JY*##)$*E@R MC%)X[![6R,99X*3^/3V!11?T5G(L;@UPA8]C3U-XFX!(LL&?TJ4E\'!BZR(^"SB1O[ MYDN`34`Z^+8![O\R%A(451#*,/73@*\HAOO`_7G^O>_)T$O$PTB&$CY)L'&; MUD#>.4'P*)Q[QP^XV`3`Q@>%)]T`'O'$X)&.=1`YL8?GXOGPZ32*DT[Y-/"Q M2>P#[`PP/JT(!W^$E01\,TGX?%7+7*OP!8X%_X<^`62FOX+W&N7[.!;OK7\1 M#'2>`VE##4!,')^ZS\):TX4S50A[9+?D+;$H"#V%$ZI55F12GUD@B%BF5(@&>7>["O&N4W&N&[_.7;FI&1> M]"R\*J,5/5=0NW/T(MPISGCX",N@TID:*%!9OK[Y<"P^D^8;N5)Z;-BORER;.H]'?X92+7\9*9VMU"-%>N]M]9O::@KFR. MMKQ%.<&+/%RK)IJGE4, MC=YCZ3F/THF5@E/&W);EUPES[YJ,N=W.,[BKU)(+R\Z9I8XH1HG"-4'C49!0^[9*2OCP"LSK=XF_S\-=O-/XJ9\[2^'O: M\M^&XN^?3<;?\]ZB^+LY1ZG2;6P_*=BA\#T_IG0&L!L?E_6<6N$GXT&=VW/: MDF&-R/!KD\FP]Y+X:_3`^:C.E5-FM11)0%D`,,V4-HI&@R3RU"LC/TD MB>*XR:C]WSZU-F+[-FGM2T#PE-:E]&V6H2O#\*'34;X MTQ=I+OV7)_?,TESR1(+>I5)?D+02&=^#H.`LAPC(0L.AW?8M*=2(%*)&DX)N M)""RT$^3(K/'7XD9OOLLJ:!!4S$"O^*00@;*32$JQQP0%I><42:U@4.=/ M`46Y(R>1>JA$<7Q$2LJ1I4B=P:JI'XBI,F>[W,+\=(6$FCH!IX/V.B>G%Y@T MD8,2!)'KI"JT.\J!P"T!C.32HC_07K,0<^\X<*Q*,"S&X4S@U.!<.B)+=)SM M+18''=VZHRB`N_K`(A$;UL,#!HIQY,D@%XOYG`T'[H_+,Y(?Q"<_^7HT!"Z# MG`4X3)**&+UO1T`$_=YW'?&SJBL0C[X,//P]_/+FVT2ZN$$5+*2SO(\0^L!/ MJ?VOJ$]=0G+"3K"C-;%I9+.RWK%BX9 MV*JLNZE*UY^=W#\,=EZ/H%EL)5J4_')UQ>=-Q*#!,/1'W6'*YS".QE8-,99C8[$VY9[FLD%9#\:A11"\ M13,`T(RX]*WK(V\=^JZX\NY]=/6*M_1)9/$Z!@)29.=PK%7'ME1E5T=UK#+6 MYY$%SI&]O,8]5]%,7W/^T^%<'F3L!!#+06[AHG6O5"6C%*$X0%TCC,8^\GN. MT+/3H^B=2T=QE-V-D-++";-]UJ7R_9`F!<\ M1QF8ZQ/G\=DMF2Q(?V@^)3TZC@@8D^MDB40?#F>&. MG/!.N6I`@$:!D/=&8RU#RX"BJOE7!H<%1Y&G9099(GK'_>^TBN?"$.U!MHM+'^A>\._00P+E?H0TQJPGH:ZM1B1[Y%@'H3<,=0`$N1 MZ&RFB@4,CTAG"*=W>"RN+-_NZ3FG8J%RCZU3T+!4^5!EW8Q.H[+DTT#PC+(H M#BS%R+F!NE)162-5 MKFH/!`%K>\0,2T(`L#'QOZT,##C(I_7)U>B26.C,(-/5L"9.ITXBBY[7C<'0 M@VH?C,(+ZX);,[K5%'>@8%@('S,5A`LID@-NDM;OGYYWS\W/STD`"W=,&\&SSG(K"(5/XGCP) M]/J;$_,Z+H8WV,!`GSGJWP$B@AUB!6X1A*%H=PG M/U3MVOA>L=L4N'J%_8W^T*F&&YUR\I2JMD+;P-9A-6YG>'-C\PS\7B^ZESH+^:.3GFV6U/GFLQ>.\P6$NTLFUQMD^86:%9 M;6LH%6&.EM.7BYH@2QS3-;:!#]T\4'H[1CWVX/KFPZ)J_U-[ZI]N<$]7JF0] MC[$\7;J^(M:EKV^#.UTY^]W"'EZO&'2$?8NS4,\NUS5BN\6OO=W#CM%(MW?9 MZ5_V]HI.%E0V'D9^NNALIUVV<#<*]:UI`&Z@HT;@.V_CU`3P5;&[+;*X]WZP M^P94/;&GL8#O`-KW*""[^YA?-]=!C8ZFAE!?YY-M[,Q/J1T##>,3+8-KY?H> M8D]C`=\!M%>U-[N/^JV9WARQWEB&T`)>`Y:V^%Z:R]7V!)L:"WA+!G44[CMC MM=]FB9.78_\>1=X#=H,XN'ZWFB#_IO:QIU#N;S[N.^':]U8(^HAQKF4?R!T1!8FTLVP936^&TO]I2@4G@1HO&.A5C=#:!08TU.Y\0M3,^OU!T?./1<" M8Z,M:L'*>\""P$2KR6V\/BI%<_I8*_MB-L MVQ%6P]%6'.`XVPP%.C;T0D)UB!3+WO!F:AI?X/>".DB#$+WD2F&0TH1TD MJC$/ESI;0*GN)08$NW='?T:Y-M9-`F,^/1&>\VA*L2M/3I=S=[C8DGKUV!^S MR[RGKR(O^*[L_E'N%*);BO,H\`+(6&`-F^IA"[*0JSSIC/`7<$SQHSA5/4WL M(G;536CS,Q9:+C/SW=UM=+@B+M/KO*G@'Q8$<_"1238(?%?-,4#Z>8Y_%/C& MV8RNU08&HDW3?U>U&U,](HC08]5G!LGSH%OXW&&)7KDED6XBDS<85*=:!C@_ MA^5Z6L_#T&8PLIS=ESM2+,#0\BX53LHS)ZPCF^.$!-$C<5OZ/`^%J@"KW("GU$XV M0=;$;;%F@FRUL[!!`/ACF69Q2)R'V[-2-YV,IKGPL)\8^W1E@`'%X_G$EVN= MA@?X<*^;8@/T7N92@P6?YMW@;VW=J@@A[\H(-V1N[`]`SH9/\%P@9K$(+/8# MX]8^I@+3=AR M>UEW^X&7!AE<7(:MXX)I%/][(O3Q:3!P3RBE?#A%)U6C'XNM@>]JQN^OA2S;2JZVMNV>;,83D+MR6(^A!$LQI1+4(0B)4# M/<*A"@]GM-NSQ^253"ELE*?Z3XESE;U9L)@JVZ4^WQOOR=YWLZ;L%'KB&3#F MZXVG>\56]L:;V1-O;3WP6J)>+5$/&T74GRU;UX@H!VDV\,._,B19P.6A'R#N MY?8!4!3HC]'EJ,:W>?DMOP\KO M@))"%]T[)O%&OR4.S(_OWEY]LLR88P/=KX4YM.7`#QX2:L38W-,^O*FC0DAP M#$Z"+>"1KY'>JXV+B81SHZ!C/C#SUT^W!H@/PR$&#J7X=Q3`#K!Q<1Z`$Q_C M"'CDF-@6:NCZYA3/LT&@;=K\]HM9;\)?Z>C%"5P_]'RWT.V>[`8_9;:'C>?] M\23"MLIJ$]QWE%B8XP<('O!B/*5G#L@?LG=9A5WY(!AK\("=;WD1VR@& M9+`:6L`C5NA.XI&0'R=I?95RPNK:7YD?D\BB55=/!M8?PRH$_NJ6[62[-@_BLS(H2%,D)4IGP?/=GK`X:]+3T%].EI= MCFW?NB/I98'\,+S-!HDD/+W!;MS)5@/<:^K3;[9()ZANIPU^MTK1_@:_$9L# M61CL@A;"/0K42>"XS"4CL&!B)5R[G;/3-\7IX)73&&@2]K!Z4GC_S\B;UZ^A+UA3:5^GL.6F?);)_&3#T.EN,&Q M?P3IX3[R?]?!E[\/0<<$B;0\>R:/M.LRBT2$`7F>>7Y!\-%Q6<*/W+LT*'&" M264Q3?DI>Z=ALZ@(8U2`G>OF86Z=2\&A@NAJ30?*4Y@E2I"L)A[4(F#L0?/2=Y:Q1%7WT5^K7!W MG@R!C#OH)(_@$E/\>6*-#T@R]+3K$R,@K%,SDT6TC@:G.#8Z'(OE'-&F[\A" M-K5_\L8['J(N_SX$.DD2-#&4(D\P@#*/+D>9P#,%7SS\*@M2A!-$#^602 M6;U%L)G4S)18.EYE:*HXD48?7+6>6B97Q+&0,C')<7UK\(P(P.:K=D0K=DQZ!9'_]-A2Y.)%7`K$/@EY7'6&YF'-"Z4OHN\B^ZO]'4D`_:V#3-`#S7O#(_ON"IW M=3YY4)8B7Q*0.3?`FL?$\NHH+3X2GS&$-8-@Z=C+_)]\+\BJM6&9V*WY`2G' MSE:F3L;=T*'ND3S#J%['91$H)"\8;<#Z'F&,&U MJ"!LQ7LZ-<-,31K-H-W<:50$1X5>#7.4WW".`7S8&E"76]^,9;9Z=<619(VJ M+G$(ST>U3H=-T9UASJMLH8_1#4.9+T/`?MRG04:&QQRT'R)78%\:.U@*=URD M_"=9M'5Y"=XH#@4UW\%+!UQ0P5E%F4D:9^H;*H6(0D-#=*EXEOM%QX9*=%:D MF#(]O0-9\&^<2_IA:)QKO^9+,C76DLS>6"H, M2Z2]T^/YC?-%S[S*SE[+0D]KW,8!*!U6]Y0C4A^94G=S:IO!I6R-[.KV6EST M3G)G,^*_(`(0O_$Z.F!`88:23BH96T7:)9PQHHZ"NN;/]20&N9;89WC/_^% MATD0=A7&=_NPTE\9Z=SD+TC8&B+-#U;[*MDQ+FCT-OJO-%5A/*)4Q]RX4^C- M/@6:[@NX'8"R/X./3!\4#1O/L92,($,+S3RB4_N(RILKD/H!15F^.>AI(UDK MAF##@4Y%L:$[_3*/J.+!5%I//:PAM:Y.=M%ABJ[AF_$TX\+CXK#D5>6()XZ> M/4@.G[&Q54F'(LD&?Z*VCYD<>0Y?+D@J5<*YE+ZRIGCCQ)CDD'R4\2VZ))O@ MN$,;TP5-#CVU)B-$N6"SE%URGL^I5QP]P=")3/D5Y]X!?J!\9+9O=A0%'D9\ ME4/O06*N).J`H":"UB?"C*[3\NBJQ!7`AQ38"I,'&Q)EHX;`^-D/"+P2Y"E8 M?XG.B+%S*69?_N0V-TDPMQ/'QUA!(>'<"#'2XPWHFQ# MJ1FZZ$(_ZYQ7SWZN&&5G<1D<:=<1W5ZG=]XC#[P-OW)WLTKQS(>ZIK[A4-E( M@[2@O%?D$L'BS\'7[>6?19+DXM(HG?+]\%$;8\Y3ESA]V.PF"8)ISQIH.3S9 MV.=\*=BZ?V1N(3<2"(; M<$G8L(A<8+9)&A8<8GD=IGK1#`UGT9##8DJ8%,YHERHQ"EX)G6.N2MG'7,+9 M6(5+%SFPG^2))PIQC+AKD6<6\J2LUN37Q!X1!1`G,6DDXDD8,XT%EL.!\)HMMOMWR*>/45A?D$_990&[2,/')$/ ME,)<0(J<>V5#2F@^#W(;ID@P+,(8B3JU\#:`@QB([U3;$&>,_N?_H!&CB52G M\FKEK4+LOD".3HEB2]5DI&B"RGUMRT@EO9":D$C@#Q(3'G7LP])@7XJ4[*`- ML$IL2&[81*'\-+;2X\0)T7?'J*+PCTNKDE2+?/YRJKB^0@^5@,8%&S*F^#22 M^$!7@F08#D-=@+QJJ/:95W.%T\%!94!@PDN.\Z: M\Y8VY%Q'#RD@28IA^C2-_4&6FL8*RGF.&$>'5)5.4^0;&N5X-C=G*P+V9;P> MQ8\8E3ID$JKD3,QS99MGQUWP'TMN\[,W)T>VY_QGM*Y0O"E;)*3B/Y6N\8%< M%A]4>86153HYF7.F3&4CL0GV)5,".9:N`X-SV"!*'SC=HGR9E7E1*KT@I'RH MZ`BXBT,VK^6(XJABP-%N6Q=W$C5`._EA.M90(&7%W(K?9*^@L%/B54J6I16R MM/.5&+8">M.+S=A@E3(W4]@1%+.4.4M:/2=JM&R:?$V_S>PZ56-S\*HP_9QR MLO.4GY)`./`/51IVG.C,:3R;1'1/OD/_&X6-IXS#I)BPP0+,'X^EYU,>OS/V M`XHQ'OBP0/%=*^V''1T^/I-$8QF%JKS7<#YR.IM_X6''48"!ST3_(V#'%CZH MBQ`4XJH'IM)E*(7IP+^GC<.22J>,A.N$=H"<4JV&@*/(88OA?C9:29P#JGG2 M]1,[-4Q7=]O1>Y%:_)W!)XV`;1Q,>5]0B(E]I<@S^&]#]KR!K(V` M="1Y3*,!H(2CR[68H=B?]4O.DSG0O*RM`79:J2QQ%,*/G&>:-"?1\==07&5W M\`N5W40U$&B\*$9U5/I=YK.A1?WZF"N2 MWQ!1@PIUH@I^_").USGR.5U1%8`EYU[J(Q6I'6P$_\S>8T? M1*+.8U;VCE+B3-X4I2%PFAC77&BKRH1G,8\M/QRW<#@$M%!`,\5RXRKD&92U M9FNS&%&U="/2>O42E0DK!T`WY0]2NRCKFZ&EL,Y.K4,CRG:EFV8X'75-)AGU M\%B\RV*DZ(X5HJ:[4K=N$D3M6+FI-V*#$Z_!5%Q[409Z"N-<8=/SG:M.LC-E M/F1NFM)7SH>C&]2^7,F.:SZJPE1S)`R@D',.^I=3\U+3CZM#]@CHN)YJ".$G MW&\CI=Q+RD;6?Z*K1&FFZPIH-&0Z[4,W( MW%'<0G')C+DM\Q:3O*@Q;G6=Q@!-[MA$DP>H1(HN?)&29E^XA%YF+7UP9UE% M:U\8OCLH05#Q$T5P";1!J3#IV9J9E=Y%\9BJUP7<`Q0/?WK5>[5B&(HZ!CJ[ M9+QT6<][BJM.U:X,8O%]@7!>^GU@ILQVYJUUFM''>N/WV.+/7'NBG(?UH0_& M=PE_6O392?3Y'*7.LK,6UW_&%15\N2*Q`H5A^<+6!5!R)8K/"U%Q8VNO];M63]SUNLAX(T?])-\;PNCM)2]U[_\KM+?MKG2_7=R$*/5FQLF\U?QS[HN M;;)=E#QK#)_M5E(W:;U64C?QUO8(2QHLJ5MQ M7%=\WE9^PYKAJ2#4I>_[M!7G#5ION^)\;G;08DG+CEYH7?1KS8WJ9KGO)>7T MCGM]@`#K+@+9:)C60D'8X:C61%1OE&N:2*]EJE2]CWSE7&4)4?3ZZP8M!/'S\CX&V1VGS:U0Q4FT[NWQQ;WLC: M=MKN>BL)9E=*K*JF;F;CVIE+O]?],^F$5EOAMS@T1,2FETD.43TQI\7:;>') M[[H-[!6W@:T%\FIA1EW/9(N]+?8V"7OSZ0PMYK:8VR3,S>_MDQP[W)/F7_ZP MAGC\I--TICV[5F?JNCP.:R6\U1+:THRG/]PJU(_^;8%DTW.I<1SZK]O)I(5!-YW/">8VM)U3'SS/:%I;2X M\$1Z[6F+!2T6[`\6[+1K'.G9T3+$6:KX[<*$@Y>;`_5L:;\=;[&BVHLS MW=\RGQ=STO?#S<4[/OG)UZ-A+"4/E,(AMK&3SCV"HKB==38YW>`2I]ON@_MF M695M"YU?OYL)\K:\)5NEJY]]'#<7>N+1ET%=HC0[&*^%>]VHKZ,^%+)>`;55 MXKG1TP=Y4C*/0;Z/<.8RSEQLJ6E=!]_M]?>6GG:&:(91/)1^BL-S7Z#*M=32 MRIXMRY[5VLM%>EP=F06Z'&=^VMK9"7FK\5*>'7?[-"BZ_@,TE_!EOMSSN&C[ MB*LXQO83N-K;QVH`]-I@]TOO*O0T=G^.\%=6'+CU@2[`QS;I!PSD<'G*@VOW MXT>:REX/TINC,')W?;(51?<-OY`ZPU8'9-E>H;'IE5+1H61[4%F"QX*GF?A5 M9]A:W*]/GZ`ZT9^20*30-H[^=M>B;58TO`&:UK+5^.V];C^=>V_N8#?6G>DX MJC4*;"NB8$\!WY2O^#BVZ/LGO,%79R[E0FR]8G(W64##+MU'[M_Y:L: MSKY;E[*!);8\:7HU;?TW-U)ZMXOLW\E!C-$,T>N3%)Q[U%T;1']!$'W[I0GM M+2YYB[T5B:VF'?D.7N7V.^!LR]C:O'0Y(^ERT4J7-4J79>M3FG;:.WB+JS** MFG;D[5763=R\NYHPKU$CTKD"\K30=^-?Q4]VW==6#1 M:OHR-_Q@]VW=M?1R;0@BU=#PK-QT[[C7AX]Z438(Y(8QJEU[D;4W5CK2O*/9 MU[5K/41A1\YX7]=>!VY=="[.5F&<;^:(*T3X2SJVKZ\/D>Z(-/F:?K/!P+9* MHRB`(TIN_LK\]/%]E,K?'80C33[$G_`N\^;Q;5>CN92H6A7Y-PBVS379*%Z; M!N&E;2.VU3KCJ74U#5O+-A,IZ@S;+B+L[Q)YOIJ7NCE\O0)&[-Q)H5MZ;7CY MO(%8HVCE2=?!>ET$9<&91A,CB<][I1K1/[,D]8>/FXLHO'4")W1E1V@E1)QV M*;PP=_;/,_K!!@IN:[ST^99K@#N]E=B=-3[A!BV]Q$7.W5:H&7AY6.>P\$^_)DFV\/SXE=B5*R#J3:^W1>J[[/3/>YW^VJ3"KE]= MTYC^=AG]LH[)]=UZW8R"M9A&2H)L53!0,_"5289M1?#W#)YU!"L.2.RLT2"I M2Z+>88OKC1"--::5%32:V!Y6;<5P6END=E4RU#C;7C[R]B4WNZ%`^9["M):$ MD5ZGMU83;5S@6KS=ULP,=FL2#-AU:6;9%?K1JB][,>HC>5 M;O=DE<(KNN*9 M"26;=FOM87!Z-<6(=3G(75^OV8V8MWV*4^D^C>1[V]$S]PC36Y;8I/6VJR&V M++$.++'E>RO)7F_Y7H/6VRK?Z[5\;\G(073/"0D7SS07:U7!;5[3^8IZ*M;E M*'=]O=UT%^X+4[R:Q'X@>KUGFLUO2Q6L2V"M`8'.TS67O.SH5;3P;!Y55S!Y MH>ZWL+YJE]5<@:F%YSDC3SA56FUX:?F\1&^3NAS!KJ^WQU=,K&KYQ6JE(NY. M3G6;>U^_.VEA6A)WU\`MZW24JR[5>GDF_M*Y\[.3\#_)P$FQ(66*_M/^D#XK^:@Q3\^RV7;TMBN\]BFMAE6-X MMR.F\-CT%]P3U*V1F\C.N^Y>;K"%W77@Q#)TI8'S=NRG(W%P??-AV6X9]I[Z MIQOYVJQ;.+M>5]-+BU][N8<=HI-N[[/0O>WM%)PLJ&U12OSY5HT8'4T.H;T=1 MG!Z!!CXVT`61$ZY*46C#W;?@*HG]C06\!U`^UYMTF!K)6`OLUPN!Z`KX#!DYKU[>`[R':=WM[:]8_77,P7ZF`+C7@ MZ0%8IL#3-G_.8C^\^P@01MZ_G2"3_.MW40Q0W_NN3#Z$\B5U!B(+?7XA2[Q7 MPI.N/W:"!`L+_KM[!E>I)QDL",NF-_+';0K'.Y9AR@4=U]%X$H7PS^3JFY\< MP3_'44AP_$8O/;WQW=CTE>?YB&-.\-'QO5_#:V?BITXPSP&<7EY>;OT0WL71 M&+/?CTZZ\/_3B'^^/#H]^4/1UQ^?9.KXH?1NG#B$KR?5>_N6^#^$?O#3JQ04 MNE?B^XV`Z&8),*T_+,S#KR&UUP](^OQM-DCN?X,7&;#T/S:!0_?B"&EOR"M9W26S4E]RY/WO0NE*B<"X)5P]RK@+DW M!QO\Q_??!G'@_X#_A7_^_U!+`P04````"`#157!'V_F^AO0+``!/@@``%0`< M`'!K='@M,C`Q-3`Y,S!?8V%L+GAM;%54"0`#6?I)5EGZ259U>`L``00E#@`` M!#D!``#M75MSXC@6?M^J_0]:IK8F_<#%D+XDT]DI0J";FDQ(`]GN>9I2C`BJ M-A(MF83LKU_)&((ODF6"L:9V\T`2HW/\G?-)Y\A'LOWQU]7<`X^(<4S)1<6I M-2H`$9=.,'FXJ-R-JNU1I]^O`.Y#,H$>)>BB0FCEUW_]_6]`_'S\1[4*>AAY MDW-P1=UJGTSI+^`&SM$Y^(0(8M"G[!?P;^@MQ9$OW_K$%\=<'S\B<71]UG-P M6OL`0;5JH'-$E\Q%6X6WOXV_@<99J]%L.&^!T_C2JJVFXGQ7T!??RH/_;%XY MCOQX-W9:Y\W3\],SPS/YT%_R[9D:JT;XLQ;_Z&'R_5Q^W$..@'`BX>K/1<.K??K\>N3,TAU5,I#-=5-E(22UI=<&H3[]C@GR\JKET7O?ABA(Z M?Z[+EG7!UG*.B-\FDR[QL?\LJ6/S`+FP)E`]8VAZ45E\]U=5V1-D-Y'G_\E$ MUG]>B([.\7SA">_4]X,<(+V$GG3Q:(:0S[.@I38N",LM9,(),]'"A5XN8*F2 MAT,I1QZ2!`VF@X6,((*73,]IA0K!-O*I^WU&O8F(8MT?2]&/KM`4NUA$S^<< M:$W4%(*_`_FLY]&G/*Y-R!RR;W+,!]-;AK@X5R@[HY>5\#MFS(!<_$"S8A"+:N"Y=BO.1AUOJ27ZS_9Y+RP'10P_Q M]@-#`>E?L3\369NA!9[T":&/ZZ'5H6Q!F5&\W5??X2P*O<:'R$7X$=Y+?7K, M:HG#H1)>@.0!"]UMS@V2@ZK]`9F?4>97Q0QM?DVA0K,]2*S#!:&Z3/9]G!(OD+& M1/#*1!%O=V!?[)VLCYFAA\@3Z78BYEC^\UAX@\NK)<&*F*V&D[!,-^90<1XQ!F62,G%OIN`A\_(]1S^6XE3=1V30'U7MCSU3..R,H<"90WIH M&\OX:Y!-#(2+B8Z&`)42AX^49HC26Q\U%ID!S:WHV"/L"HFK`8_?2(?*XM1A M1II*:V$SMMQFF(D7'B'"$^\9(F+2Q<0(4XAJD4)Q.7L`,-*OQ?\1";3R$9F@R4:/-.20-61Q M6"H,2_\.J(*-U.Z?D$S`6@6(Z"C*#G5A.8JW*4!NJW?B[\OV=?NFTP6CS]WN M>`1.[@A<3K!@ZLVF*+_!ZE$W@L^3JP*418D/X06E_RGD]T']?\FK#Q`NZK)# MU)'G\\V1H(M4&TZX#/!3>/C/=3&CLV2RJ+PY@0?OD1><]L^P7:Q9O3S`L@BJ MQKG^-@YOA_LV)U M>C&`U11DR=D1LQ34F!EM'5?7&-YC#^^N_26)B32R(!&&RQABLBJ.L"6:[``T MSHM&2LJ.!BGT*))D#I]8UPF#TLL8L?D-)9>0?`\*,,(2N63%8VM624+-I,L. M'ME,YO&"=13&%AHW>#-'8Y9.L.1*GF:$I;0MM:_-YY0$H((= MB;K>%6]9=D!7NSW1K=*-/&!'2A:KY)%=]_8Y7RJ"KVR:VK+L0)OM825T2X?J M#M:@ZL_E6JS+<'2+@K;WI\J5'5OW&0L:!UC'6WLRP1(A]&ZAW.#5@0OLO^P2 M39F:J@3,F#HMGZD,DX\:O,;T$@V1OV0$3<9TS!#D2Y:6Y6+Q0"5G1L);>P*; MW@'6#9>A7`814+N0$4P>N+B.6K)>I.19AII(FO&W[OR!Y&Y(ZSC<&>Z M+*Y<\LPQLR7+GKJ9VA9C,^T*PHBV$J]0\]BG::@U\V,];N6U^/]HJX3I-VY$ ME@Q;QDN&X"2B[DW!RYWZ&SPB-IS&;!B-V^/N[]V;,1CTP."V.VR/^X,;6]8_ M0VO(0[BHH)G])MM"X)K6^V].3V M67E_)64=RG5+/ZKV90=D4V+T]EI'SQ!Q).#,1)*Y0H_(HPL9FT(;=5,\K5C9 M%[.F9!E9;QUG81>3JPN3.2:8^^M=D9FL90J6?6F;<`ZYH*[S!'/'E^) MAF5?[YHRH[#0.B:"TM6EZEZGM'6M]/9E7\>:\J*WUSIZ/HEK;GY-N3!H0+HK M:>`2\]EZFGV%[C75!P-1,]+>ETZ:L1=2^*L>N);WE0F3Z'0J3[R@'/L#(N^? M553PE*W-7/^A/-=KT5LZ6FZ0WR?B@A3)OJ(>&;%F95_JI**.C0`U70?L\0>Z M7/9GB-U00C>0U\9EIOHLN;(O?(QH,K+=MA)4WH==1&HY;W6UG-%XT/GM\^#Z MJCL<_0RZ7^[ZXS_`R56WU^_TNS>=/]Y$2CQ'JT\EGY(1,>F=SJ1.>_09]*X' M7VTI3\GMQ\*>6T8?L?#(Y?,=E[O]MA&C+1_FE+&7+H^._\?W_($C)T&QJ)(> M>6Q+OG*''Y+>R(STR986Q/;74:0ROOBUY6"C"'&#/99SRGS\G\!>$>1>UEQ[ ME(T0>\1N:@R0:G)K*;NRM3]C>YEKZ9@384$NH*,KM/[=)^KGXJ055TRDRZZ% MO7ILYG&2?=/I)/KH+2YYZ(U+EEU,*X#:=.?\%6@UV3._SUC6ZRN[;E?@Z#9Q M9/'YN0[N MWXNPA'#9U;]"&%.XZ!C;*XG/\/UR/87+F.FJ&IM1\L6M;1ZJ"$ROD/.U#WV720)HUV$)KPGG!(..Q$/APAZ72[K\\&#BS7LFHE; M6GS,P7`>-_U5(E4/$TCR-#YIZ-/T7I53K.NT MNZ`WQ>1(]=B,3H6HI1%I/TZU[K&:V-W>&*SL[S=.=T0M735Y_6!-N,0U1SG$]+V;%Y'YN3:\]YKYJLO(^L.%?HYFFO M<$5Q0:`X5^CBB&5[GO9[`4UDF]![^811S%V/\B5#XA^G!@*U@$[!KF+Q5:`: MA+I!3'FQVY[RO:0F8N&'N(7-&@CU21MW-((7E>!%9[&&[?O6FHB)9W$36\)$ MJ1EL58,GH1MLE(,=[2"BOE!K-4O6N_8XC;@]I[4--QRD+>L7@E998HA@=>)8 MW];`BR2(5V"*Z46*5^1$@#;C0-^)3A((RB=C@5"R4)P9[\R)P&W%X;ZO@1UY M(!6`Q#/("G*O_ETZ$=RG<=P?I)NE@N" !^QTE!FT537K<3`?LV#O9,@)52 M8!!_E$TA"!.OXHF@>Y?(38T:>!$IWG=Y]A`[R4SJA,X,U?P,UHK`R8NJHO<+ MYWE)3\2:1-9T1-H,M8%`'=C5%SR<_$5CP5$DZU4^$4L2R=%IR4BRU1%`CV@I M>"JC>-O/+NAF(@,ZIW+6LA$%&UD+9EW:V5:OPC?6&[T7*&): M(J%J(CTX66LJ_OX`Y=N#(M@3V34>^(\%6/%RH0C81$K=S0/'`IK_Y4(1&Q*9 M-D<\/5KG>=WKAB+V)G)WSG$?G@5L3U-\`#![25'$RD3.3YE3EV*+T1N,(J8D M$OXVFMVG1+-0U3'#F19](LDGXUEYD)U4S*U$CE=B!DX)J)OIJ!,)/8'Z!7;S M6-E#US=:B3P=31]'ZA?*-RM%L";RT((+5N&4)+IM$\]P'RACIZM[[N[J2[M6?GWY>S$WP"K%M(.OC0>?PZ`!`2T=3PWKZ M>/!YW.J/!]?7!\!V-&NJF72&]= M6S/T([C5YO`<_`(MB#4'X1_!'YKIDB^__WEM.>2;[ABOD'Q=M7H.C@\_:*#5 MXJ`Y1B[6X9K@W6^3/\'16>^H>]0Y`9VCWWN'BQEI[U)SR%_IQW]W+SL=^N-T MTNF==X_/C\\X6W(TQ[77+1TMCOS_5M5_,@WKZSG]\:C9$!`E6O;YPC8^'CP[ MSLMYN_WV]G;XUCM$^*G=/3KJM/_\=#/6G^%<:QD65:8.#X):E$I2O<[9V5G; M^VM0-%9R\8C-H(U>.V!G39G\=>JL*X0+G[17?PP7-5)(AYBVC7/;D^0&Z9KC MF4TF1X!9@OZK%11KT4^M3K?5ZQPN[.E!@).G;(Q,>`]G@/[_\_WUNM47C!ST MU;"@8RP.=31O.]H"66B^;-.2;0*L.X>6T[>F0\LQG"5%&<\]SHDT'NEG#&VDD`(TFHU>J+,AN&1J+K62%-[&#M*_/B-S M2AS>\&^7V-$EG!FZ01SM,@>W/&2D\#_0[.?BU?D%DP!H@8GC8^DQ_.II!>BSDZ$<[$!.H97<^U_"2@&L\609!4R/>1M>1 M2]JSGNZ02?'-UGLN*@*YUTQH]Y\P]$#_8CC/9(#'\,687EL6>EUUK0'"+PAS M^=M=Z8F3R->:?0]U:+QJCY1>.L_L&N*X(EK0K">#T.[;-L?@P"HO$/EGA)T6 MF%,!VC^`BV; MKSND5Q/IZ\G(,GKA'#[C9<5Q\D7#F#BO3"ZVRPG6QAHGO8)22K`=.^I0JE<2PQ/8U%5=J,+;<8?-6E>PB_X1U=Q%9M.3Z" MET5V%:E\=79@K%,(9]T=..O*\ZR<.#**2^,G$S]6^4*]/:?R\E-*DT+#>B!( M4N$P*XR`=!`7IY'H$X_#9T("Z^XC;$T-,O6TO068WU!84VLJAN6T2=&V7Z:= M2$`^W^O&6E,TUXR<3,=K%\"QUU)K#N>/$.=D-UI5/J^::>;CT*L@GR\+.?V\ MK`5U"K5).--$F$\Z4^&GX:W$S"Z M`J.[X7U_3O\"[R^'5 M]>!Z>#OXZX>(D+Z(@9`FTB.2F33YC'"B(_(DU_7T)G:(S2]MA_\PDEEVPJP/@D'LE/8 M]LMML[PQJ3X.F/>],.=0MW+]YSJR'&*$0]-KC0P?\(G^$G`VPVB>J4]?=RA5 M@K"""2,'`&%BMA\/.D<;7DQ$EH,?#QSL)HA^E-A%D",XD*!B4_,LU!)53CB$8`%3O>H M\N@\=!)D$`50,$G=UQ?NBZ`G)`O$7KD@TIP.LKR9QB=_]<8",%;T03AVT64D M`Y?T7H*R>1;M[.)A%?HEK-IKVW:I-B"TXG:(*A9KMXR>N8TFH_'"N.1!XY6,@< ME^NT[FDPGO`\U+!E6$]VEK=*+O]PHC!2V9RSL#DI%QLOYVG3`7`3\$E8189* M/7PH!P?^5?XVL\RAH>0%_7:@+&T5OUU6?122668.'N5CL;*82Q?3+180&V@: MMJ0KA,<0OQJAW6T,G+CI5`/#?.(PAR`5\?7.:>T/;S*9JJ*;(@US#!,[\?.6 M8Y8.1[/(Y&<,'<>$WIZB2;"E:&6*C"E@;CKJ0K:[."S,3DO#;'^T:H-3*D+O M"T#HSL7TJS-!=]AX)=+=F9KN9_)FD#J%_#V,EV8%4H1KB>^V?$R(3KBRT'JBK%B:Z0RTK([TVWEOANB<<$68V@D7AX M:PML-J0J19"N0L>QA?9;0K>6\&Z)Q]QBH$8023R\M04V&U+!V]SV,L"QL9#1 M;0G96H(;E8Z)\*Y!*,$("\>VKJAFX2DX(I5O6PP[@)^;CMKH[28.$S3!0:9< MNUUR8\8D4TG(TJ5A(E9L&&FUG^*."&[8-L)+>AGC/IL5V/34QG`_L9A@%ALK M2N*R/Z?W78D#'EE8^)LQI1(AD( MUQ?;;%2+"!2%QOF^-1TYSQ![LX#\(VHZI0IBR"$0"[J=STF+@"[_^)E.J4;0 M<8R9HD\S;OC[3/1E"]MXFXM:52#,+Q031FFQ'$X>.7MA+FHU@Y&G-PH.X5QI MQLH3>.YB==4KF4_[UX0RCT/2NCQ5U0:(6P(F&H)C,_16=FP\NK3]T2SE'-;J M0'128;4UGL(S4\>"HRD,T(-[7W\PJ(N"';0&[A\"G1T4,400;DF!#4ZI*6UP+J:3`9C3W5%F#N- M#4E'AV!31;KF\EQOW(F/GQU?E3Z9[\&*$'BW(25Y6I#G":^(,+&QLD,&2Y\: M\,B!,#WO[O(-1;G^(^N=KX@@L2&QTZ,^9$W#XSQ"1>[TA?$26)CG;FS$"[P+?I-]J3G7BV$1R6+#:(J'!^]6E*1?SFQ,W7;X!?'+>'0LPFML(`W[_X+XS/_F6$2$V/B:PY$693G[/4(6$3_Z[Q/SGQJF2PU]#'47&S2",ESHIDNZ\!71"1U( MW%78930+;IN\@]@;;"Z6R0327PJ0VJC:[PP4H&_57BE(YOA6F\.L*_&S:Y;S M=D$1(/*835R'RCV"(`]\E9]&4,]`U'YC81U/NX2/SH;][!<74BN6]/X"=U_= M?HHA4Q@U_;N_&LH"*U*LK(<`=L0FSCO3W98\UKYI>#HAK61,P*+%%)\R)#N#TJ=D\>1+:%\M-F3MM2;]YDFW$LZ9W9-7-,S;*::VDR50BO`GW MK$O2KG)3INJ;DM)3LY+,3>4)6"APFS6*QXJ6]:J)5)>0<'MY3&86EB6_@++G MTH.YAUC,RL;??_M>\@_(*VR0&H82!REJ"L M0T#P$;M:QLN9T4)EO>.;-RC,X)SI>04?[_VO:Z4_E+PI4)4P>P+7P@/LK,N: MX(OCM9K^N&ZT5%F/ZNZBUR36F4Y`EG)'&28;+UA67&DO%4>Y5S1"5-(+E*>* MQWQV$(2I8.6W&C2[5A0)\E7?E)0.)C:[5L3N6OD&-ZTHN^;)U`I+ M*?XD>>0Z-EG736?%TJ1F&/154%#^F5U09>UBOS(LZ)H M.[4WH01QF4-*I>TGU%>^0./IV8'3_BO$VA,<+LCJPK#A'3;TM&5H,0S4WN+R MZ(%EBN7>P;?[3"&QTTDR1W%,5-\D!>N"99:[OJ\@T"QC^RWC'?.1H81;>LC- M)G)OR>\IYY)`L;X\,\,J"^&A&D99G"K28HIE&Z6P^_4I#";%&:3PFQ2F$T*\QM,8:X7KWW; M=N>K.?.]87^]PA!>DPZ&H>W(J/67EDI]MJ=;)P MO31>C2E9-!9H>$E-?UN&Q]3`-^#Q`MG_0"8A8QK.L@33BS;^;1I?@@Y$;_5@ M''().+A">`8-Q\6080*T=')A=2'+X%GAW1"[1$33#(P&/CL9'5M*F^H:1S&B MLVQ,K3#S.FD1#3/'GO&(A9DW<>9N$V=NXLRUC3,GC_JK0ZI]UWE&V/@?G'XF M/1&'NA==;I-U>627R3WU*^G1:BF-J1WSEJC?:LS@N42-"[I;M'//QLJ)F\LT M$6'&F(5018+OU;%&E4/OE;;80F\MHON)3E)O*@F54"H"+\8K(*:@HL>P%``Z MF0!TRKTPJD`$PI(R(9"`03<3@VZY5TP5B$%84N;H*0B8&O7*OHRH0@["D MS,%``@;'F1@\P M-/@KVY!B3=7>D)(EYDAL%YUT#-YN3[N7K]=-?_6]N9.O2336/='8'&A1=9A3 M_A1"894B* MCSO-/7QEF%".>_BJ[8@V6^QMXJ*'BQ<#>Q0*,*G,IFMO97P:J&>(L3)ID[H; MH8@+($_4-L7F`DC%3+*@"R`5OY=TW]&A'+^Y%UO5-UWIVF$9\WME$D&,"\YZ M7)F@YG*S)A=4XUS0P-1L>S3SS7Z$[VEO3\\+I511.T>4*:MJB^5$AK-B]:F5 MRLG>9"N>`RC%$S*BL5(Y/2(03Y4S'M]PGESQ6(WRRYCQ:\+D5O_')&^+!9%U,K1.-TC")RLOT MS)(P(86X>DJHH%JG'.7ALB4QTX/)0>8*N9@'F$TYM4X^2L-E2V`6+*(/0`:M M&Z]<_6533JW#D/)@B0K,3.;)@65L+'A061=3ZW2D-%"B\C(S60H&SD*)XYP1 MF5#-ATY9+I$W<G`0LXP7/G1&;LK,P?KLP_03;,>Q MO&7W$/A$@4<5A,D"TNU!0+@YX-8D->N?U&3UL(ME^"_I4?T\--0.^>?7AFIY MT#"?62'8I++EQ.)WT#L;.,7#[/LAI'*(6P**A4:OR2P40S+TC^>&\SP8CE+7 MM,F%2SK%E6+^B(?E@J;58]?6K"$3G"5KM_$LF4%I?GTRV99>%Q94-9> MUY%K.?:=MJ2#(IE5DR]D1C*],;1'^OZ%`>V!BS%,7/X$B2U^(J4%XWAGBE,,B!@7&E M!-:2*R@/2QK?>P07_._T!WWU@WSY/U!+`P04````"`#157!'3D%H=CX>OT)!:+FVY7@N_OF5 MZ[WZK__\W_\+T?_[R_\Y/$17!#OV)W3A+0_'[IWW$[JQ'O$G]!F[V+="S_$ M_6HY:_K+W_\Q=D/ZVS(D&TQ_C;[Z"9W^^&<+'1YJR)QY:W^)4X'3O\W_@=Y^ M/'E[_/;H'3IZ^_>3'Y_OZ/Q_\4A[N^?V/\LK``CVHAN\.DY(#^_>@C#U:GGY\ M.OG1\^_?'+]]>_3F'[]' M)T<_/@?VJZ3Q>0OZGH-O\1WB9GX*7U847P%Y7#E,*?[;@X_OQ,HXOO^&\;]Q M\3UUN,T^])%]Z.@]^]!_Q#]?6POLO$*,\LOM6&K7QYRLF.F-:66GV">>?>DV MT[K(W9/ZM._XX0X&9/F-FS#W0LMII'R6T[C:-[A9BV_YS+WJL!^OZ;_E5,3/(79M;"=*,A&*",R_P`>&6'8JW5OFY#HLFGN^ MT'8N\LX*%ESN.CB\MZS5&S9HOL%.&"2_'+)?#M\>Q>'[/^*??SOW'A\]=Q9Z MR]]_P8\+G'Z$6_CS*P7=FZ+6C&/D)ZI;_K+"_ICBS=*CH]HM1R9%;[JM:+-7MT*"5+T;![^&7V MZC\C.L0)__)F*ZD_?+`$"C]B-[S\8TW"%ZK@BF:/;AB,GDD@L;:"QR1NM-3/ M8DC)``9/.EH6L97R'*"("VW9T#?&^"\8D!O9-F&YJ^5,+6*/W7-K1>B0K`Q/ M%3PF(:>E?A9R2@8PD-/1L@BY+0]B3'1FAF(V&$B[Q:%%7&Q?6KY+9\J!$F(R M8I/84BNQM+\3G# M@+8V>83H'6OLOV&^8^MH*U_Z(50=2L?<03'6-$ MT47%!P-=]9151I[00PN,$@GL/Q,97:'-H'LD80/YY<3!;@DE.:PI%1U M"QTA&1"DJ'0K`2,F1IP:O:;T/\#(DF\Q7V696G[X,J<3[(`=\J!1\NPE^Q?% MQ+2.`+,+9W4-RR^FZ7+WCL;&*A=!&I,A3M?25$Z6-JT#R_WJ>;;EV^=7BD@E M(327,JD4W29,(JK>@5&I6BE98K0H)J9!Z@I*D!H]487F]"NJ!;(\C=$E+9%Z MN46H+$'ON%!I55KH832($8%:V^$9UD0^X5+0F=V+EJB9WW\N$($!B$PS\23+ MBZ97'8T8[&3HD7R1+1@-.=TV5"UGM?Z;W/M*];<7NEA`C3HTX>;=I-PL!Q^H@ M>MQ+$#U6!-%C:$'T6#.(GO(@^N<.?7FB]N5)+[X\4?CR!)HO3^H,B,=O._3E MJ=J7I[WX\E3ARU-HOCS5].6?._?E.[4OW_7BRW<*7[Z#YLMW2E_^0M5Z0$?' M/,"^[\B1"6#DOBQ2&'.G6+74H_D_PW"J4"=Y'Z7>Z,BM_[UV%1OWV;\:GO32=S?87WCI+3N=YNO3Y6RP_Z!.ES[TDBY]4*1+ M'R#UW[)"PIA\\K:=-3V%']^K_?B^%S^^5_CQ/30_OM?V8U?+"O$Q>V4`+M,8 M\ZA,O=2M10(8OI5H);GC@"A=U\=9XT_-G[Q*/V=H3/NYI%[1SRD!*#\7M9+Y MF=*9\C,EJN[1.2KCOBZK6/+VE@26OTMZ23W.*`WY_(K:6>GR+)%ICY<5+#I\ M2P'*WR6U9.YFA*:\33;5'3Q+9-S;)05+WDXI8'F[J);4V^PVE!EOS\ASI;,S M-*9]75*OZ.J4`)2GBUK)'$WINO;SA;=^=$,2OK`:9_XCWXP>+8*0 M%6,3SB*T^,S-P&J8L9V::3#!P$T-38M82EB1Y=HH8D89;O0MX6_UR%V`ES_> M>YLW-B;L`,XI^Q>&OM/,N1OZTV^10K?XGC`EW)#5UBLT@)S,!+JJE&1@DM'T MCIT*Q4H'12)T;&EYJM;SMBU\?/?\(O4N!*=66!(U,PCHT`$"!IB MS238B(D1IT:4O`]T)"&-'1<6F)7_LRDLB)1*()#]&PC/"Q22CAN,I@\OC^C7 M;:;!E6/="VPH_-V4GX5J)8[._1&$IT4:E0[?)S2($?79H]/ZI&R16H';`IWI M/BY4L]C93"0DYI"0)6R"1AD="!P M4:%L08>@T.46)Z11SLGU,5[CU?/E$H4)F=)@A5S$\2T/$+]ZSMH-+3_2O7@11T%G%A02-?.P*!`!`H98,PDT4N(()#O? MX&L.CJ_8D_N#%N!YV*;5>\IK7%KT)L%2X7:>=!(B`&!1ZVA!$2,"7$N ME+"AB*_'=:IH2+S%*\\/68K%GP:1+[A(R`VO6BF5+BQ>"6D!04FIH&PI*TYD M4J;X29?^<#1=+QRRO'(\J[CE(J$QBQB!>GF89`@`8:.LE000$2'BE#T&DVUE MJ.@RZ&0=\L>5*$+E^%?2V[1 M/"Y:Y;FBOXG&+06MZ:4WJ;K%Y;<2(0@D56DG78:+I]OQ:AQGZ1\U;/*OAYD, M93^(*:DJQDM*!A`M1=VJL,*79EI'2@L/ODSNKHAKN4M">X`7$,51DWJLO3S_ MHF&,\!48!5_OV&N@K/1-&.3=H909)=P='3O9H?17$.`PJ(!AD&1-TR/@J$P&`BUDZV!Q'QP$#- MN14\2$R+_F2TH']&F5S5?OH[&(]GE"DYF/X)AEM'RZ6W=L,@*N;-*KS?X##& MGPS)2A:CH4%#^5R$4-"#@8V&DH)GGC@+\E,>]/K&"S$Z!5)Y=.KCE47LRV=6 M"0RK\26A-0DLI;I91`D)P4!)I5T10S$MPA%QP,]3VWC%$EH@0U!N"-499GM, M5"H3%#`@$6E5.C?#7G9&RS@ML0"E)73J14)\S=ZA&+LAU9F]:1.91,.FQ.0J M)I.HT3,@"R,U!QA<::E9!-J6,D99/(Z]`S*.1?HK>U(?04<>;8S"(CPZ&U^/Y^/+&1K=7*#9?'+^M[].KB\N;V=_0I=__S*>_Q.]OKB\&I^/ M+V_._PDD2F6LUEOF43'TA$V-!1\Y-43\U5OZR3#"P%0RQYQ:+VQ^27L3_<5? M8[ML8L7$5DM"'\L(-4P3K2IHL(/!97V=I6L.JT@$GR]:D1#D0$/O[,'SPSGV M'V\\]\QR?[_V+)>-""RY3!I!MDFDQ6JV.KV^,?ER\]5\8!!:0]G2WAQC/0PI M+W(85SR'>`]D=,X\OIHU1AT\JYAZ>DY788#D-5T!!QC,::FI>DO793A+`F*$ MN@]`4)<)[-6Y2F]97T6:!VLV6U9,O6X&;U2L.Z.%,H>M-VL=P#RU]LPTRT!G MHIR%SD3Q'5D2["Y?@$2=S)G27RUG+ M'A^MM3P,BB@MA3\TDYY+@$ZSM.>(&7 M\:]'_-=31"6M\#(D&^R\Q(/IT='.N*Y^8CIYZKS0X'*R/I^BSV)51M,[5BL4 M4V&58XG1_H1KAJ#4JMA\CHY'SNE?7J7B]DZBE\*@R0 M!%,!1^]PK:6F^!''($,9G\J@`9&XR+(W%GO`VF`\$S_`7M%%94Q]Q#JU`:+( M)^;H'5BUU%1&Q=!#"TR!%?&R_PQC;FCA;63;_$2TY4PM8H_=40'"^'V-"60ZJ.(S0\Q0#K`$F3@R.PP*>IK1B* MF55>/@$="#0S:>G4\B<^O^!F\R6E*?;Y_*=ZFB3G[&E"6F6*9%8J8P,SONKK M*IE&Q'?U*3/B7.SF=71S'QP455P577F4EL")2N*#*Z:<#J(.H-!94-,DKV^BQ](HK254; M'7JX"*NN:".&68NU;/3WGZ*/:VZE),1][D7E%5;M2$64O>-$2SVMW:EX*PI& M(!J[2^\1IQ4J*LYT2*E-AI\*E;.11T+:.YCT]"M?>&+4:%M.!%KAD,D*^Q8K M'QC?(JVJ(:*@-PFH2K6SD)(2@P%5E8:EPFPQ&0P,?<8N5=\Y]URNL^>?>X'T M%IV,V"1ZU`IGH2.F!(,;I7J"DZS!VN&E0N\P3HY-'QT#6:&*;6%W%>Q'XO(W MG-CIH!CKZA:0<_6`JRH3!`"3L4!#6H6>1F4CA_DTQ$"09! M2O7*M\4H\>&"4;-3SRDY#!!]MH@;7'L!S>4G[N4S2\[6)'B(BE9>X(5L&J;! M9S3QT34CE_I4,9D!W,<(<"Z^9WMLJGUC785+61#E0VQ-"8>ADU85#?+7&+MZ M"-LG(?;N[IB"O-C3Q)U9XL/O4E)SSV*KE=V^CBVFZSU`:2A7>BN;45,XW#%( MQ/6X.%:L](KA"9`![Q8'F#;H`YT#7.`-=KP5@[(Z=:[@,7LH3T/]_'D\!4/O M6*NC91%T"4]@@(`D?,!^ MM+K.7I777+RN8#(*'RT#3.[!(2P&\_U MDLX1V:0>[ZJ8C".LTH`2PJ0>C\F]B_#S\H'^CM$]R\I?.S2= M!Y)?W>`P,H1-,22F%VA,PDFH7A8].0)8)WY%JA4!0FD00P.Z\WQ$$896_+$: M&-A(+EHDIS_/K(`L6A&2NH>BZLMQ21,&YJ8A6U- M$6!@W$SOTHI&+`59D1CD%R M%�)E1+_@[3-TX&Y-14JM8UHK(OW="ZFZ#-+;#9!HDD3QX(=*P%3?`#G#]\1E:30ZLQQ61"4Y MG]];'VYXT=IL;]5U@%Q/#4>,'EDQ8"#]-#G*C^V+M4_5C!Z5S2+LRO-GV-^0 MI73OH*X0XS?\:QM8`J6V!$!C?0.U2\?)V)4-5H(I,]_@=SG8LDX0\QZ`NM`A ML9M?W-T1T#(9`/"L-D\#SF(!T-&LU+HAF*U6PK/D!$FBP^0N5]IJQ@^SI&6\ M>?UN^96V!D*,G3II;&!Z'J6VA-Y!NI/:VB@-O?C,$_U94D4[^ZP`B4\"MQ6= M=P?TCJT&$\2[P'=PP#4&6?,Q>+KVV:_AW)OZ9$,GY%/'6L;OG=]A-N+4C,?Z M`ON%=5W#U4#7E088^C5-T.X,JU@NZQ6K2#):):+9H44NNX]P76UQBXT''^]M M(7W0&.\*W7`C^\05'N3>729TO)?,;R?$4X%05MK;-.:[B/?M]H5!]((6\;\G MR.\0\^V,`NTL&":EQ#.ECVYQ2'SIQI6*P>128+7BV74_.77O>8JVBLKR0J(" M[["6IG/V\:7+T?*/-;./59KX!8;" M\R>O]12*RX2>!93,;R<7I@+W(2,H&O-=Y,+M]H5!]((6\;\GR.\0\X!'`2JZ M_3616"KT/B!H@I;&`B9R'_I$V9SO8SQHN5<,I#^TVA/VI@]TBGZX(\,5;?_6 M(TDD%'H_*#=`.\,"D[@//:)DS7-!NAQA&5VBS$^P+_+L$/MSQ8$:>6P\A7";T M+E`ROYW!@`KK=(I0<&VL@Q!C" M&QN8`KNV!%!X;JI]KS=%ZX%5?$FP'E85,OJ&:J5Y54B5"A@"4*N4'\PET.T8 M$MV\FE+'DR#P_!=6M[KQY2.5,"AI1+7!NEF$7%+O1\I:4;]1\A!?P5NE8OD- MO'Z399&E45V,EIHM$089XWF#=\%X)&FP&,^IWRK&`2^1X`TN/G#3FE0HJ*_1 M!"TME#"1H/*6ULSY/A9+VNX5`^D/K?:$O>D#7:+?_,B0F9^,7)O77>>SEYJY M?968?K&N9Z0:XFH9@+,<+<4;S4AYG0R/"40;)K&/Z"VSKF;>7B4&)G[KY.IJ M&0/$;[/\7(U?0_'WBTO"H)WB+C5%]8#C1L8*L%Q+#C0\-U%>A>DUDP>B*<[L=)0LJ-O(@=$<[?$<#./3?TR6+-/C6Y MDQ1_55(:`Y%:U10V8C(80%'J5KXFOR7F#_G&Y&9#S5?+]VD4K!]KBHQ]!QNQ M(571)L\%`T5U5*T1;YYB?HV`TX'K&C[_9K8(OL@E:KU:>/VMP\:N]=Q#'^\- M7+K*E]*%^I6>`XF>?AKX:P\G`%M?KF65#V`]]!`_,D/#J14\7#G>4]4#OVJ6 M7AY>4B@O?`!(0`\FE&HH*7^6B0YKC`EQ+O0MX0/R^@^-_TR[J>]MB(WMLY4;TTT$&7[&M:&AA<&^IA0P(&ZL>FD>,)K]%5U=3[[. MT-7MY!CN;CF\]H=#X?_SJ>CR]G,,`]LO]G'82L%P8W%"'4>OXZVMR[ MQ0PQQ,&Y)&GNM=,5NO^LR8YCJA&SW:SK;X+IE(8,+7;AS&?9N`5_M'Z9OCR$H_\@E(+U\N?]>-DT^LT6N)KLF*6/?*YEB0S3W36(N&."K MHVJ#G9/[2$`_"^;U<5;B[!MH$E-TU\R'`#6QKDU6S37`UF&^\]DB;L!25G;# MZ_*998YK$CQ$BR@7>"%,^RN93*WY?HRA'/G5":.YE>&^;X_.J3$'MW=\R`E1>0<.+.+*=\4U%"!^?M;BTMBW[A M].Q0!7.'';%P/U$F&+,>.BEDU!QBJ7%N0>Z'_AH#!-I]$HC`YS.L1:$`?2E+UL,IT[LAV8X!8O,=FP M]P:U6TO$VB]@Y<:HH5KFZV.X4XUT-706K`YP0K;:%%-"!>/4QRN+V.KUI&JV M?D$H-D(-P#P/?/`)]2T"+R9".***8F(\I@-Y;D;>K:;1XZML-21Z>O5Z&\QK M]U&U,!@Q4\=@O2BJD@0E.6W%"FFD%;W"@C<,32D$`H*QAJ`:D%5+`S-$:JUYU>&)\ M\^OE#.3A"6KK$F,[N*)(B!=-@HE[BRWG,F"'F]CZB2PD:_*:A'`M<[*HU6($ M`]0ZVA:Q>0%QG8OF/_RKR0-->MMJZ98G6L&#`4'\`V'D$@3JT[S:D#R)+E>LMS5)7L0BT M>$&OXY3U!_K_L:"AY*Q7Q+7<90LYJU(0`&!K&*H!<(44,*E`8]6KNJC1#EJ<*F<``4U?3TIV*_)%"%GJY M'/3:3Z7\<,#.L,)&8P,@PL%@7?@-`GDU0+<]J0$/9,)*01I-(>'K"VY*,V28 M$S*!!)Y*TUH5FUC^"0.$^JG&SKD*U"1RM^1Q$+,CN=Y:LZ.[A!WX<3$K MXZC3K":/N=`\&@?AU"+%>PAB$K-'4LK*Y0^:;/\.)J\4*"5"`^('H%C.2&(& M*(!@-UOGUC,.E)@H4!D^J212L7`$*4L""!PBO:KPP7A0R)A@8&2V7JVB";?E M)-4WQB[5]9%?Z*NJC*++;;1(2CV3OJ7%ERVW_T*QF?*A0^1Z M[B&?8U`!;L"F%)Z[^_EV:5G"=*:>OF`5GRL]IY]=.R$O@J^J5EA+@,$BA@T, MR]0VK,'=.R8;JURNA)A9B8FJTT4+,JF`KJ\4EZQ(7NOARY5S[#]>LXMC6@T@ M8^T/@VICY.@3\P'%G5)9'<1MWU(JU%HP`+I;'*Y]EQDQ9]/GM?]28;.(H0^` MR147P:I,#0Y,4A65$/)C+@:B,.8S.71:03A;+X*E3Z*K\=J1NLS8[U`I,T0] M1!:YP*&J4E7=(7%%^5&0%6!Z1,R_7UIDW2UWJK6K M,,AZ3##WXJTZRTGKD,J.\VES&8.?O@DIZ*I98$!-6\_2/A1C9/$M945;7G!% M92?^O>7&!;?8I-ISB!TM][@VG6L';#TG*NHE:(D+$BP=CR:D>(Z?PS-'?H2E M_<^87`3LJI&RJX5M?Z/W7M2Q8<5N=V8%)&`A/2L3':+/'EOC.6=.]EWTA?TC MM&B(!W.B84;N77)'EG08BF\#4X6GM)665,6J?J7+;'3)O)9!N15S+4XPR*ZE M;GF]_/&1K913Q&;DH*T@E$CJ*/W@U\M&]S[F/>TK"1]H!N7C%;''KNMM>/\) MSCU_Y?FJW9L=91E+578U-TU@F@KJ';9M:%]",1.'4GF("42)1)01B3(R@0"Z M.GMI3RQ8F%=D)VW)'";X];./8C]X,M$/6IH!L*L[Z['GV$W$XF,&EVW<>:C'?!< M>^Z]+G8DM":AHU0WBQPA(1C@J+03O.*[P7[(PP[;54!Q@4$8^-E&STQ9?#JK MN<4.JSUS[@5AP-_+/+,";*?E9BJ0MK-4DYALJ0FRZ-U1)!BERJX?>VA2`'#TS*U2L\ZQ'0P!KOR>\5L0-:?[M7@-_L$<$VSU"]- M2YBA57"NJ[@P`,7\?T*1!/3Z`M^Q[3IW^?)#1T$I'CNGEA^^S#,W:4:N';^. MK3PY5(O=6"!K8%0:XFKPP@A^]14N8B^6@+@(E)6!J)#DE70@45-FKG[\$Z^]7U)1AM-9( M$_-R]1;J"``#XB9:B\ZSQS(X;G-2(&]79!37#\%53#V!5C/0JCD@PE(_G,IQ MN/,%L99F3!R"\! M[5V704@>:1XL*[!8)#*),+&"623E*<`@1JA6$1E?HF<+4C(8H,A<:DMO0(Q= MFCBN^=`>@5YBMB:O20C5,B>++"U&,("KHZWP#N*OR1W$[3VQ##\,:%Y:/JOY MQPHQ\JTWO:&SDLLD'#5-R`*Q@@4,!/7T+(*//7[.2@TBSL,G#E,OI)BC"'1> MZ/3568=D@]$,+]<^H,JOV]WB[,YOM`W(3Q\NF0T;/*76JH-F(TEFCTDU-C5_ MAJJV&'!;-8U-,'5TH*O]1;U0J\'7[WZB1KBM9`(3<'4U517`,+PW*`R$6AR] M[P"6`YL&>>]8T==1?W<$1HRZP4^9";GON?1?ESB3[>J%K/IBS+XBT,S(_%L" M]63TCMD=%2\#F8W*N:O,.5DPX)Q9[A0F&?S78+0.'SR?_!O;7UP:]C/GU'C* MO1E*G\X<,XU?1GF9LR/U._=9#<&@^J1V0]3J&^0`E7X#;B^(3^J,GR[>S;<-6,:-"$302/,8'N)OV MJ%T^TG?OVKV!JGI:\R^`[G4[FZ7J@9M$""OEETCA5?Z\=NX/F!FW1NPL_#W/ MGL]>Q$V7M!H.Z!QRY-J7SRN\#%FE3O;39!T&H>7:-!EO9;SK4J&^>[+9AJ\S MOG:G#>@(8;0)5-$DCAGLA3P<)]-HQ;+IKNZ?;1M#>&4AN2,S\6_)_4.X3524 M=]5V%VKN7EM;#;"]`[>KQ-Y[2JMFJ-`>RX";G&I97F.DJRNOIX&JF=F2<::> ML-[!WY8%E2L=Q>M=3.A!TB4"1!/(2'!_5[WXZ+7KA:^BD-XW?2H-K'/Y*R^A M=_#NI';#BV`H$@8M=LM:H>;D1%=,/Y&ZGI'B`*TGHW=H[ZBX*AS[,=!7'.C9 M%^1@@'KDAL2.#TUMSTQ=/B^=M8UM]HH\F[^LDR+7Q4-;HT>V229ISI9DFX1_ MJ\V1[1.M"`;34=JTIE0",B,['HN,OH&ER-!!&]THK;9UY MON\],16E9\4$E+U4-RNK*BQMMB4#`TNY;N*B9GH/V75]XBQZ`^:"XMR]C]Z, MC[9$T[=A1*]B-I-@^`%WW6H6]?4O/5NR?ES0GI_L6@69AYK8\ZWX<>5X+Q@G M#V>V49I%574I4IR?D4]B7O33C>7V6AB5\N@7.:FQ=D[+!NI6\3B MW`LM!P8"=]U`R>R41(.#-&=H_3O]7[9HH9FJKV+L\!&CO645910AG8'7OZRQ MNY'%/I:A.T`+?$]<-G/9CT[W.7K4T(V2N(X:NOB1(74W<0.UV=?R7P`S+'5B M5JEKQ3O<]XP8VWU-ZH89DLU.#:.@?.G:9D.R;/Z8"\J8_W,_(G+&L*^8[?EA M>T2GY=8]SAVH[MX!ZJ\/*8;7;-*.>JWJTWN>7FF87JK'&[,@*^(IG(#:YF%H M$6T]#J3W![6&S2XB0)L:@(H"[3=MK4C0WN>'DP.V;K,T#,0\*&%"G.M@?S)' MJ"/3?F>96J8+02D?FJ)L%."XM*ANLH6DR6[8VS#L@'.AP7@'O[!"G-8G4OG, MD`+&1R6C#5L*`D:^#C9#-6E]Y>BTK;2UYRN%.X4!DUJ`RE"[:>+N%B-A105S MJY6=Q`,`F>KW,$Y!S5?-6E\+F>"63W=H*WEN?XL?+<+&8U:WG)UT7UL..WIV MW)'7&FDRI-1UAZ9N,S8T4`/6L-6+[94!(A6`KLD=I%ELDU$^#9"9R_VW)/C] MRL=X3$=EZM?PE@;2MK,+_>\.(D^MVXRM9*:Z'X75J0U86KJB14D/[R@M(C$Q M\BGU'G;=Y(K]!=D0FV8OIKJN^+N#[;JJ9NRLZXH^NI]=5V%IL>LF).B%8$\FQ%&]Y7@/:)-R M=G1K)?GJE>??81*N?2SH4$I*8S=/U*JF=TO$9+T#K%HW*2#N4FIHB5B3*:>J MH["9Y5';]R;6*F63J_^";XSB&E@53.UV=5*']F;CB:S M3%Z:("G`B;><`XW2QJ^QP:M;T8U]1?!$]03V(RQO9[M!5->6^%Q"U_=%-;X[ MI+"MW8QM=L?*C^Y-6->UM)2<)\4U,6.!>X5@?ZZU#&],Z,#XNA?=GA*8DN]I M9.GAZNN..NW5B&1Z:6DGA;Z?D:R#>[1/-49!<_'EW+&"8'(7#]%Q5>W1,Y'5 M8E30F^R7E6IG^XR4&`R>JS0LO3O+Z+.E_).RY>@;X_H78&QEEM;J-$:.K7>D M"8RH!%R&!S;NRHK*UVV2U+ZCO7>A?H$J1]%G,[8K7\.(=(M>@Z=W$-545#(K M+-PS[^X0!_%?V`V.5%?)Z8,RFE*B/C=HQVFI7NG,Z-QU\FX$.U\7Q!)`^';NS7`8,H3&+Y]< ML]=,JKTJY@/N3Z72.IX,/>H])H%VSU[??RG:-_?.\"T.U[[+K)S[V`K6_HO* MC6(.L`Y4J@M[5!.K7IUGJ/@&YB?H.GB<],\O!P>C>QUR;KR1\&+NACU?$'KNNMXF.:IY[_LJ+ MCFU>D&#I>'0ZOGU_ON38%F3"\GQ[!@$*QZ\!P;^\'E'VLZ M.V?(32:%R:;H:!F2#?V;PO^[2@3F_9;,*;W^'-&W.=_`83(0%])/ M=&`&QP>Y%?X640'SH4+%DE_X.)N\XO<-@@MFZT6P]`E72;+F*Z$#Z`:IDA"# MXSJPW*^>9UN^?7XE.W8DI`+6\@H5`;9[$E/E0:=$`:N]9>I)+VSV'6=NL MZYY:/AVYJ$H!S4A9`)QZ#EF6-P'5Y+!\H:4KP$X@6:6/1Z9H-UIW.R+'!,L] M-30&Z"1>BIPLUM$2O.)$BX@,EB.4.H)L^G2%I=ZQA0$=61CH<87MT2=R=8I^O'$8_W7@N?EPYW@O&\8$UEI^(YQLUA<#R MX@X6`'3J;@5I03E&J2/`IF?7JXXD4\/,WV`USR$ECU1 MM.P)U)8]&4++GBI:]A1JRYX.H67?*5KV'=26?0>]93-3\&1!*DULQ]0X]Y[= M`AT%`19D@G688?FF@>80G8<7_MJ2'@;/_QF8`T2Z`6SB_UZ[LCM]VS_!:MJ2 M7@";]:M/0NS=W4WN+O#*"T@X<=E6>WFM7TP'J\'52I;6_1DUHN1L]]>.&!`[ MY$-98"S>)(>6II2&!('G\\WNZN4;,1\L7]53NMZEKE4J@E=-@'/(4O?LZ,0M M>WE7@;#/[DM=N_J<"]<'G1FKUS_(./6P[M M7.0^.3]CS[ZY_XJV=;O>9Q+WR/D9<_;.]V33OB1W^YC6M9K0[4\JMY])7)OIV]XD;GN9LK69K.U-FK:? M"5J+J=F^)&60T[',CL'%FFD;/6$2)9+IUG%RO36@L<`&DL:O(]S9@S/QQ63?[S!;FM#\%;DH+RN M;\\>N;]5Q^^/RP?H[$S",7+M2?B`HT-]=49KM8P!N%;+@*%[M,[8K)8Q8(\. M9SS^XI(P:*&47RTY4#W;Q(A]\&YEGZTE9^#>A=YW*^H"URLYD.>"Y;DZ*@/T MTXS^D9_MEA6DR?\=5MN+E8/"&9FYCTC^AB!B-PJ@(+']_(/30 MU/)I@.X?ZB/7UO-.%0_,3J%65=%3HLX]FA(I./]Y3-[GWI- M@H=HX^L"+T*1ERJ9``RT]74M^HESHM<1[P^LP$N>G55_80)Z\MQDA=F+->X] M*[GI!N+QI$0$J`/)=2MZ(J5$"6E?0TSFK+1P<,G\'5`?$*I5&E`XT0&*R,"< M)^JU\DW_+FS7#ME+=4T%#P@E+9?)&38R.L#$L-#0836=82.C;$>K,8,*'A!* M6KZ*/VQD=(")8:&AXT),PT:'R))V(P<3/2"T=%#?8=@(Z00;0T-%I]6\AHT/ M@2&M!A`F>4!(:;UDR+#1T04N!H:(3JO!#1L=`D/:C1U4\H"0TGH1FF&CHPM< M#`P1'583'#8VRG:T&CBHX"&AI-V21@-'1@>8Z`<-?50^`N+[YHH+SUO4D03( MTQT>;X3MYVJ]-=TL%32DZ-YMU1P@2&C1DG8S`29Z2&AIO\C.P!'2"39Z0$5R M*F3L+MFSY/@"1_\![3S)*IJ.B[F3LZ1@7%:`JBI]<+`-')M M^HM/LXV*\^+-)(%V<"T#ZO;76"@_=QN+1?V?7+_!X;D5/$Q];T-L;)^]?`FP M/7;38X^C94@V4@SH
P.EB[ZF(A"3@1(A:/&"7C,YU.4_H.VAT:VLGOQ+ M4<<&_6#NC99_K(F/5>_R:C,!\J:^KD4G)ISLMD+,B[;,J->[.A*,CMT-#AIW M2P$W($$9=F\DW]*^"&[U^5TC7]FXKJW[],2YH^L'^P M.S8;RV&1)EK0*>8=(@_7X0?DXT9JEZ[X,@^S+(G_2T;.`8HD(4&J!>;B'ZM] M?4&"I>,%:Q_/\7-XYE`:D9.UF0%YN+[.6K<'F1"TE8*^,3F("_I7GQ=NSBBV M[+34'_%HELC^EV*<8I!BDFS8PHH;3#V'+,67/NN+@>3N';07WO(Y7#!A*"OM M`$7R>)]/)2(N$D4RT;?XGT!@L2BVR(@5G[CGZVMG+UN2.,4`L``00E#@``!#D!``#M7=USXS:2?[^J M^Q]XLW6UV0=_R/9,,K/);%9ZT`#B#R?W@W.#Y]9P'?02[TYS^\ M^SPY&DZN;F_?64%H^Z[M(1_\\,Y'[_[Q/__Y'Q;YW_?_=71DW4#@N9^L:^0< MW?HS]'?KWEZ`3]:/P`?8#A'^N_6K[47DEW_^=NN'Y#G9Z>#]];@])_GQZ\S\KUK.R3_2G_\[[/K MP8#^\6$Z./]T=O'IXJ/DET([C(+METY?3]/_)=V_]Z#_QR?ZQY,=`(LPT0\^ MO0;PAW?/8;C\='+R\O)R_')^C/#\Y.ST='#RVR]W$^<9+.PCZ%-F.N#=IA<= MI:S?X./'CR?QOVZ:%EJ^/F%O\XWSD\UTMB.3?X6<]IF9!/!3$$_O#CEV&,N" M\#,6LP7]KZ--LR/ZT]'@[.A\TH3*^U9WRRIY@$*T'@V7M(5A.`BY!RW4R-SFX3(^>,9 M>2Y9Q49_1D2.KL$,.I"LGFN%V-C_3/\,;4@T%DCH487!:N1RM%C8>$W`A7,?$C1MLMHX M#HK(]_SY`_(HOF*^*XU2X^QM#P3#.08QZ%]@^$QV;0R6T+WU?;1*5.L*X27" M4NMMU?'JHRCE6O`('`!7]A,=CS]G=H_Z9D6X8/MS2,8>!H'$YL!J7R/RSPB' M1\1"6]PA6V+-+6]>WWR(MA++-*0DWZ,0/-AK&>SXO>KD%MD'CZB%XUZAQ1+X M@9PZ\+O5N=:3G66\E-P^BVWKF\D7&V.R>`EGD6]7,R\J;]9M[M"/P"/;K4ML MK'`])=P(Z&F)H$*LU=0($[)188@Z=76Q@"%=X>EWB`[234J&O<*.=>[+3P'X M,R*?&JV`A#RRVK=M*=1K,31H.90O;5.Z_DKL)A*=FUD=)2?([%'_2BDWH_+6 MK:Y%4H=0Y58^FL49MS&)3)D.N>^,K1/KABDM$KG0^"[P-T,1"FITXE,?J8#IK[_@75D;7IE_VK[KI4,867'2,G8 M$.(A9V?N'G6U(RSB)OWE=]YK$Q?`$S+_"_H72LC%T>D@=?W_A?ST>S*'1S"']--^2,,M)3,G3:%8\A=BR$R4&-(+89T\;.CE`4HQ5IBY-E[-<^OAV02+IW(C6?/RYF=:R+)[7.3N%U*I4[1?@`8(D*"2R/R?!G/ M-95D_X5)[.=2K0,&8GS11([)>O&$O'+VYYI(LOV]26POI5('NZ\B3$F\@8%C M>_\"-N8*/KNU)`@?3`)!1+L^.^<&>@!?D:G,$>9:.;F&DBA\:Q(*'(KU`?`K M\B+"-YS,*^!!4&@J"<)WYH'`H%H?#%^`Y_WLHQ=_`NP`^<"]#8((8!XQY(%]!$L$:9.Y"0!D7LJ8_20/IR9APZ?"?K`>8B>/.C<>,@N M\[)LI[_33!8&`P_))>1J5`RT6"`_]A+'`8!@'(5Q.C*1#ZYZ M(3H/?8D-F!R";LAOC$6,TUP6'*,.WT+R]6-"[7)I1#*-9?$P\C3.(+T$C>]/ M"M3=D1^:BD84<[++HPYGUI&U3<(E?[\=P&0P,4LU`@]X*8#,_^5=ML0LI-J*2&9O$X6(Z^CT(4V(X8L_MI2V^40$1 M&?K-0.H!@Z4-W=$KS4X"0H@8S;4%/RI@PZ78#%!VR)'<)C2&0JHH2!F%9C"? MV!W$-KV#*^#F;[`0)6:C(>JG+4A2`1XY'IB!U^[E(I:6:`R/5%:/$CZ32<\` M&<&]2^AD3BV>5XA"VXM;:D7H#MI/T(/T[B(Y$A>OIX@-8OD1M,5?]C_`J++) M#/7+S%KZ?,/KHRU24Q4%)HA&GX$V%FIZVY"02G[!$5E8"@2(#7:I0?1%>>2A M*;?B%7AD!KCQ-8DIP(M[Y%_:_A_Q90DR?7J]-,C=+RWQ;4GUUABOKIBR55Q4Z.$V:@EB%.:@O4&3ZJBD<)C5VW4JO8I358H@W$ MH.JQ9+IB@&:BRW'M*]ZRF&\IBU%C/A-E5%C4[HL%XQI/YG,T[XAA.-"FI2UE M^=N8TT.>OTP:#)7U))."WOAW,-PMA,&5_-)^LC@UYAS91P\XG&A>*Z;H$CR" M,,(^<*=HBH$=1*59NSGY8O631:)!!T9%C>%SP@S]&;IN[(FQO0>;EG.ZLI
Y#1_$GHY> M+F]JE0'M"7_EI51WLO_.I;/_K&]VANNS`=LX-Q"6CW$\83<^0#X`'!O04H<' M=N?NY@TJ\,:,';9P]!E&X3/"\-]O:BUQ`LQVTIU86`]Z+&88BEI\CTL%L4T' MW:F)=:*URP1#D>+?WV&15N7V3F,._CHQ:^#VCKSW,9F"O`]RTUYWAF(5``0D M,5FOPTKDU[/?,1`O<@;B9#JWXWM3[HG<^H1&L)VO MV!AD=M"XI*60^/,TZU7B8@BGBV9;3X!(;OD2DF[&II,\/N/1,!H!H(@CCS<`%Y.3+&E;JM-%0@6K68@$1N.EZR' M',H2`9V2YH>Y=_YB<5WPPIVZ^?6(LC$/K%TR.+&@VHQ-=TA/>V*";6RS58`0\MJ3P)K0-!-]T73E152XH+9@!6($WA MM*K_(LF>Q]2Z5KBI&:'D_616S**^L.RN^S9,GP MQ8P%+'\;4[1RL=KK#LA76;+XM)N!C]S5"D/O4Q2.N&5Y+.PK$VH.[V7\W@/Y M-@[UN[U;NC3Z+F`9E(Z'6$R2J1/"N2E=P;A"<`KZ##B^>KCF., M+2(E`,H,,F1Q+9][?%5R?VQ9PQACV%2$EL^>AHS.^!#H.V`\VS&S)B`,Z06B MM!!B7`&1>Z.JPCC&F#9,O"H29@I@^T.E/[NP=I!TP/,08?IK.$4/&*X(00^> M[:3Q%[*!T^<`E75+?DS=B8=[0*C*.+-`K1=._8F*C0)I)H1IIH'/RLK>?UCM M>8DMJ&>&?Y5/+RN`GU``&LC#KTA:[4*A)`[-!W":$`=#!*&>4\[&_9BI>/`( M0HAY#B5>'^UIE=('&#'E9IQ#=^89'Z^&SI\1G2>]//P+")^1+%;,WMK3):NA M)N"&B;OP]`4UL0O'PVI/CVQA%\[P[W!VX=J%0DD<-/J2]B7QT`0AE7$R=".V M>CJP`77*FU\GLCP\'`%I0#04A<)$)YDBWPY''!)9OT$1*Z&BAG$-J-'>^&J1 MY>#A2$?]-&!;)N`:4FV]^I;] M+=5D8%ELN^SFV^%A]Q9M)G$-B(::4'33T]=)<NTQ?:)^NXM&DGZ MFI&!X,MQJ2XU#ANGWT8!K4EO"N.)HN?,>ZQ2MPR M!4-)_5,<319#8WQ:E;C5$(8W-DRT/EX:DA+VQ$X?)Z^=,Z\[T[YR7671T>QZ M4N%#8^4<_!##IXA^<3SCW'9,:AR4-Y9EMV;O#Y_6=F7]BXTQ4<1*PI[O*\M^ MS?X7)4Z8D9K=:.7AE/*)F\1Z]=(7OY_)LUZCDX,Q\ST/J4G9A)&_UQ,@ M)E2_4$%1HU>"._^&L-1<)/C*#IYO//3">`?S`Z\B\-5P\I-UFE=Z.B$WK`:`4)P)?KSP%P;_WM,QQ#)X0K&$*9-RJJC*7Y#4T9-(M; M7T6.F;$_-OLH0E-`[<'USE@N0_?_HB"DTAC<(]\AY,8[R!0]`H?\-_3`SN2G MJ#;-;?[+NHN+U28_;8%DB$@Z#@84(^%K-\66NHN1M884$C"B%;UU\E M;`N===F*=0!WK-NN$/Z/WBQIR4FDRJUIY!G@+<2+Y.NV\A M-^;=U*'T\D\J=[3.$N$7K5P#KD'R_QD.I8\AB,_O*F-HK\A6VU%9,S(\V>"(@>`;CB/[DFUUM[H;4*X(C097-IWW7?Q%7@`8.E#5VAXT7<4WOE MM09DH9P[AR@'&ZE_L-=4Y*GSP7%P1"8+[2?HQ0MEE=6"/Y[VNF\-KA\RG.R^ M72&_S=81T3.@QER=(2)%SE66%D.>VV90?.NO0%!3%)@[ECD%Z?:.`TOPS`PK ME$S<`<`-;@@OTJ,5.5T_`ML;!90;])3%61HDNVNO*+<'3*@*P49!;*_CP_H4 MI:50;PGG_3FDFU\0@)`'K[BK]KIP]4$KRZ?NVY?R/*MCA3>@1EQM0J+.N0.U M"FZ@;_M./58!=RQSJLGM;15(\,R0+2.SRSV2(W:R,(YG\84[?OQ"HJOV.G![ MP,.V!KA\,AO6:HBJ@=EV3F!]8)J-8^DU63DP&5VUEU]K!%$NG\R`59[N.G98 M`PJKU0:T.N>Z;I51^2_^/7AQ9D6,G]6G&5S_R/D^VM*B-8DY%-GE+K`J? M#D$V^)B;5'%-#5 M.071Y)$KH],,^RC)*9K:KR`0@9!K:$[Q,A4<2JDU`XI)M%QZ,4&VMR'HUI\A MO$AX*KX**3N`.27&Y*%3Y$YC&<;;<\ZV.&F:,'&%_"#RPKC&F2#Q6&D,_27! M%#F/*I/:+G1*;U]+]]9?":Q&N+2\A)V9Q2,((^S3>6S>(!3#4]9'?WFO6D!A MLZ/-Y[=97(D(CD3V0NV0E,83^$F#5(:O"K!+<=)1GN;0#&(QG#YEACWY$ M-+D2^0[`_F?Z9VA#?\=UNE.WY5OKR+J&@>,ALL8#\A^#8RL>UD(S*SLP^:=X M:"L=V]H=O$;II0H23%'J_;6]K07/BU#3GC(=-1ZZQGAN^^EU8VJ2(@^ZB73Z M;I;3XUD)!6\838F@7'K<*%']7])5X446UM)S7%,,-T3[)]%B8>/U>#:!V8O;:+72P\4"1T6+9_ M)S53C3FFZ!O-#1W.,8A)_`+#9V(>8+"$[JWOHU7\G>`*X27"\=_+->]C7O/. MB>;1D:WMT-8+&=O:#&YE1K>RP]?Y.^\JE0?FPU1=,X5Q:PJ#T[SJGQQO-DM`RO3N=\MQ;8QS;A+SEAJEJZ@7R=W M1SEF&*(LS"/RCJH,\JKR_MAZZVFE7356_$#(?8&>1TX&>8+>IBT.BRD.HS<< MSIB>A-9)==9<%+02HL58NBR3#-'&.'IR%!;")SO*>)97Q@_$!(T[TKB+E?3L M-RV)(N5IJ(JF&,L/P*,W3*]0$`8Q?V/V;F^VBK5H[X$[ MJ6\UL=,4S:31XW$NHK^CCN_SZOB1J"/M96VZ';0.\IX_3QD@]."5M^V6]',( M,4J@-V'U^L MRP6ZF%(Q2)?G=)B_6LE`UC=O0U5[#:&&5M/(0MB<'9LI:-9\7!6=CS+ M]EUK.V*-^BI!@$!QE4;0J,&L>2KIL-(@.K6X`JXY=:[`+T/V39H)"Y,RT_0" M+XI3/-B;9B$M8G!.W6_;,6+=RXZB\=8G@S((E&)%BL/HO.;Z-E,E/17UTQPA MJH1C_IZL%&L,44EZ5P#\&9$A1RO`.H^=%;(:!A6`\RW->QE"5Z=Q-$U6>+<8HCDRF+3?C]JR0`:&4<6M]L_E;?U"4T+ST8D0. MHW7RIX3RR?;OI/ZI,<>,"^N?`[)"-<[DRL0[^^5Z]`JP`P/P@*$#'FU_+A5";N'; MG70LM`>**2M"-OF*LPP44LOS^7J][M>I^QE4TLK1ZYB]=>BVQ-B'J;O23#7# M.BNC)TW\';[8V,W20UTV"3I!$"TRZEQ18/;Y3C<=ELUPVUQ)RFK&D.8OSF,V M7:[+R=]0#@)RN!GZ\8.G#GVI'-&?QE$8A+;O$J.XKF6JR3EUTS6K'T5#;)9M MOBW'7BE<]\FF9'\EM@KKDL&;')5F6FZX-,:/Z-7Q(K(VTI<6Z:DX"M/" MN/ETF,MU^0##5\B!L]&/=D@N&N5#QIXW3K[N[06X1@L;^JI"DNUI!M(M:)"4 MV&0Y\V8+:KTFM"V61`O?O,WT%[!X`IB-O+"CMJ.L-`"EN$DRQ`SG17JP%F&5 M:Z8MR7,_9$J)-0.'V-4\)5\1;*F[SQ$M!E>\PUJ]I&^WH//+C=-<0[NEMJ5\P(6:@.5E-[M?7U[EN.] M1!BC%RI`O"VXI'&W(J@\2@S3E-+$Z53*RQ6E4)IGFSG]5)(YG0[5JTGO$N]= MXD:>^GJ7>.\2[UWBO4N\*RYQULNZX`E'-EXSS_;QB[*Y1MHR9BLZ2YG[A]_'L"\`HZO&I#JN-TQ5U7C3\Z MY8+W)$`RX;@NS\;B2'ZZ1SY8+#VT!H`^#QUY8;9*?=F+`E7'#SC.#MG^NDTY>8^[$D-,<11FK@ERO8.%:L'%"]6]2[!W M"?8N09-=/R:[!+_.)!S-CK(^":=/PNE.$DYS-GN?A".[(`BNZF?NY-]'`CFH M_U.=.2LTQN;*'H%EXF\(;1P:X"W:DST_QA>6;_W$B=*<".:_H]M1WIK\E3.X M7\+V_=3O9_HC`_H6,4I]+[OXAEV/,%T,H+P!VN`+;G8*=<7RO2R9^` MMK*W&B56!I*O9#-F&L>EFT5#LESG)+35^JU=GNN'YN#V>*/75@5[X#OSI;$^ MGAR8E5!(U"XR[8G!M'MZXY66Q\NQ+-;L:X+<]H44@3"W-`=I5X\9XMPJ,E^) MO;#/GJ0LUFU.1%:V->8>Z&*-<<;#5[/D*I@0`T,>!J9F79D#6I-/"J; MHB#EB-_%A`R7[B4;R<#0IQD9ENK2IQGU:49]FE&?9M2G&?5I1C7[B+;'M\Q3 M-H\P^.,&`W#KAX`@&CZ29;(!KY#\ISMSZ:@M%`Y0Z#9/T5S#%73)^:=%H2O_ MM/;%38O4\6`X8*G[%7ED&`^&:PURE__XX6==JD/1T)WHS4=O$)X!&$88,/"G MK5F-S<]2Y,W>.-VNXLGC"11UV`T$*MW0-[N5>M@HX\WUE+XYS=YZV9E$[+;2[39K3A>QIJH0K#1U1Z9<&0OX/ M3*G4UR+_!ZWQ_TS(_S-3:ONUR/^SUOA_+N3_N2EU`%OD_WEK_+\0\O_"E$*! M+?+_HC7^?ROD_[>*_&_N[F![_/^V-?Y_$/+_@R+_F[OKUA[_/QQ4)+QC-]D, ML+0-N\=VL'+8%W[16_BEPU*4*@AUBS4M126?TGX6:DN*F&PV).J5/A;*K4AZ M?I8/>`U.CZU-S[X::1_IZB-=AD^FL"_34![2^K'\+U`(-? M8_\J#J*=/T'T!4@5ZF,T)X$5"Y!VW\2]N3+6[9T0/:"T>L2XGB$ M%F11XM-?C9M.&H9^SVVQ9&[W'7=]R=RO*QC67-J!^<&P0S8?O]:2N1TH`=UH MR=S>*BTWA_2LUGM.2WOJC#'6[%>9YF"TA=$7CFZU<+0!07)&`;USJ2AYS<7S M^CAY'R?OX^1?09S\RK.#8#Q+UY,Q?J2K+S]FSNG2(4PX5)@12R^=H"@DSNUD M!CI"B9,!RJA@]5>::W+6YYKTN29:-!&DEIR$Y#,Z^[-H=)D4G-HG*#(BP#2K:= M]EA4NY@46=0P)'`EI2?9=MK#*2U#4F!1LY!,X*L,(IEFVGW][0)28)`9WOO2 MPUS&^ZMXLMWIV97,35D>-*1!I9\/1,$/VE6JI_D)C-*D-`I#'(1;TUOMVVDP MV%[:4OM11;8$+(M(0RXJ/@*/S(ZLMSA<3\G\`MN)(U)DK;VTR6+K`/X=QHM" M=.;LV$H'M>)1K>RP%E%Q:S-P,U<EA2=KG._@O?AZTR1H=04R'+C.A0=EXBWW596S/`41=)#G#-.I6)Q4@(_QD-=9M'+.E)F<<1('M?T'()8?=JQL^>QEM=;N+Y;C+ M)=2,4_K0<5#DA\&#O::+)C%#R"\X`NX=M)_H2QD0!%<1IBSAA#M5!NG*V;T" M9\R`=/*,<$C?1[A$&*,7Z,^YE;M+&NM>NQ22$9FDFH'%%7WB&H>0%N^A25VI M,'%\7ZP.YGL!1!14<`:D_T+_H*^#D%_^'U!+`P04````"`#157!',RF9^^`, M``!IB```$0`<`'!K='@M,C`Q-3`Y,S`N>'-D550)``-9^DE66?I)5G5X"P`! M!"4.```$.0$``.U=7W/B.!)_OJNZ[Z"CZFIG'X`8DLPDF^P6(62&G4Q@`KG, M[,N6L$50Q5B,)"=PG_XD_\.V;,<&IC`A>4B!U-WJ_G5+[I8M<_;'?&J")T09 M)M9Y1:L=5`"R=&)@Z^&\HM@;M;K<"_OC]7_\$XN_LW]4JN,+(-$[!)=&K M76M,?@,W<(I.P4=D(0HYH;^!_T+3%BU?OW4M+MITCI^0:'6'.06'M0\05*LY M9`Z(3744".Q_'GX#!R?-@\:!=@2T@Z_-VGPLQKN$7/3*QO\T+C5-_CL>:LW3 MQN'IX4G.D3CD-@M&.I@?>'_YV+]@I@?,]>/'&7L_O\7?'I#UP?[\_=M7-H#W MO1^PS^=_S3Y,_S(O[/O9T>CKX_'UXOGQPOI@VNW.Q\;EX_W=W=V?[I!G3)^@ M*03"0Q8[KTPXGYW6Z\_/S[7G9HW0AWKCX$"K?_MR/7#H*B[AZ=S$UF,2N79R MGU2A7(^HJ8ONEF7W2/(4"!9].(,>FPQ#BT]0F_P@"%,?%1W.R.D.)'T MV"7%/JF!8G0,Z;4'\E07'8)>.ZP>:-6FYI/;K/H`X2Q@&4,VYDIRB!TD,W)VCD]"=K- M'OD\8)A1PLDCMA#'\YI.I@Z]G%5B[IMHBBQ^1>CT$HVA;0KW_;"AB<<8&17` M(7U`7$8\FT$=Y9#H3QUH643,,#']O1;9-IMA,85$PS_.9*R=2FR'P@(@/]S= M=M/EX"L#&>2630BH@U'%4,-`8 M6]C1TYO_&J@"GSW\$5H&<&6!D+"S>EQ,2+C-D-&S?G<^SRAB0HS#="T:/$:/ M)(5)AZ9NF\5XEJHDLG@-/O2K.,/QP04TY=P?3!#BS`4]VI2-S.9]8@!O:A/[LKVP&',`X-A:]CYTKD9@MX5Z/4[MZUAMW?S M-@UBT`\XT1\GQ#1$8MGY88NE6%RTL(Y%!KM0G)%)G.V>HRSW#(:]]N=/O>O+ MSNW@%]#Y>M<=?@?O+CM7W7:W<]/^_NN;UZ)>:T,VN3+)LSI?ECW9_CC.\D>[ M-?@$KJY[]V_3Q;UJ,,QZXW[(K.I'(LJ[-A$7"VK=R?\<8I')H."Z780EVU7O M9PIU-(%V+YP@^6R,)U M*))872>V@,5ZZ!-3KF#^3,I'F^VP#W&'-6K`$RQ=%A(-EK*!+WQ__01%6=AZ MH,A9D^XQGW0M3M$,&UU1^3RY64";T!FAH;*D,%>V[T[BOFL*W\DA0#`&>!:# M`'\4$!H&A,;96S=Z(&H#Q?+]2*E+QOM9ASM]S40$@2D).") MVEO4!Q-(455N2QMM,ITABX6OIRF=V;@?QG'_(*-<2KJ0DD!8U/[B+LOGWBRR MT1%JR4;X*([PB4!8L@./?V]AO8>4BES:@S3XE@WGL5)4'=2`S[NW4.;9#5IU M"TA3ZUC-"V%/WB_`E0C>+67N[Z[#+1)Z(:,/*5\,15@R>0]8S/.697C;U%[$ MYR',]HQ2L&JB8O7$`D$\OV(!]3V;-B5.C=>#;QA[2?S89QC;=D8*S5MN$1XPS='VAF&/C]Y MME>4.KA`KOKFM'P7YTO$(3;9C8QU^=QID0N[PIOM3J4.+WB!]X8#P7A[[-OH MOG2*$U\@RO:64L(G;&:_^>3E[,M#*#/]\FFR/:*4[D'^-4K(OSR9>^R/4*(5 M=4)"1S;R2J&NIF!O<*NH:JEX:]F`-Y5:/15PH+U!'@*VD0IYXP7(E?);@7R) M>6-_,?>+@LB*$F_,1EJIHZ/%QMZO)#$TM42,7UI!E*HY$>1]7CUR5&F1("]` MG^T:M=@N4M:]ONDA_\D,[A:-@7/@[%2>2SJO,#R=R2/SBCR95/6/ M"_TM3*O-IZ9/(D5G'#ASO!Y'PQO8%P&IKDA1#L3)@)K)QRP0J_O*^P(XYI(] M\JRJ'$<$47T3)IMP5-1DP8+,GVCKM92_42-%]!4U,A:P/\G4]G*4C1HLIDY1 M@Z.S[2?9>QD,$C;7.Y!77Y[(\[['3^V="<-%Q0PLY0A@UG%0]R#K-=$=41DL M\EO5YZO*IJK6J#:UVIP92TV+*+&$H9@2/M\*2B2?<\TYO,\@QSTJ-&+:,=B4 M@1-YY(?JDCGO^)EG:K/&3V2L(Y,SOZ6Z%+6*-NIYV-75<62MH$^.H\!Y@B/, M>>,RRB`YD<&I':^IS&J*K*Q%)/B3!,O+UM_R$0UB.<5QES%;WF=P M]N'$Y4'JZ3X0DD:`35-^/Z]P:LO+C7Q+P*FX#&%B#)VKI;N@BS70O7BZ!,QA M[W(TE43"/GO$Q#7*EM9]I,2>^818D.34?4@NQ#63V]1"QI`,*8(B'U\DV)!* MF-\6MVOD9O'G%9TB`\=,%*.)U)XN-FNDCW^&:TILR#T5%&0\[HTOT8PPS'N6 M/*'B&Y/>_:)!ANV?K(E99*#13S3(P5R,TQM'XFN`.)=S1$SUH7^_(CJE5F$L M`,)/FFMBD<4CA[$W'B#ZA/7P(I'2N[KO?G(T7D%,G7>V.$YP[S40NO!W53[* M__*]%ZY]N:G+'JLMRVA-18#A_T'75Z$(O"(T[M?B;&4%(+96(D.H+0K[&<3R M(4=FF_(&K1K6Q9AVQOCDQ2;5[%3R'3`X5U:P6D:P?>.640D9E\]_ZA3[!S4R M0CB!N*S&AE9>?[4-[%!/$BJK=1Z>TEZC4N=AGY(I9DQ<@>3!L!>GK4*^`\Y. MNLRZ5N6\)@?$I75OB@'>+!C(6ZUH-(-VQ9H\0SYJ+LKP>1M!JB*/NV*XG$ZB>41(IB,(1225/%22$IL<:T5. M`;L:)$E&Y5@W<@K8=DB$,MM+6T9LWQG;U2](\/T5L&<%B?$JC-LV=M5)C.?K M+@..A%V=`2\L;NNC$Y*SHR%RY3Q4OQ8*GHC7&20;P"++^-U!LHF$(I*VM50>2;K!HHCX96&R=KHA.7L:(B$ MDO:U)+S.$%D?G;"<'0V1-1%XM<&QD<@H:UADWZ\NQE+6FU^A70IGU[:/J.,4 MM^E&##2=F62!D/?H@?ON.&6'HPAO85];]E3VN[+7-[DSGR&=.[LO8R0$4'0+ ME_D\Y-1 MI]R7L:GEPW\7CV)F2F<9%`]>;A-7.JFC#`JG'1YTWNX1/%WT(E493)&_'V?8 M)DKZC12Y]^^[P%^Y6O+W_$2?&F`;$%0*0))O%3@7U15N,63QE38-S7[6)-^3 ML0IQ6;.NA&?HOZ#I"`5[>UD$JT:L0:806YL*U_"C?%'=T[NWKOF+1S)2O?`" M^?8M,^4/I>EH,!791+O3BQF2UKMUO071M!='-+%GZ_K*"?->G4/ORZ7AL:KA<7DT]+>: MXAY/:"^+KL-GDJAKN+TTNLI;L,G:1GK*HJ]\N"!1W4A':;3%3\G@1CK*HNT` MSQ.5#;=O7=>LGS]O"9D4ZL%N;SY:Z'WR;=KZ=K#<7V)#T2WJN-&K\Y<.BARO;8M;7XAE%PUV7PV^@MEQQM(9G_2N526X,VE* M9U+^]PZNX%"%A.9P`` M0H8%`!$`&````````0```*2!`````'!K='@M,C`Q-3`Y,S`N>&UL550%``-9 M^DE6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`T55P1]OYOH;T"P``3X(` M`!4`&````````0```*2!F6<``'!K='@M,C`Q-3`Y,S!?8V%L+GAM;%54!0`# M6?I)5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`-%5<$<^KPI`&!,``!!# M`0`5`!@```````$```"D@=QS``!P:W1X+3(P,34P.3,P7V1E9BYX;6Q55`4` M`UGZ259U>`L``00E#@``!#D!``!02P$"'@,4````"`#157!'3D"TR,#$U,#DS,%]L86(N>&UL550% M``-9^DE6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`T55P1[3>T1=.(``` M%#H"`!4`&````````0```*2!^[D``'!K='@M,C`Q-3`Y,S!?<')E+GAM;%54 M!0`#6?I)5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`-%5<$ XML 16 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

3. Sales Agreement with Intrepid Innovations Corporation
9 Months Ended

Sep. 30, 2015

Sales Agreement With Intrepid Innovations Corporation

Sales Agreement with Intrepid Innovations Corporation
During the year ended December 31, 2013, the Company entered into an agreement with Intrepid Innovations Corporation ("Intrepid") to sell the exclusive rights for the application of the AAGP molecule. The total purchase price for the exclusive rights to the application was $2,500,000 and was to be paid as follows:

• $25,000 cash deposit (received);

• $25,000 paid by cash on or before April 22, 2014 as a balance of the transaction deposit (received);

• Six monthly payments of $25,000 on or before May 22, June 22, July 22, August 22, September 22 and October 22, 2014 ($5,000 received); and

• $2,300,000 paid by the issuance of 3,500,000 restricted shares of the buyer as payment of the outstanding balance. These shares can be redeemed by a cash payment at any time within the first 6 months of the effective date of this agreement.

Once the Company had received $2,500,000 in total through payment, sale of the shares and through the redemption of the shares, any surplus shares would have been returned to Intrepid. In the event that the total payment had not totaled $2,500,000, Intrepid would pay the difference to the Company no later than 13 months after the effective date of this agreement.

The agreement was terminated during the year ended December 31, 2014 due to non-payment of the agreed to amounts. The amounts advanced are non-refundable in accordance with the agreement and as at December 31, 2014, the Company recognized a gain on deposit on sale in the amount of $55,000 to the statement of operations.

X

- References
No definition available.
+ Details

Name: pktx_SalesAgreementWithIntrepidInnovationsCorporationAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_SalesAgreementWithIntrepidInnovationsCorporationDisclosureTextBlock

Namespace Prefix: pktx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

9. Stock Options (Details)
9 Months Ended

Sep. 30, 2015

$ / shares

shares

Outstanding, ending | shares 14,600,000

Stock options

Outstanding, beginning | shares

Options granted | shares 14,600,000

Outstanding, ending | shares 14,600,000

Weighted average exercise price beginning balance

Weighted Average Exercise Price, granted $ 0.03

Weighed average exercise price ending balance $ 0.03

Weighted Average Fair Value, beginning

Weighted Average Fair Value, granted $ 0.03

Weighted Average Fair Value, ending $ 0.03

Weighted Average Remaining Life 3 years 4 months 2 days

X

- Definition
Net number of share options (or share units) granted during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average grant-date fair value of non-vested options outstanding.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 18 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

8. Share-based Compensation (Details)
9 Months Ended

Sep. 30, 2015

USD ($)

$ / shares

shares

Number of Shares issued to non-employee consultants | shares 1,500,000

Total $ 69,000

February 2015

Number of Shares issued to non-employee consultants | shares 1,000,000

Value per Share | $ / shares $ 0.04

Total $ 40,000

June 2015

Number of Shares issued to non-employee consultants | shares 100,000

Value per Share | $ / shares $ 0.07

Total $ 7,000

September 2015

Number of Shares issued to non-employee consultants | shares 100,000

Value per Share | $ / shares $ 0.07

Total $ 7,000

September 2015

Number of Shares issued to non-employee consultants | shares 300,000

Value per Share | $ / shares $ 0.05

Total $ 15,000

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_StockIssuedValuePerShareIssuedNonemployeeConsultants

Namespace Prefix: pktx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pktx_FebruaryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pktx_JuneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pktx_SeptemberMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pktx_SeptemberOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 19 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

9. Stock Options (Details 1) - Stock options
9 Months Ended

Sep. 30, 2015

Risk-free interest rate 0.73%

Dividend yield 0.00%

Expected stock price volatility 125.00%

Expected forfeiture rate 0.00%

Expected life 4 years 1 month 24 days

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_ExpectedForfeitureRate

Namespace Prefix: pktx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iv)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.D.2)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section D

-Subsection 2

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

9. Stock Options (Details 2)

Sep. 30, 2015

$ / shares

shares

Outstanding, ending 14,600,000

Number of options exercisable 8,849,998

March 12, 2016

Weighed average exercise price ending balance | $ / shares $ 0.10

Outstanding, ending 1,000,000

Number of options exercisable 500,000

February 25, 2017

Weighed average exercise price ending balance | $ / shares $ 0.04

Outstanding, ending 2,000,000

Number of options exercisable

February 24, 2018

Weighed average exercise price ending balance | $ / shares $ 0.05

Outstanding, ending 1,000,000

Number of options exercisable 1,000,000

February 25, 2020

Weighed average exercise price ending balance | $ / shares $ 0.04

Outstanding, ending 4,000,000

Number of options exercisable 2,800,000

February 28, 2020

Weighed average exercise price ending balance | $ / shares $ 0.04

Outstanding, ending 5,000,000

Number of options exercisable 3,750,000

June 30, 2017

Weighed average exercise price ending balance | $ / shares $ 0.10

Outstanding, ending 1,000,000

Number of options exercisable 499,998

June 30, 2018

Weighed average exercise price ending balance | $ / shares $ 0.10

Outstanding, ending 600,000

Number of options exercisable 300,000

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date5Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date7Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=pktx_Date6Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

2. Summary of Significant Accounting Policies
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Summary of Significant Accounting Policies
Basis of Presentation

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2014, included in the Company's Annual Report on Form 10-K, filed April 14, 2015, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

Use of Estimates

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity related instruments issued and deferred income taxes.

Fair Value of Financial Instruments

Financial instruments, including cash, accounts payable and accrued liabilities, short-term loans and convertible note payable are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 "Fair Value Measurements and Disclosures" which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:

Level 1 – quoted prices in active markets for identical assets or liabilities

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

Level 1 inputs are used to measure cash. At September 30, 2015 there were no other assets or liabilities subject to additional disclosure.

Loss per Share and Potentially Dilutive Securities

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period. Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. The effect of 14,600,000 stock options (September 30, 2014 – nil), 12,262,500 outstanding warrants (September 30, 2014 – 11,000,000) and debt convertible into common shares nil (September 30, 2014 – 12,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company's losses.

Share-Based Compensation

The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services. The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

The Company accounts for share-based compensation under "Share-Based Payment," which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model.

The Company accounts for stock compensation arrangements with non-employees in accordance with FASB Codification 505 – 50 "Equity-Based Payments to Non-Employees", which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

Common stock

Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty's performance is complete.

Transaction costs directly attributable to the issuance of common stock and stock options are recognized as a deduction from equity, net of any tax effects.

Pursuant to ASC 470-20 "Debt with Conversion and Other Options", the proceeds from the issue of units is allocated between common stock and share purchase warrants on a pro-rata basis based on the relative fair values as follows: the fair value of the common stock is based on the market closing price on the date the units are issued and fair value of the share purchase warrants is determined using the Black-Scholes Option Pricing Model.

Related Party Transactions

A related party is generally defined as (i) any person that holds 10% or more of the Company's securities and their immediate families, (ii) the Company's management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Recent Accounting Pronouncements

In August 2014, the FASB issued Accounting Standards Update 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance on determining when and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessment of an entity's ability to continue as a going concern within one year of the date of issuance of the entity's financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is substantial doubt about the entity's ability to continue as a going concern. The requirement is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

10. Warrants (Details)
9 Months Ended

Sep. 30, 2015

$ / shares

shares

Outstanding, ending 14,600,000

Warrant

Outstanding, beginning 5,200,000

Issued 9,562,500

Warrants expired (2,500,000)

Outstanding, ending 12,262,500

Weighted average exercise price beginning balance | $ / shares $ 0.09

Weighted average exercise price warrants issued | $ / shares 0.08

Weighted average exercise price warrants expired | $ / shares 0.05

Weighed average exercise price ending balance | $ / shares $ 0.09

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Net number of share options (or share units) granted during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 23 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

BALANCE SHEETS (Unaudited) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Current Assets

Cash $ 163,526 $ 317

Accounts receivable (Note 4) 7,983 $ 5,497

Prepaid expenses and deposits 637

Total current assets 172,146 $ 5,814

Intangible assets (Note 5) 65,000

Total assets 237,146 $ 5,814

Current Liabilities

Accounts payable and accrued liabilities $ 79,178 270,893

Short-term loans (Note 6) 63,250

Convertible note payable (Note 7) 100,000

Total current liabilities $ 79,178 434,143

Stockholders' Equity (Deficiency)

Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 206,502,433 and 175,662,433 shares issued and outstanding as at September 30, 2015 and December 31, 2014 respectively (Note 11) $ 1,103 939

Common stock issuable; nil and 3,840,000 shares as at September 30, 2015 and December 31, 2014 (Note 11) 20

Stock subscription received in advance (Note 11) 25,000

Common stock to be returned to treasury (Note 11) (25,000)

Additional paid-in capital $ 26,777,414 25,411,550

Accumulated deficit (26,620,549) (25,840,838)

Total stockholders' equity (deficiency) 157,968 (428,329)

Total liabilities and stockholders' equity (deficiency) $ 237,146 $ 5,814

X

- Definition
Common stock issuable
+ References
No definition available.
+ Details

Name: pktx_CommonStockIssuable

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_CommonStockToBeReturnedToTreasury

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6403732&loc=d3e21300-112643

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesSubscriptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ConvertibleNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51662447&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount at the balance sheet date of borrowings from a creditor other than a bank, not elsewhere specified in the taxonomy, with a maturity within one year (or within one operating cycle if longer) from the date of borrowing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ShortTermNonBankLoansAndNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss for the period $ (779,711) $ (168,654)

Adjustments to reconcile net loss to cash used in operating activities:

Accretion of short-term loan 2,630

Issuance and amortization of common stock for services $ 69,000 $ 8,667

Fair value of compensatory options granted $ 290,728

Fair value of compensatory warrants granted $ 40,300

Contribution of services $ 8,780

Gain on settlement of short term loans $ (7,272) $ (3,116)

Write off of deposit on sale (55,000)

Changes in operating assets and liabilities:

Accounts receivable $ (2,486) (2,068)

Prepaid expenses and deposits (637) 12,874

Accounts payable and accrued liabilities 35,557 (26,090)

Net cash used in operating activities $ (386,041) (190,457)

CASH FLOWS FROM INVESTING ACTIVITIES

Deposit on sale $ 30,000

Purchase of Intangible asset $ (40,000)

Net cash provided by (used in) investing activities $ (40,000) $ 30,000

CASH FLOWS FROM FINANCING ACTIVITIES

Short-term loan proceeds (repayments), net $ 68,250

Short-term loan settlement $ (63,250)

Issuance of common stock for cash 652,500 $ 100,000

Net cash provided by financing activities 589,250 168,250

Net change in cash 163,209 7,793

Cash, beginning of period 317 3,065

Cash, end of period $ 163,526 $ 10,858

Cash paid for interest

Cash paid for income taxes

Supplementary information - non-cash transactions:

Common stock issued for consulting services $ 69,000

Common stock issued to settle short-term loans $ 25,000

Common stock returned to treasury $ 25,000

Common stock issued for past subscriptions 25,000

Common stock issued to settle promissory note 100,000

Fair value of warrants issued for intangible assets $ 25,000

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_CommonStockIssuedForPastSubscriptions

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Common stock issued for consulting services
+ References
No definition available.
+ Details

Name: pktx_CommonStockIssuedForPrepaidConsultingServices

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Common stock issued to settle promissory note.
+ References
No definition available.
+ Details

Name: pktx_CommonStockIssuedToSettlePromissoryNote

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Common stock issued to settle short-term loans
+ References
No definition available.
+ Details

Name: pktx_CommonStockIssuedToSettleShortTermLoans

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_CommonStockReturnedToTreasury

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_ContributionOfServices

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: pktx_FairValueOfCompensatoryOptionsGranted

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_FairValueOfCompensatoryWarrantsGranted

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_FairValueOfWarrantsIssuedForIntangibleAssets

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Issuance and amortization of common stock for services
+ References
No definition available.
+ Details

Name: pktx_IssuanceAndAmortizationOfCommonStockForServices

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Write off of deposit on sale.
+ References
No definition available.
+ Details

Name: pktx_WriteoffOfDepositOnSale

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 410

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 35

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866

+ Details

Name: us-gaap_AccretionExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash inflow related to amounts received in advance from a potential buyer showing or confirming an intention to complete an acquisition of land, buildings, other structures, or any item classified as real estate.
+ References
No definition available.
+ Details

Name: us-gaap_ProceedsFromDepositsOnRealEstateSales

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow in other borrowings not otherwise defined in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfOtherDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 25 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

8. Share-Based Compensation (Tables)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Schedule of Stock Incentive Plan, Issuances

 2015
Number
of Shares Value
per Share Total

February 2015 1,000,000 $ 0.04 $ 40,000

June 2015 100,000 0.07 7,000

September 2015 100,000 0.07 7,000

September 2015 300,000 0.05 15,000

1,500,000 $ 69,000

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

10. Warrants (Tables)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Schedule of Warrant Activity

Number of

Warrants

Weighted

Average Exercise

Price

Balance, December 31, 2014 5,200,000 $ 0.09

 Issued 9,562,500 $ 0.08

 Expired (2,500,000 ) $ 0.05

Balance, September 30, 2015 12,262,500 $ 0.09

Schedule of Stockholders' Equity Note, Warrants or Rights

Number of Warrants Exercise Price
Expiry Date

1,600,000 0.10 January 1 , 2016

300,000 0.05 January 1 , 2016

300,000 0.15 January 1 , 2016

500,000 0.25 November 8, 2018

6,000,000 0.10 April 22, 2020

3,562,500 0.04 December 28, 2015

12,262,500

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule of Warrant Activity [Table Text Block]
+ References
No definition available.
+ Details

Name: pktx_ScheduleOfStockholdersEquityNoteWarrantsOrRightsActivityTextBlock

Namespace Prefix: pktx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 28

-Article 5

+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

1. Basis of Presentation - Going Concern Uncertainties
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Basis of Presentation - Going Concern Uncertainties
ProtoKinetix, Inc. (the "Company"), a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999. The Company is a medical research company whose mission is the advancement of human health care.

The Company is currently researching the benefits and feasibility of synthesized Antifreeze Glycoproteins ("AFGP") or anti-aging glycoproteins, trademarked AAGP. During the nine month period ended September 30, 2015, the Company acquired certain patents and rights for cash consideration of 25,000 Euros, as well as other patent rights for cash consideration of $10,000 and 6,000,000 share purchase warrants with a fair value of $25,000 (Note 5).

A Cease Trade Order ("CTO") was issued in respect of the Company's securities by the British Columbia Securities Commission ("BCSC") on May 9, 2013 based on the Company's failure to file annual financial statements for the year ended December 31, 2012 by the deadline of April 1, 2013. The Company has since completed all of the required filings for annual and interim periods and received a full Revocation Order from the BCSC during the nine month period ended September 30, 2015.

The Company's financial statements are prepared consistent with accounting principles generally accepted in the United States applicable to a going concern.

The Company has not developed a commercially viable product, has not generated any significant revenue to date, and has incurred losses since inception, resulting in a net accumulated deficit at September 30, 2015. These factors raise substantial doubt about the Company's ability to continue as a going concern.

The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities. Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective. Management is presently engaged in seeking additional working capital through equity financing or related party loans.

The accompanying financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company fail in any of the above objectives and is unable to operate for the coming year.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35735333&loc=d3e288-107754

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares

Sep. 30, 2015

Dec. 31, 2014

Statement of Financial Position [Abstract]

Common Stock, Par Value Per Share $ .0000053 $ .0000053

Common Stock, Shares Authorized 400,000,000 400,000,000

Common Stock, Shares, Issued 206,502,433 175,662,433

Common Stock, Shares, Outstanding 206,502,433 175,662,433

Common stock issuable shares 0 3,840,000

X

- Definition
Common stock issuable shares
+ References
No definition available.
+ Details

Name: pktx_CommonStockIssuableShares

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

11. Stockholders' Equity (Deficiency)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Stockholders' Equity (Deficiency)
The Company is authorized to issue 400,000,000 (December 31, 2014 – 400,000,000) shares of $0.0000053 par value common stock. Each holder of common stock has the right to one vote but does not have cumulative voting rights. Shares of common stock are not subject to any redemption or sinking fund provisions, nor do they have any preemptive, subscription or conversion rights. Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid as of September 30, 2015 (December 31, 2014 - $nil).

During the nine month period ended September 30, 2015, the Company:

a) Issued 1,000,000 shares of common stock with a fair value of $40,000 ($0.04 per share) pursuant to a directorship agreement entered into on February 25, 2015 (Note 12).

b) Issued 3,840,000 shares of common stock with a fair value of $192,000 ($0.05 per share) pursuant to a settlement agreement completed on March 2, 2015 with a convertible note holder (Note 7).

c) Issued 15,000,000 shares of common stock at $0.025 per share pursuant to a stock subscription agreement with the Company's President and CEO. The proceeds of $375,000 were offset by certain amounts owing to the President and CEO as previously included in accounts payable and accrued liabilities and short-term loans (Note 6). The remaining proceeds of $205,000 were received in cash during the nine months ended September 30, 2015.

d) Issued 2,500,000 shares of common stock to two investors (one of which was the President and CEO of the Company) at $0.05 per share for gross proceeds of $125,000.

e) Cancelled 250,000 shares of common stock that were returned to treasury. The shares had been issued in error and the Company had accounted for the return as "Common stock to be returned to treasury" as at December 31, 2014.

f) Issued 250,000 shares of common stock pursuant to a stock subscription received during the year ended December 31, 2010.

g) Issued 1,250,000 shares of common stock at $0.08 per share for gross proceeds of $100,000 pursuant to private placement offering.

h) Issued 312,500 shares of common stock at $0.08 per share for gross proceeds of $25,000 pursuant to private placement offering.

i) Issued 375,000 shares of common stock at $0.08 per share for gross proceeds of $30,000 pursuant to private placement offering.

j) Issued 625,000 shares of common stock at $0.08 per share pursuant to a stock subscription agreement with the Company's President and CEO. The proceeds of $50,000 were offset in their entirety by certain amounts owing to the President and CEO as previously included in accounts payable and accrued liabilities.

k) Issued 200,000 shares of common stock with a fair value of $14,000 ($0.07 per share) pursuant to a consulting agreement entered into on March 1, 2015 (Note 13).

l) Issued 1,250,000 shares of the Company's common stock at an adjusted conversion price of $0.08 per share on conversion of a promissory note (Note 7).

m) Issued 625,000 shares of common stock at $0.04 per share for gross proceeds of $25,000 pursuant to a stock subscription agreement with the Company's President and CEO.

n) Issued 300,000 shares of common stock with a fair value of $15,000 ($0.05 per share) pursuant to a settlement agreement entered into on September 29, 2015 for services and other value received.

o) Issued 3,562,500 units at $0.04 per unit or gross proceeds of $142,500. Each unit is comprised of one share of common stock and one share purchase warrant exercisable at a price of $0.04 until December 28, 2015. At total of $42,038 was allocated to the warrant component of the unit under the relative fair value approach, using the Black-Scholes Option Pricing model with the following assumptions: Risk-free interest rate - 0.52%, Dividend yield - 0%, Expected stock price volatility – 125.00%, Expected forfeiture rate - 0%, and Expected life – 0.25 years.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information - shares
9 Months Ended

Sep. 30, 2015

Nov. 13, 2015

Document and Entity Information [Abstract]

Entity Registrant Name ProtoKinetix, Inc.

Entity Central Index Key 0001128189

Document Type 10-Q

Amendment Flag false

Document Period End Date Sep. 30, 2015

Trading Symbol pktx

Current Fiscal Year End Date --12-31

Entity Filer Category Smaller Reporting Company

Entity Voluntary Filers No

Entity Well Known Seasoned Issuer No

Entity Current Reporting Status Yes

Entity Common Stock, Shares Outstanding 207,939,933

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2015

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Document and Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: pktx_DocumentAndEntityInformationAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

12. Related Party Transactions and Balances
9 Months Ended

Sep. 30, 2015

Related Party Transactions And Balances

Related Party Transactions and Balances
During the nine month period ended September 30, 2015, the Company:

a) Entered into a directorship agreement effective February 25, 2015 with a newly appointed director of the Company. Pursuant to the agreement, the director was issued 1,000,000 shares of common stock as an engagement fee (Note 11) and will be entitled to a compensatory service fee. The director is also entitled to 1,000,000 stock options on signing (Note 9) exercisable into common shares of the Company for a period of 3 years at a price of $0.05 per share.

During the nine month period ended September 30, 2015, the director provided $8,780 in contributed services, which were recorded as professional fees against additional paid-in capital.

During the nine month period ended September 30, 2015, this director resigned from the board but has been appointed to the Company's Business and Scientific Advisory Board as a consultant.

b) Entered into a consulting agreement dated March 30, 2015 (effective January 1, 2015) with the Company's President and CEO whereby he will be compensated at a nominal amount of $1 for services through to December 31, 2015. The agreement also stipulates a termination fee that would pay the Company's President and CEO $100,000 if terminated without cause or in the case of termination upon a change of control event, the termination fee would be equal to $100,000 plus 2.5% of the aggregate transaction value of the change of control.

c) Entered into a consulting agreement dated March 30, 2015 (effective January 1, 2015) with the Company's CFO whereby she will be compensated at a monthly fee of $4,000 for services through to December 31, 2018 ($4,000 per month for fiscal 2015, then increased by not less than 5% each year thereafter). A total of $36,000 was paid or accrued to the Company's CFO during the nine month period ended September 30, 2015 (nine month ended September 30, 2014 - $nil).

She is also entitled (as of February 26, 2015) to 4,000,000 stock options (Note 9) exercisable into common shares of the Company for a period of 5 years at a price of $0.04 per share. The options will vest monthly in tranches of 400,000 over 10 months. She will also be entitled to an additional 2,000,000 stock options exercisable for a period of 2 years at a price of $0.04 per share that will vest only upon a change in control. If terminated without cause, the agreement also stipulates a termination fee that would pay the Company's CFO three times her monthly consulting fee in effect as of the date of termination or if terminated without cause after January 1, 2016, six times her monthly consulting fee in effect as of the date of termination. In the case of termination upon a change of control event, the termination fee would be equal to two times the amount that she would receive as if terminated without cause.

d) Entered into a directorship agreement effective July 1, 2015 with a newly appointed director of the Company. Pursuant to the agreement, the director was issued 1,000,000 stock options on signing (Note 9) exercisable into common shares of the Company for a period of 2 years at a price of $0.10 per share. The options will vest in monthly installments of 166,666 options beginning July 31, 2015 with the final 166,670 options vesting on December 31, 2015.

e) Recognized $137,810 (nine month ended September 30, 2014 - $nil) in share-based compensation associated with stock options granted to key management personnel.

As at September 30, 2015 and December 31, 2014, the following amounts are due to related parties:

September 30,
2015 December 31, 2014

Clarence Smith (CEO) Accounts payable and accrued liabilities $ 495 $ 129,592

Short-term loans $ Nil $ 20,000

Convertible note payable $ Nil $ 100,000

Susan Woodward (CFO) Accounts payable and accrued liabilities $ Nil $ 12,000

Amounts included in accounts payable and accrued liabilities are non-interest bearing, unsecured and repayable on demand. Amounts included in short-term loans and convertible note payable have terms disclosed in Notes 6 and 7 respectively.

X

- References
No definition available.
+ Details

Name: pktx_RelatedPartyTransactionsAndBalancesAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

STATEMENT OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Expenses

Consulting fees (Note 12) $ 15,000 $ (2,312) $ 65,000 $ 46,966

General and administrative $ 23,240 20,977 104,790 84,049

Interest 8,635 3,969 27,835

Professional fees (Note 12) $ 49,325 $ 42,661 219,848 $ 52,930

Share-based compensation 117,485 290,728

Gain on settlement of short-term loan $ (7,272) $ (3,116) $ (7,272) $ (3,116)

Write off of deposit on sale (Note 3) (55,000) (55,000)

Research and development $ 29,850 2,115 $ 101,970 14,990

Total (227,628) $ (13,960) (779,033) $ (168,654)

OTHER EXPENSE

Foreign exchange gain (loss) 121 (678)

Net loss for the period $ (227,507) $ (13,960) $ (779,711) $ (168,654)

Net loss per common share (basic and diluted) $ (0.00) $ (0.00) $ (0.00) $ (0.00)

Weighted average number of common shares outstanding (basic and diluted) 202,076,618 175,662,433 194,626,737 171,302,543

X

- Definition
Write off of deposit on sale.
+ References
No definition available.
+ Details

Name: pktx_WriteoffOfDepositOnSale

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs related to general contracting services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralContractorCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.2(a),(b),(c),(d))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section 45

-Paragraph 3

-Subparagraph (k)

-URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849

+ Details

Name: us-gaap_ProfessionalFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 34 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. Short-Term Loans
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Short-Term Loans
During the year ended December 31, 2013, the Company received a loan of $20,000. The loan was to be repaid by November 8, 2014, along with $10,000 in interest. In addition, the Company issued 500,000 warrants to the lender, exercisable at $0.25 for a period of 5 years. The proceeds of the loan were allocated between the debt and warrants based on a relative fair value approach, which bifurcates between the values of the two securities at the time of issuance. Using this approach, the fair value of the warrants was estimated at $4,400, with the remaining $15,600 being allocated to the debt portion; to be accreted to its settlement value over the term of the loan.

The loan was settled in August 2014 for $23,500 (Note 7), and total accretion for the year ended December 31, 2014 was $2,630, while accrued interest on the loan principal totaled $7,653 as at the settlement date. A gain on settlement of $3,116 was recognized based on a settlement payment made totaling $23,500 (Note 7).

A total of $60,250 in short-term loans were paid directly by the Company's CEO. The amount was owing to the CEO and had been included in accounts payable and accrued liabilities as at December 31, 2014 as no formal loan agreements had been completed. These amounts were settled in part of the financing detailed in Note 11(c).

The remainder of the short-term loans in the amount of $nil (December 31, 2014 - $63,250) were unsecured, non-interest bearing and were repayable on demand.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for short-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_ShortTermDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

5. Intangible Assets
9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets
During the nine month period ended September 30, 2015, the Company entered into an Assignment of Patents and Patent Application (effective January 1, 2015) (the "Patent Assignment") with the Institut National des Sciences Appliquees de Rouen ("INSA") for the assignment of certain patents and all rights associated therewith (the "Patents"). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company upon payment to INSA in the sum of 25,000 Euros (paid).

During the nine month period ended September 30, 2015, the Company entered into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the "Patent Rights"). In exchange for the Patent Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company's common stock at an exercise price of $0.10 per share for a period of five years. The Patent Rights had a total fair value of $35,000, which was allocated as $10,000 to the cash consideration paid, with the remaining $25,000 being allocated to the warrant component of the overall consideration.

The remaining 50% ownership of the Patent Rights was acquired from the Governors of the University of Alberta in exchange for a future gross revenue royalty further discussed in Note 13(c).

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

9. Stock Options (Tables)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity

Number of

Stock Options

Weighted Average

Exercise Price

Weighted Average

Fair Value

Weighted Average

Remaining Life

$ $ (Years)

Outstanding, December 31, 2014 - - -

Options granted 14,600,000 0.03 0.03

Outstanding, September 30, 2015 14,600,000 0.03 0.03 3.34

Schedule of valuation assumptions for options

For the nine month period ended
September 30, 2015

Risk-free interest rate 0.73 %

Dividend yield 0.00 %

Expected stock price volatility 125.00 %

Expected forfeiture rate 0.00 %

Expected life 4.15 years

Schedule of options by exercise price

Expiry date Exercise Price
Number of Options

Outstanding

Number of

Options

Exercisable

$

March 12, 2016 0.10 1,000,000 500,000

February 25, 2017 0.04 2,000,000 -

February 24, 2018 0.05 1,000,000 1,000,000

February 25, 2020 0.04 4,000,000 2,800,000

February 28, 2020 0.04 5,000,000 3,750,000

June 30, 2017 0.10 1,000,000 499,998

June 30, 2018 0.10 600,000 300,000

14,600,000 8,849,998

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

13. Commitments and Contingency
9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingency
During the nine month period ended September 30, 2015, the Company:

a) Entered into a consulting agreement effective March 1, 2015, whereby the Company would pay the consultant $10,000 on signing (paid) and $5,000 per month for an initial term of 1 year for providing research and development services. The consultant is also entitled to 5,000,000 stock options within 30 days of the consulting agreement (Note 9), with each stock option exercisable into a common share at a price of $0.04 for a period of 5 years. The stock options vested 25% on grant and 25% every 3 months thereafter.

b) Entered into a consulting agreement effective March 1, 2015, whereby the Company would pay the consultant $2,700 per month for an initial term of 1 year for providing public relations services. The consultant is also entitled to 400,000 shares of common stock, which will be issued at a rate of 25% (100,000 shares) every 3 months over the term of the agreement. The consultant is also entitled to 1,000,000 stock options on signing (Note 9), with each stock option exercisable into a common share at a price of $0.10 for a period of 5 years. The stock options will vest at the rate of 25% every 3 months over the term of the agreement.

c) Entered into a royalty agreement with the Governors of the University of Alberta (the "University") whereby the University had developed certain intellectual property (the "Additional Patent Rights") in conjunction with and by permission of the Company employing patented intellectual property of the Company. The agreement assigns the Additional Patent Rights to the Company in return for 5% of any future gross revenues (the "Royalty") derived from products arising from the Patent Rights. The Company will have the right and option for two years from the earlier of the first date that the University publishes its research related to the Additional Patent Rights or September 1, 2015 to buy out all of the University's Royalty for consideration of the aggregate sum of CDN $5,000,000.

d) Entered into a consulting agreement effective May 1, 2015, whereby the Company would pay the consultant $4,000 per month for an initial term of 1 year for providing research and development services.

e) Entered into a consulting agreement for business development services effective July 1, 2015. The consultant was granted 600,000 stock options exercisable into common shares of the Company at a price of $0.10 per share for a period of 3 years. The options will vest in monthly installments of 100,000 options beginning July 31, 2015 with the final vesting on December 31, 2015.

f) The Company was delinquent in filing certain income tax returns with the U.S. Internal Revenue Service and reports disclosing its interest in foreign bank accounts on form TDF 90-22.1, "Report of Foreign Bank and Financial Accounts" ("FBARs"). In September 2015, the Company filed the delinquent income tax returns and has sought waivers of any penalties under the IRS Offshore Voluntary Disclosure Program for late filing of the returns and FBARs. Under the program, the IRS has indicated that it will not impose a penalty for the failure to file delinquent income tax returns if there are no underreported tax liabilities. The Company may be liable for civil penalties of up to $10,000 for each of its foreign bank accounts for not complying with the FBAR reporting and recordkeeping requirements. The Company is unable to determine the amount of any penalties that may be assessed at this time. Management is of the opinion that penalties, if any, that may be assessed would not be material to the consolidated financial statements as a whole.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a)(19))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

9. Stock Options
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Stock Options
Stock option transactions are summarized as follows:

Number of

Stock Options

Weighted Average

Exercise Price

Weighted Average

Fair Value

Weighted Average

Remaining Life

$ $ (Years)

Outstanding, December 31, 2014 - - -

Options granted 14,600,000 0.03 0.03

Outstanding, September 30, 2015 14,600,000 0.03 0.03 3.34

The fair values of the stock options granted during the nine month period ended September 30, 2015 were estimated using the Black-Scholes Option Pricing Model. The weighted average assumptions used in the pricing model for these options are as follows:

For the nine month period ended
September 30, 2015

Risk-free interest rate 0.73 %

Dividend yield 0.00 %

Expected stock price volatility 125.00 %

Expected forfeiture rate 0.00 %

Expected life 4.15 years

The following non-qualified stock options were outstanding and exercisable at September 30, 2015:

Expiry date Exercise Price
Number of Options

Outstanding

Number of

Options

Exercisable

$

March 12, 2016 0.10 1,000,000 500,000

February 25, 2017 0.04 2,000,000 -

February 24, 2018 0.05 1,000,000 1,000,000

February 25, 2020 0.04 4,000,000 2,800,000

February 28, 2020 0.04 5,000,000 3,750,000

June 30, 2017 0.10 1,000,000 499,998

June 30, 2018 0.10 600,000 300,000

14,600,000 8,849,998

As at September 30, 2015, the aggregate intrinsic value of the Company's stock options is $nil (December 31, 2014 – $nil).

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Stock Options [Text Block]
+ References
No definition available.
+ Details

Name: pktx_StockOptionsTextBlock

Namespace Prefix: pktx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

7. Convertible Note Payable
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Convertible Note Payable
On July 1, 2011, the Company executed a loan agreement under which the Company issued to a corporation an 8% convertible promissory note in exchange for $300,000. The note holder had the right to demand payment of outstanding principal and interest at any time with a 30-day grace period. The note was due and payable no later than June 30, 2016, and was convertible into shares of the Company's common stock at $0.025 per share. No beneficial conversion feature was applicable to this convertible note.

During the year ended December 31, 2014, the Company and the corporation commenced discussions in regards to the settlement of the convertible note. A settlement agreement was finalized during the nine month period ended September 30, 2015, but the Company has accounted for the transaction as at December 31, 2014. The settlement agreement stipulated that the convertible note plus accrued interest of $84,000 (included in accounts payable and accrued liabilities as at December 31, 2014) was to be settled through the issuance of 3,840,000 shares of the Company's common stock. The fair value of the shares was determined to be $192,000 ($0.05 per share) and the Company recognized a gain on settlement in the amount of $192,000 as at December 31, 2014. The settlement agreement also stipulated the payment of $161,750 to the corporation to settle other amounts included in accounts payable and accrued liabilities and short-term loans, all of which has been paid as at September 30, 2015.

On June 17, 2014, the Company executed a loan agreement under which the Company issued an 8% convertible promissory note in exchange for an initial amount of $10,000, with the ability to be increased to $100,000, to the Company`s President and CEO. During the year ended December 31, 2014, additional amounts totaling $90,000 were advanced, $23,500 of which was paid directly to settle certain short-term loans outstanding (Note 6). The note holder has the right to demand payment of outstanding principal and interest at any time with a 30-day grace period. The note is due and payable no later than December 31, 2015, and is convertible into shares of the Company's common stock at $0.25 per share. No beneficial conversion feature was applicable to this convertible note. On July 1, 2015, the Company`s board of directors approved an adjustment to the conversion price from $0.25 to $0.08. During the nine month period ended September 30, 2015, the Company issued 1,250,000 shares of the Company's common stock at the adjusted price of $0.08 per share to settle the promissory note. A gain of $7,272 was recognized associated with interest forgiven on the note.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

8. Share-Based Compensation
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Share-Based Compensation
During the nine month period ended September 30, 2015, the Company issued shares of common stock to non-employee consultants for services and other value rendered as follows:

 2015
Number
of Shares Value
per Share Total

February 2015 1,000,000 $ 0.04 $ 40,000

June 2015 100,000 0.07 7,000

September 2015 100,000 0.07 7,000

September 2015 300,000 0.05 15,000

1,500,000 $ 69,000

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

10. Warrants
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Warrants
Warrant transactions are summarized as follows:

Number of

Warrants

Weighted

Average Exercise

Price

Balance, December 31, 2014 5,200,000 $ 0.09

 Issued 9,562,500 $ 0.08

 Expired (2,500,000 ) $ 0.05

Balance, September 30, 2015 12,262,500 $ 0.09

The following warrants were outstanding and exercisable as at September 30, 2015:

Number of Warrants Exercise Price
Expiry Date

1,600,000 0.10 January 1 , 2016

300,000 0.05 January 1 , 2016

300,000 0.15 January 1 , 2016

500,000 0.25 November 8, 2018

6,000,000 0.10 April 22, 2020

3,562,500 0.04 December 28, 2015

12,262,500

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrants [Text Block]
+ References
No definition available.
+ Details

Name: pktx_WarrantsTextBlock

Namespace Prefix: pktx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

12. Related Party Transactions and Balances (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Accounts payable and accrued liabilities $ 79,178 $ 270,893

Short-term loans 0 63,250

Clarence Smith (CEO)

Accounts payable and accrued liabilities 495 129,592

Short-term loans 0 20,000

Convertible note payable 0 100,000

Susan Woodard (CFO)

Accounts payable and accrued liabilities $ 0 $ 12,000

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_ConvertibleNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),16(a)(1))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Subparagraph 2, 3

-Article 9

+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pktx_ClarenceSmithCEOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pktx_SusanWoodardCFOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

2. Summary of Significant Accounting Policies (Policies)
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Basis of Presentation
The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2014, included in the Company's Annual Report on Form 10-K, filed April 14, 2015, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

Use of Estimates
Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity related instruments issued and deferred income taxes.

Fair Value of Financial Instruments
Financial instruments, including cash, accounts payable and accrued liabilities, short-term loans and convertible note payable are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 "Fair Value Measurements and Disclosures" which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:

Level 1 – quoted prices in active markets for identical assets or liabilities

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

Level 1 inputs are used to measure cash. At September 30, 2015 there were no other assets or liabilities subject to additional disclosure.

Loss per Share and Potentially Dilutive Securities
Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period. Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. The effect of 14,600,000 stock options (September 30, 2014 – nil), 12,262,500 outstanding warrants (September 30, 2014 – 11,000,000) and debt convertible into common shares nil (September 30, 2014 – 12,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company's losses.

Share-Based Compensation
The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services. The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

The Company accounts for share-based compensation under "Share-Based Payment," which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model.

The Company accounts for stock compensation arrangements with non-employees in accordance with FASB Codification 505 – 50 "Equity-Based Payments to Non-Employees", which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

Common stock
Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty's performance is complete.

Transaction costs directly attributable to the issuance of common stock and stock options are recognized as a deduction from equity, net of any tax effects.

Pursuant to ASC 470-20 "Debt with Conversion and Other Options", the proceeds from the issue of units is allocated between common stock and share purchase warrants on a pro-rata basis based on the relative fair values as follows: the fair value of the common stock is based on the market closing price on the date the units are issued and fair value of the share purchase warrants is determined using the Black-Scholes Option Pricing Model.

Related Party Transactions
A related party is generally defined as (i) any person that holds 10% or more of the Company's securities and their immediate families, (ii) the Company's management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Recent Accounting Pronouncements
In August 2014, the FASB issued Accounting Standards Update 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance on determining when and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessment of an entity's ability to continue as a going concern within one year of the date of issuance of the entity's financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is substantial doubt about the entity's ability to continue as a going concern. The requirement is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_RelatedPartyTransactionsPolicy

Namespace Prefix: pktx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 60

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(f)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21459-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_StockholdersEquityPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

2. Summary of Significant Accounting Policies (Details Narrative) - shares
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Stock options

Antidilutive Securities Excluded from Computation of Earnings Per Share 14,600,000 0

Convertible Debt Securities [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share 0 12,000,000

Warrant

Antidilutive Securities Excluded from Computation of Earnings Per Share 12,262,500 11,000,000

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 45 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - 9 months ended Sep. 30, 2015 - USD ($)

Common Stock

Common Stock Issuable

Additional Paid-In Capital

Stock Subscriptions Received in Advance

Common Stock to be Returned to Treasury

Accumulated Deficit

Total

Beginning Balance, Shares at Dec. 31, 2014 175,662,433 3,840,000

Beginning Balance, Amount at Dec. 31, 2014 $ 939 $ 20 $ 25,411,550 $ 25,000 $ (25,000) $ (25,840,838) $ (428,329)

Issuance of common stock for services, shares 1,000,000 1,500,000

Issuance of common stock for services, amount $ 5 $ 39,995 $ 40,000

Issuance of common stock to settle convertible note payable and accrued interest, shares 3,840,000 (3,840,000)

Issuance of common stock to settle convertible note payable and accrued interest, amount $ 20 $ (20)

Issuance of common stock pursuant to private placement offering, shares 15,000,000

Issuance of common stock pursuant to private placement offering, amount $ 80 $ 374,920 $ 375,000

Issuance of common stock pursuant to private placement offering, shares 2,500,000

Issuance of common stock pursuant to private placement offering, amount $ 13 124,987 $ 125,000

Common stock returned to treasury, shares (250,000)

Common stock returned to treasury, amount $ (1) (24,999) $ 25,000

Issuance of common stock pursuant to private placement offering, shares 250,000

Issuance of common stock pursuant to private placement offering, amount $ 1 24,999 $ (25,000)

Issuance of common stock pursuant to private placement offering, shares 1,250,000

Issuance of common stock pursuant to private placement offering, amount $ 7 99,993 $ 100,000

Issuance of common stock pursuant to private placement offering, shares 312,500

Issuance of common stock pursuant to private placement offering, amount $ 2 24,998 25,000

Issuance of common stock pursuant to private placement offering, shares 375,000

Issuance of common stock pursuant to private placement offering, amount $ 2 29,998 30,000

Issuance of common stock pursuant to private placement offering, shares 625,000

Issuance of common stock pursuant to private placement offering, amount $ 3 49,997 50,000

Issuance of common stock for services, shares 200,000

Issuance of common stock for services, amount $ 1 13,999 14,000

Issuance of common stock pursuant to settle promissory note, shares 1,250,000

Issuance of common stock pursuant to settle promissory note, amount $ 7 99,993 100,000

Issuance of common stock pursuant to private placement offering, shares 625,000

Issuance of common stock pursuant to private placement offering, amount $ 3 24,997 25,000

Issuance of common stock for services and other value, shares 300,000

Issuance of common stock for services and other value, amount $ 2 14,998 15,000

Issuance of units pursuant to private placement offering, shares 3,562,500

Issuance of units pursuant to private placement offering, amount $ 19 142,481 142,500

Fair value of compensatory options issued 290,728 290,728

Contribution of services 8,780 8,780

Fair value of compensatory warrants issued $ 25,000 25,000

Net loss for the period $ (779,711) (779,711)

Ending Balance, Shares at Sep. 30, 2015 206,502,433

Ending Balance, Amount at Sep. 30, 2015 $ 1,103 $ 26,777,414 $ (26,620,549) $ 157,968

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_ContributionOfServices

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_FairValueOfCompensatoryOptionsIssued

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_FairValueOfCompensatoryWarrantsIssued

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockForServicesAndOtherValueAmount

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockForServicesAndOtherValueShares

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOffering

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingFive

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingFour

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingOne

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSeven

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingShares

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesFive

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesFour

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesOne

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesSeven

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesSix

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesThree

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSharesTwo

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingSix

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingThree

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToPrivatePlacementOfferingTwo

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToSettlePromissoryNoteAmount

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockPursuantToSettlePromissoryNoteShares

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Issuance of common stock to settle short-term loans
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockToSettleShortTermLoans

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Issuance of common stock to settle short-term loans (Shares)
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfCommonStockToSettleShortTermLoansShares

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfUnitsPursuantToPrivatePlacementOfferingAmount

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_IssuanceOfUnitsPursuantToPrivatePlacementOfferingShares

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_StockIssuedDuringPeriodSharesIssuedForServicesOne

Namespace Prefix: pktx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: pktx_StockIssuedDuringPeriodValueIssuedForServicesOne

Namespace Prefix: pktx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of common and preferred stock retired from treasury during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_TreasuryStockSharesRetired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=pktx_CommonStockIssuableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=pktx_StockSubscriptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=pktx_CommonStockToBeReturnedToTreasuryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 46 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

4. Accounts Receivable
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Accounts Receivable
Accounts receivable consists of refundable sales tax paid on purchases made in Canada.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
+ References
No definition available.
+ Details

Name: us-gaap_OtherAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

6. Short-Term Loans (Details Narrative) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Notes to Financial Statements [Abstract]

Short-term loans $ 0 $ 63,250

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),16(a)(1))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Subparagraph 2, 3

-Article 9

+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 65 160 1 false 29 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://protokinetix.com/taxonomy/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS (Unaudited) Sheet http://protokinetix.com/role/BalanceSheets BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://protokinetix.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENT OF OPERATIONS (Unaudited) Sheet http://protokinetix.com/role/StatementOfOperations STATEMENT OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) Sheet http://protokinetix.com/role/StatementOfStockholdersEquityDeficiency STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - STATEMENT OF CASH FLOWS (Unaudited) Sheet http://protokinetix.com/role/StatementOfCashFlows STATEMENT OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - 1. Basis of Presentation - Going Concern Uncertainties Sheet http://protokinetix.com/role/BasisOfPresentation-GoingConcernUncertainties 1. Basis of Presentation - Going Concern Uncertainties Notes 7 false false R8.htm 00000008 - Disclosure - 2. Summary of Significant Accounting Policies Sheet http://protokinetix.com/role/SummaryOfSignificantAccountingPolicies 2. Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - 3. Sales Agreement with Intrepid Innovations Corporation Sheet http://protokinetix.com/role/SalesAgreementWithIntrepidInnovationsCorporation 3. Sales Agreement with Intrepid Innovations Corporation Notes 9 false false R10.htm 00000010 - Disclosure - 4. Accounts Receivable Sheet http://protokinetix.com/role/AccountsReceivable 4. Accounts Receivable Notes 10 false false R11.htm 00000011 - Disclosure - 5. Intangible Assets Sheet http://protokinetix.com/role/IntangibleAssets 5. Intangible Assets Notes 11 false false R12.htm 00000012 - Disclosure - 6. Short-Term Loans Sheet http://protokinetix.com/role/Short-termLoans 6. Short-Term Loans Notes 12 false false R13.htm 00000013 - Disclosure - 7. Convertible Note Payable Sheet http://protokinetix.com/role/ConvertibleNotePayable 7. Convertible Note Payable Notes 13 false false R14.htm 00000014 - Disclosure - 8. Share-Based Compensation Sheet http://protokinetix.com/role/Share-basedCompensation 8. Share-Based Compensation Notes 14 false false R15.htm 00000015 - Disclosure - 9. Stock Options Sheet http://protokinetix.com/role/StockOptions 9. Stock Options Notes 15 false false R16.htm 00000016 - Disclosure - 10. Warrants Sheet http://protokinetix.com/role/Warrants 10. Warrants Notes 16 false false R17.htm 00000017 - Disclosure - 11. Stockholders' Equity (Deficiency) Sheet http://protokinetix.com/role/StockholdersEquityDeficiency 11. Stockholders' Equity (Deficiency) Notes 17 false false R18.htm 00000018 - Disclosure - 12. Related Party Transactions and Balances Sheet http://protokinetix.com/role/RelatedPartyTransactionsAndBalances 12. Related Party Transactions and Balances Notes 18 false false R19.htm 00000019 - Disclosure - 13. Commitments and Contingency Sheet http://protokinetix.com/role/CommitmentsAndContingency 13. Commitments and Contingency Notes 19 false false R20.htm 00000020 - Disclosure - 14. Subsequent Events Sheet http://protokinetix.com/role/SubsequentEvents 14. Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) Sheet http://protokinetix.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. Summary of Significant Accounting Policies (Policies) Policies http://protokinetix.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - 8. Share-Based Compensation (Tables) Sheet http://protokinetix.com/role/Share-basedCompensationTables 8. Share-Based Compensation (Tables) Tables http://protokinetix.com/role/Share-basedCompensation 22 false false R23.htm 00000023 - Disclosure - 9. Stock Options (Tables) Sheet http://protokinetix.com/role/StockOptionsTables 9. Stock Options (Tables) Tables http://protokinetix.com/role/StockOptions 23 false false R24.htm 00000024 - Disclosure - 10. Warrants (Tables) Sheet http://protokinetix.com/role/WarrantsTables 10. Warrants (Tables) Tables http://protokinetix.com/role/Warrants 24 false false R25.htm 00000025 - Disclosure - 12. Related Party Transactions and Balances (Tables) Sheet http://protokinetix.com/role/RelatedPartyTransactionsAndBalancesTables 12. Related Party Transactions and Balances (Tables) Tables http://protokinetix.com/role/RelatedPartyTransactionsAndBalances 25 false false R26.htm 00000026 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) Sheet http://protokinetix.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 2. Summary of Significant Accounting Policies (Details Narrative) Details http://protokinetix.com/role/SummaryOfSignificantAccountingPoliciesPolicies 26 false false R27.htm 00000027 - Disclosure - 6. Short-Term Loans (Details Narrative) Sheet http://protokinetix.com/role/Short-termLoansDetailsNarrative 6. Short-Term Loans (Details Narrative) Details http://protokinetix.com/role/Short-termLoans 27 false false R28.htm 00000028 - Disclosure - 8. Share-based Compensation (Details) Sheet http://protokinetix.com/role/Share-basedCompensationDetails 8. Share-based Compensation (Details) Details 28 false false R29.htm 00000029 - Disclosure - 9. Stock Options (Details) Sheet http://protokinetix.com/role/StockOptionsDetails 9. Stock Options (Details) Details http://protokinetix.com/role/StockOptionsTables 29 false false R30.htm 00000030 - Disclosure - 9. Stock Options (Details 1) Sheet http://protokinetix.com/role/StockOptionsDetails1 9. Stock Options (Details 1) Details http://protokinetix.com/role/StockOptionsTables 30 false false R31.htm 00000031 - Disclosure - 9. Stock Options (Details 2) Sheet http://protokinetix.com/role/StockOptionsDetails2 9. Stock Options (Details 2) Details http://protokinetix.com/role/StockOptionsTables 31 false false R32.htm 00000032 - Disclosure - 10. Warrants (Details) Sheet http://protokinetix.com/role/WarrantsDetails 10. Warrants (Details) Details http://protokinetix.com/role/WarrantsTables 32 false false R33.htm 00000033 - Disclosure - 10. Warrants (Details 1) Sheet http://protokinetix.com/role/WarrantsDetails1 10. Warrants (Details 1) Details http://protokinetix.com/role/WarrantsTables 33 false false R34.htm 00000034 - Disclosure - 12. Related Party Transactions and Balances (Details) Sheet http://protokinetix.com/role/RelatedPartyTransactionsAndBalancesDetails 12. Related Party Transactions and Balances (Details) Details http://protokinetix.com/role/RelatedPartyTransactionsAndBalancesTables 34 false false All Reports Book All Reports In ''BALANCE SHEETS (Unaudited)'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''STATEMENT OF CASH FLOWS (Unaudited)'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. pktx-20150930.xml pktx-20150930_cal.xml pktx-20150930_def.xml pktx-20150930_lab.xml pktx-20150930_pre.xml pktx-20150930.xsd true true XML 49 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

14. Subsequent Events
9 Months Ended

Sep. 30, 2015

Notes to Financial Statements [Abstract]

Subsequent Events
Subsequent to the nine month period ended September 30, 2015, the Company:

a) Completed a private placement offering of 1,437,500 units at a price of $0.04 per unit for gross proceeds of $57,500. Each unit is comprised at one share of common stock and one share purchase warrant, exercisable at a price of $0.04 to December 28, 2015.

X

- Definition
Notes to Financial Statements [Abstract]
+ References
No definition available.
+ Details

Name: pktx_NotesToFinancialStatementsAbstract

Namespace Prefix: pktx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 855

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662

+ Details

Name: us-gaap_ScheduleOfSubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

10. Warrants (Details 1)	9 Months Ended
10. Warrants (Details 1)	Sep. 30, 2015 $ / shares shares
Number of Warrants	12,262,500
Warrant One [Member]
Number of Warrants	1,600,000
Warrant Exercise Price \| $ / shares	$ 0.10
Expiry Date	January 1, 2016
Warrant Two [Member]
Number of Warrants	300,000
Warrant Exercise Price \| $ / shares	$ 0.05
Expiry Date	January 1, 2016
Warrant Three [Member]
Number of Warrants	300,000
Warrant Exercise Price \| $ / shares	$ 0.15
Expiry Date	January 1, 2016
Warrant Four [Member]
Number of Warrants	500,000
Warrant Exercise Price \| $ / shares	$ 0.25
Expiry Date	November 8, 2018
Warrant Five [Member]
Number of Warrants	6,000,000
Warrant Exercise Price \| $ / shares	$ 0.10
Expiry Date	April 22, 2020
Warrant Six [Member]
Number of Warrants	3,562,500
Warrant Exercise Price \| $ / shares	$ 0.04
Expiry Date	December 28, 2015

9. Stock Options (Details)	9 Months Ended
9. Stock Options (Details)	Sep. 30, 2015 $ / shares shares
Outstanding, ending \| shares	14,600,000
Stock options
Outstanding, beginning \| shares
Options granted \| shares	14,600,000
Outstanding, ending \| shares	14,600,000
Weighted average exercise price beginning balance
Weighted Average Exercise Price, granted	$ 0.03
Weighed average exercise price ending balance	$ 0.03
Weighted Average Fair Value, beginning
Weighted Average Fair Value, granted	$ 0.03
Weighted Average Fair Value, ending	$ 0.03
Weighted Average Remaining Life	3 years 4 months 2 days

8. Share-based Compensation (Details)	9 Months Ended
8. Share-based Compensation (Details)	Sep. 30, 2015 USD ($) $ / shares shares
Number of Shares issued to non-employee consultants \| shares	1,500,000
Total	$ 69,000
February 2015
Number of Shares issued to non-employee consultants \| shares	1,000,000
Value per Share \| $ / shares	$ 0.04
Total	$ 40,000
June 2015
Number of Shares issued to non-employee consultants \| shares	100,000
Value per Share \| $ / shares	$ 0.07
Total	$ 7,000
September 2015
Number of Shares issued to non-employee consultants \| shares	100,000
Value per Share \| $ / shares	$ 0.07
Total	$ 7,000
September 2015
Number of Shares issued to non-employee consultants \| shares	300,000
Value per Share \| $ / shares	$ 0.05
Total	$ 15,000

9. Stock Options (Details 1) - Stock options	9 Months Ended
9. Stock Options (Details 1) - Stock options	Sep. 30, 2015
Risk-free interest rate	0.73%
Dividend yield	0.00%
Expected stock price volatility	125.00%
Expected forfeiture rate	0.00%
Expected life	4 years 1 month 24 days

9. Stock Options (Details 2)	Sep. 30, 2015 $ / shares shares
Outstanding, ending	14,600,000
Number of options exercisable	8,849,998
March 12, 2016
Weighed average exercise price ending balance \| $ / shares	$ 0.10
Outstanding, ending	1,000,000
Number of options exercisable	500,000
February 25, 2017
Weighed average exercise price ending balance \| $ / shares	$ 0.04
Outstanding, ending	2,000,000
Number of options exercisable
February 24, 2018
Weighed average exercise price ending balance \| $ / shares	$ 0.05
Outstanding, ending	1,000,000
Number of options exercisable	1,000,000
February 25, 2020
Weighed average exercise price ending balance \| $ / shares	$ 0.04
Outstanding, ending	4,000,000
Number of options exercisable	2,800,000
February 28, 2020
Weighed average exercise price ending balance \| $ / shares	$ 0.04
Outstanding, ending	5,000,000
Number of options exercisable	3,750,000
June 30, 2017
Weighed average exercise price ending balance \| $ / shares	$ 0.10
Outstanding, ending	1,000,000
Number of options exercisable	499,998
June 30, 2018
Weighed average exercise price ending balance \| $ / shares	$ 0.10
Outstanding, ending	600,000
Number of options exercisable	300,000

10. Warrants (Details)	9 Months Ended
10. Warrants (Details)	Sep. 30, 2015 $ / shares shares
Outstanding, ending	14,600,000
Warrant
Outstanding, beginning	5,200,000
Issued	9,562,500
Warrants expired	(2,500,000)
Outstanding, ending	12,262,500
Weighted average exercise price beginning balance \| $ / shares	$ 0.09
Weighted average exercise price warrants issued \| $ / shares	0.08
Weighted average exercise price warrants expired \| $ / shares	0.05
Weighed average exercise price ending balance \| $ / shares	$ 0.09

BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash	$ 163,526	$ 317
Accounts receivable (Note 4)	7,983	$ 5,497
Prepaid expenses and deposits	637
Total current assets	172,146	$ 5,814
Intangible assets (Note 5)	65,000
Total assets	237,146	$ 5,814
Current Liabilities
Accounts payable and accrued liabilities	$ 79,178	270,893
Short-term loans (Note 6)		63,250
Convertible note payable (Note 7)		100,000
Total current liabilities	$ 79,178	434,143
Stockholders' Equity (Deficiency)
Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 206,502,433 and 175,662,433 shares issued and outstanding as at September 30, 2015 and December 31, 2014 respectively (Note 11)	$ 1,103	939
Common stock issuable; nil and 3,840,000 shares as at September 30, 2015 and December 31, 2014 (Note 11)		20
Stock subscription received in advance (Note 11)		25,000
Common stock to be returned to treasury (Note 11)		(25,000)
Additional paid-in capital	$ 26,777,414	25,411,550
Accumulated deficit	(26,620,549)	(25,840,838)
Total stockholders' equity (deficiency)	157,968	(428,329)
Total liabilities and stockholders' equity (deficiency)	$ 237,146	$ 5,814

STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$ (779,711)	$ (168,654)
Adjustments to reconcile net loss to cash used in operating activities:
Accretion of short-term loan		2,630
Issuance and amortization of common stock for services	$ 69,000	$ 8,667
Fair value of compensatory options granted	$ 290,728
Fair value of compensatory warrants granted		$ 40,300
Contribution of services	$ 8,780
Gain on settlement of short term loans	$ (7,272)	$ (3,116)
Write off of deposit on sale		(55,000)
Changes in operating assets and liabilities:
Accounts receivable	$ (2,486)	(2,068)
Prepaid expenses and deposits	(637)	12,874
Accounts payable and accrued liabilities	35,557	(26,090)
Net cash used in operating activities	$ (386,041)	(190,457)
CASH FLOWS FROM INVESTING ACTIVITIES
Deposit on sale		$ 30,000
Purchase of Intangible asset	$ (40,000)
Net cash provided by (used in) investing activities	$ (40,000)	$ 30,000
CASH FLOWS FROM FINANCING ACTIVITIES
Short-term loan proceeds (repayments), net		$ 68,250
Short-term loan settlement	$ (63,250)
Issuance of common stock for cash	652,500	$ 100,000
Net cash provided by financing activities	589,250	168,250
Net change in cash	163,209	7,793
Cash, beginning of period	317	3,065
Cash, end of period	$ 163,526	$ 10,858
Cash paid for interest
Cash paid for income taxes
Supplementary information - non-cash transactions:
Common stock issued for consulting services	$ 69,000
Common stock issued to settle short-term loans		$ 25,000
Common stock returned to treasury	$ 25,000
Common stock issued for past subscriptions	25,000
Common stock issued to settle promissory note	100,000
Fair value of warrants issued for intangible assets	$ 25,000

BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common Stock, Par Value Per Share	$ .0000053	$ .0000053
Common Stock, Shares Authorized	400,000,000	400,000,000
Common Stock, Shares, Issued	206,502,433	175,662,433
Common Stock, Shares, Outstanding	206,502,433	175,662,433
Common stock issuable shares	0	3,840,000

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Nov. 13, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	ProtoKinetix, Inc.
Entity Central Index Key	0001128189
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Trading Symbol	pktx
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		207,939,933
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
STATEMENT OF OPERATIONS (Unaudited) - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Expenses
Consulting fees (Note 12)	$ 15,000	$ (2,312)	$ 65,000	$ 46,966
General and administrative	$ 23,240	20,977	104,790	84,049
Interest		8,635	3,969	27,835
Professional fees (Note 12)	$ 49,325	$ 42,661	219,848	$ 52,930
Share-based compensation	117,485		290,728
Gain on settlement of short-term loan	$ (7,272)	$ (3,116)	$ (7,272)	$ (3,116)
Write off of deposit on sale (Note 3)		(55,000)		(55,000)
Research and development	$ 29,850	2,115	$ 101,970	14,990
Total	(227,628)	$ (13,960)	(779,033)	$ (168,654)
OTHER EXPENSE
Foreign exchange gain (loss)	121		(678)
Net loss for the period	$ (227,507)	$ (13,960)	$ (779,711)	$ (168,654)
Net loss per common share (basic and diluted)	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding (basic and diluted)	202,076,618	175,662,433	194,626,737	171,302,543

12. Related Party Transactions and Balances (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Accounts payable and accrued liabilities	$ 79,178	$ 270,893
Short-term loans	0	63,250
Clarence Smith (CEO)
Accounts payable and accrued liabilities	495	129,592
Short-term loans	0	20,000
Convertible note payable	0	100,000
Susan Woodard (CFO)
Accounts payable and accrued liabilities	$ 0	$ 12,000

2. Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Notes to Financial Statements [Abstract]
Basis of Presentation	The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2014, included in the Company's Annual Report on Form 10-K, filed April 14, 2015, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.
Use of Estimates	Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity related instruments issued and deferred income taxes.
Fair Value of Financial Instruments	Financial instruments, including cash, accounts payable and accrued liabilities, short-term loans and convertible note payable are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments. The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 "Fair Value Measurements and Disclosures" which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value: Level 1 – quoted prices in active markets for identical assets or liabilities Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions) Level 1 inputs are used to measure cash. At September 30, 2015 there were no other assets or liabilities subject to additional disclosure.
Loss per Share and Potentially Dilutive Securities	Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period. Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. The effect of 14,600,000 stock options (September 30, 2014 – nil), 12,262,500 outstanding warrants (September 30, 2014 – 11,000,000) and debt convertible into common shares nil (September 30, 2014 – 12,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company's losses.
Share-Based Compensation	The Company has granted warrants and options to purchase shares of the Company's common stock to various parties for consulting services. The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model. The Company accounts for share-based compensation under "Share-Based Payment," which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The Company accounts for stock compensation arrangements with non-employees in accordance with FASB Codification 505 – 50 "Equity-Based Payments to Non-Employees", which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.
Common stock	Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty's performance is complete. Transaction costs directly attributable to the issuance of common stock and stock options are recognized as a deduction from equity, net of any tax effects. Pursuant to ASC 470-20 "Debt with Conversion and Other Options", the proceeds from the issue of units is allocated between common stock and share purchase warrants on a pro-rata basis based on the relative fair values as follows: the fair value of the common stock is based on the market closing price on the date the units are issued and fair value of the share purchase warrants is determined using the Black-Scholes Option Pricing Model.
Related Party Transactions	A related party is generally defined as (i) any person that holds 10% or more of the Company's securities and their immediate families, (ii) the Company's management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.
Recent Accounting Pronouncements	In August 2014, the FASB issued Accounting Standards Update 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which provides guidance on determining when and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessment of an entity's ability to continue as a going concern within one year of the date of issuance of the entity's financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is substantial doubt about the entity's ability to continue as a going concern. The requirement is effective for annual periods ending after December 15, 2016, and interim periods thereafter, early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - 9 months ended Sep. 30, 2015 - USD ($)	Common Stock	Common Stock Issuable	Additional Paid-In Capital	Stock Subscriptions Received in Advance	Common Stock to be Returned to Treasury	Accumulated Deficit	Total
Beginning Balance, Shares at Dec. 31, 2014	175,662,433	3,840,000
Beginning Balance, Amount at Dec. 31, 2014	$ 939	$ 20	$ 25,411,550	$ 25,000	$ (25,000)	$ (25,840,838)	$ (428,329)
Issuance of common stock for services, shares	1,000,000						1,500,000
Issuance of common stock for services, amount	$ 5		$ 39,995				$ 40,000
Issuance of common stock to settle convertible note payable and accrued interest, shares	3,840,000	(3,840,000)
Issuance of common stock to settle convertible note payable and accrued interest, amount	$ 20	$ (20)
Issuance of common stock pursuant to private placement offering, shares	15,000,000
Issuance of common stock pursuant to private placement offering, amount	$ 80		$ 374,920				$ 375,000
Issuance of common stock pursuant to private placement offering, shares	2,500,000
Issuance of common stock pursuant to private placement offering, amount	$ 13		124,987				$ 125,000
Common stock returned to treasury, shares	(250,000)
Common stock returned to treasury, amount	$ (1)		(24,999)		$ 25,000
Issuance of common stock pursuant to private placement offering, shares	250,000
Issuance of common stock pursuant to private placement offering, amount	$ 1		24,999	$ (25,000)
Issuance of common stock pursuant to private placement offering, shares	1,250,000
Issuance of common stock pursuant to private placement offering, amount	$ 7		99,993				$ 100,000
Issuance of common stock pursuant to private placement offering, shares	312,500
Issuance of common stock pursuant to private placement offering, amount	$ 2		24,998				25,000
Issuance of common stock pursuant to private placement offering, shares	375,000
Issuance of common stock pursuant to private placement offering, amount	$ 2		29,998				30,000
Issuance of common stock pursuant to private placement offering, shares	625,000
Issuance of common stock pursuant to private placement offering, amount	$ 3		49,997				50,000
Issuance of common stock for services, shares	200,000
Issuance of common stock for services, amount	$ 1		13,999				14,000
Issuance of common stock pursuant to settle promissory note, shares	1,250,000
Issuance of common stock pursuant to settle promissory note, amount	$ 7		99,993				100,000
Issuance of common stock pursuant to private placement offering, shares	625,000
Issuance of common stock pursuant to private placement offering, amount	$ 3		24,997				25,000
Issuance of common stock for services and other value, shares	300,000
Issuance of common stock for services and other value, amount	$ 2		14,998				15,000
Issuance of units pursuant to private placement offering, shares	3,562,500
Issuance of units pursuant to private placement offering, amount	$ 19		142,481				142,500
Fair value of compensatory options issued			290,728				290,728
Contribution of services			8,780				8,780
Fair value of compensatory warrants issued			$ 25,000				25,000
Net loss for the period						$ (779,711)	(779,711)
Ending Balance, Shares at Sep. 30, 2015	206,502,433
Ending Balance, Amount at Sep. 30, 2015	$ 1,103		$ 26,777,414			$ (26,620,549)	$ 157,968

4. Accounts Receivable	9 Months Ended
4. Accounts Receivable	Sep. 30, 2015
Notes to Financial Statements [Abstract]
Accounts Receivable	Accounts receivable consists of refundable sales tax paid on purchases made in Canada.

6. Short-Term Loans (Details Narrative) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Notes to Financial Statements [Abstract]
Short-term loans	$ 0	$ 63,250